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ABSTRACT 
 
As our population ages, the proportion of frail elderly people requiring assisted 
accommodation in aged care facilities is increasing.  This population is at high risk of 
falls and fractures, which bring significant morbidity and mortality.  The prevalence 
of osteoporosis also increases with age, but there have been few studies of bone 
density in residents of hostels and nursing homes.  This thesis looked at the 
prevalence of osteoporosis and falls in elderly people in residential care, to define the 
size of the problem and identify risk factors for low bone density and falling, with 
particular reference to vitamin D levels. 
 
Two thousand and five men and women aged between 65 and 104 years were enrolled 
in the Falls and Fracture Risk in the Elderly Epidemiology (FREE) study between 
1999 and 2003.  The key findings from analysis of this population were firstly, that 
quantitative ultrasound (QUS) measures were higher in men than women independent 
of age, and that in men there was no significant decline in either BUA or VOS, but in 
women BUA declined by over 3% per decade and VOS by 1% per decade.  Both 
ultrasound machines used in the study were shown to be reliable, with precision 
unaffected by advanced age. QUS was found to be sensitive to longitudinal change 
even in this frail elderly cohort. 
 
Vitamin D deficiency was found in the majority of elderly aged care facility residents 
but supplementation conferred higher serum 25-OH-vitamin D levels.  Vitamin D 
levels were not shown to be related to BUA, VOS or the risk of falling in this 
vi 
population.  Serum parathyroid hormone might be important in determining future 
falls risk.   
 
In summary, the results of this thesis give an important insight into the prevalence of 
osteoporosis and falls in the frail elderly, and how these might be predicted.  Future 
study of prospective fracture rates in this group will then be able to assess relative risk 
factors for osteoporotic fracture, and identify those individuals who might benefit 
from directed fracture prevention strategies. 
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INTRODUCTION AND BACKGROUND 
 
 
2 
INTRODUCTION AND BACKGROUND 
 
1.1 Introduction 
Osteoporosis, a disease characterized by skeletal fragility and an ensuing increased 
risk of minimal trauma fracture, is a major public health problem which is growing as 
our population ages.  The direct costs alone of treating osteoporotic fracture in 
Australia have been estimated at $1.9 billion in 2001 (1).  Hip fractures are the most 
costly to treat and associated with a significant increase in mortality, but any 
osteoporotic fracture brings with it a significant morbidity and impairment of quality 
of life (2;3). 
 
The elderly have a high incidence of both involutional osteoporosis and of falling.  
The combination results in a population who are at particular risk of osteoporotic 
fracture.  The group who are likely to be at highest risk, those elderly individuals who 
are unable to live independently due to disease or frailty, have not been extensively 
studied to determine which factors in particular contribute to fracture risk.  The 
purpose of this thesis is to measure the incidence of both osteoporosis and falling in 
the frail institutionalized elderly, and describe potential predictors of osteoporotic 
fracture in this high risk group. 
 
3 
1.2 Assessment of Bone 
Bone is important as both a solid structure for support and movement, and a dynamic 
organ involved in calcium homeostasis.  Measurement of the both the strength and the 
activity of bone are important in health and disease.  Static measures of bone density 
are used in clinical practice as a surrogate for bone strength, due to the relative 
inaccessibility of bone in vivo.  Dynamic bone turnover can be quantified by 
measuring serum markers of bone turnover. 
 
1.2.1  Quantitative Assessment 
Bone mineral density (BMD) first became measurable in the 1960s with the 
introduction of single photon absorptiometry (SPA) (4).  Steady improvements in 
technology have seen the development of single x-ray absorptiometry (SXA), dual 
photon absorptiometry (DPA) and more recently dual-energy x-ray absorptiometry 
(DEXA), considered the gold-standard for BMD assessment.  Alongside 
absorptiometry techniques, other imaging modalities used in the assessment of 
osteoporosis include quantitative computed tomography (QCT) which can assess 
volumetric BMD, and quantitative ultrasound (QUS) of bone which is thought to 
incorporate connectivity and porosity in addition to pure density. 
 
1.2.1.1  Dual-energy X-ray Absorptiometry (DEXA) 
Dual-energy x-ray absorptiometry is the most commonly used technique for the 
assessment of osteoporosis.  Two incident beams at different energies are passed 
through a tissue from an x-ray source, and resultant photon attenuation is measured. 
Differential absorption and scattering of the incident photons in different tissues allow 
differentiation between bone and soft tissue.  The technique is used to measure areal 
4 
BMD in g/cm2, the integral mass of bone mineral with a standard chemical 
composition (hydroxyapatite) in the measurement region of interest (ROI) divided by 
the projected area (5). 
 
Early versions of this technique include single-energy x-ray absorptiometry (SXA), 
which used only one incident beam and thus required correction for the thickness of 
soft tissue in the ROI.  Single- and dual-energy photon absorptiometry (SPA, DPA) 
used a radionuclide source of photon emissions, which had a lower photon flux and 
larger diameter source, resulting in much longer scanning times, poorer image 
definition and poorer precision than DEXA today. 
 
Current precision errors for DEXA are quoted between 1 and 1.5%, and patient 
radiation is relatively low (10 μSV at the lumbar spine and 2 μSV at the hip) (6).  
Limitations of the technique include problems associated with incident beam 
hardening and the stability of the polyenergetic spectra, which can result in 
deterioration in measurement accuracy.  Variation in the soft tissue composition of the 
ROI can also impair accuracy.  As calculations are based on bone mineral being 
uniquely made up of hydroxyapatite (Ca10(PO4)6OH2), problems arise when this 
assumption is not met, for example with fluoride or more recently strontium therapy.  
The atomic number of strontium is 38, compared to 20 for calcium, and so when it is 
incorporated into the bone mineral a disproportionate rise in BMD is seen as 
measured by DEXA (7). 
 
A working party of the World Health Organization (WHO) has defined osteoporosis 
in postmenopausal women as a BMD more than 2.5 standard deviations below the 
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young normal mean BMD, (8;9) based on DEXA measurements at the hip.  This 
allows for comparison of fracture risk between different DEXA machines, and 
simplifies interpretation of scan results in this population.  There is some controversy 
as to whether this classification is generalizable across other populations (10) or 
different methods of BMD measurement (11); nevertheless the nomenclature has been 
widely accepted by the clinical community as the standard method for reporting 
imaging of osteoporosis. 
 
Dual-energy x-ray absorptiometry of the hip and spine has been well proven to predict 
osteoporotic fracture in post-menopausal women (12-14).  Measurement of other sites 
is less predictive and not used in clinical practice (15;16).  There are few studies of 
DEXA and fracture prediction in the very old.  A large prospective study of 7598 
independent women over the age of 75 years (17) showed an increase in the relative 
risk of hip fracture of 1.9 for each standard deviation decrease in BMD at the femoral 
neck.  There are no studies of DEXA and fracture in the institutionalized elderly; 
Chandler et al (18) showed that low BMD as measured by SXA at the radius is a 
significant independent risk factor for osteoporotic fracture, particularly in those who 
were transfer independent as opposed to transfer dependent. 
 
1.2.1.2  Quantitative Ultrasound (QUS) 
Quantitative ultrasound (QUS) is a more recently developed technique for assessing 
bone strength.  It uses non-ionizing ultrasound waves at a frequency of 0.1-1MHz 
which are passed through tissue by means of transducers.  As they pass, some of the 
energy is lost as the beam is attenuated causing a change in the resultant sound 
intensity measured at the receiving transducer.  Any sound waves will lose energy 
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exponentially with distance, and so the waves are measured in the logarithmic scaled 
decibels (dB) to allow a linear relationship between dB and distance travelled.  Bone 
ultrasound attenuation (BUA) is the measure of this energy loss across bone, and is 
given as dB/MHz.   The interface between air and soft tissue causes pronounced 
attenuation, and so in practice air needs to be removed from the ROI.  Early QUS 
machines used water baths to achieve this; dry systems use gel applied to the limb and 
transducers. 
 
Velocity of sound (VOS) is measured as the speed at which ultrasound waves traverse 
the tissue, in metres per second (m/s).  At the calcaneus, this is the average of the 
velocity across soft tissues and the velocity across bone, which in practice is similar to 
velocity across bone alone.  This is dependent on transducer separation. 
 
It is thought that QUS is more related to the so called ‘quality’ of the bone than just 
bone density, as measured by DEXA (19-22).  The more bony trabeculae present in a 
given area, the greater the scattering of sound waves, suggesting BUA is related to 
bone structure.  Velocity of sound also reflects the elastic modulus of the tissue.  
Whether these factors give an improved estimate of bone strength in clinical practice 
is not yet clear. 
 
Advantages of QUS over other methods of bone assessment include its portability, 
ease of use, low cost and absence of ionizing radiation.  This makes it an ideal tool for 
individuals who are less mobile, such as the institutionalized elderly.  Disadvantages 
lie in a slightly poorer precision than DEXA, error ranging from 1-5% for BUA and 
0.3-1.0% for VOS across different machines (23).  Collagen diseases such as Ehlers-
7 
Danlos syndrome and systemic sclerosis are thought to alter the relationship between 
bone density and ultrasound properties (24), which might limit the usefulness of the 
technique in certain disease states. 
 
There are a number of QUS machines in use both in research and in clinical practice 
today.  Most measure QUS at the calcaneus, as a surrogate for the clinically important 
vertebral bodies or neck of femur; the calcaneus is a weight bearing bone, has a high 
percentage of trabecular bone, and has a similar pattern of bone loss to the vertebral 
bodies.  Earlier water bath systems, including the Achilles+ (Lunar), UBA575 
(Walker Sonix) and DTU-one (Osteometer), have largely been superseded by more 
portable dry systems.  The CUBA Clinical (McCue) was the primary machine used to 
measure bone density in the following research, and correlates well with the Lunar 
Achilles+ machine (25)  Transducers are 19mm in diameter and spring-loaded to give 
constant pressure over the patient’s heel, and are silicone-capped to accommodate 
heels of different sizes and shapes.  It is easily portable at 10kg, and easy to operate.  
Calibration is by electronic and water-filled phantoms.  Measures of BUA and VOS 
are calculated.  Other dry systems in use include the Sahara (Hologic Inc.), which in 
addition to BUA and VOS calculates a quantitative ultrasound index (QUI), relating 
measures back to a young adult normal value of 100.  QUS is also used at other sites, 
including the proximal phalanges, the tibia (primarily measuring cortical bone) and 
multi-site machines including the Omnisense (Sunlight Ultrasound Technologies). 
 
The DEXA-derived T-score is not necessarily applicable for other methods of 
assessing bone strength.  When the principle of expressing raw data as standard 
deviations from the young normal mean is extended into QUS measurements, 
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classifying patients as being ‘osteoporotic’ with a T-score less than -2.5 results in 
vastly different proportions of disease as is seen with DEXA (11).  Faulkner et al 
showed that in 60 year old postmenopausal women, the prevalence of T-score-defined 
osteoporosis ranges from 3% when measured by QUS at the heel to 50% as measured 
by spinal QCT, suggesting that the use of WHO T-score thresholds to define fracture 
risk should be limited to the DEXA measures they were derived from. 
.   
Quantitative ultrasound of the calcaneus has been shown to predict fracture-defined 
(26;27) and DEXA-defined (28;29) osteoporosis.  A number of studies have shown 
that BUA is significantly higher in men than age-matched women (29-31), although 
this relationship is not seen as clearly with VOS (31).  A cross-sectional study of 
healthy Japanese shows lower rates of bone density loss as measured by QUS 
compared to DEXA (32), decreasing by 0.6% per year in both males and females over 
the age of 20.  In women, DEXA at the hip and spine was better than QUS at 
discriminating between subjects with and without vertebral fractures (33). 
 
Quantitative ultrasound has been well demonstrated to correlate with DEXA measures 
of BMD at the calcaneus (34;35).  It has also been to correlate well with BMD at the 
spine and hip (35-37), and is associated with similar risk factors for osteoporosis 
(38;39).  Normative data in different populations has confirmed that BUA and VOS 
decrease with age (40-42), although there were few individuals included over the age 
of 85 years.  The clinical importance of QUS however lies in its ability to predict 
osteoporotic fracture. 
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Case control and cross-sectional studies have shown that QUS of the calcaneus is able 
to differentiate between fractured and non-fractured populations in women (43-45) 
and in men (27;46).   The relationship exists for wrist (47;48), hip (49;50) and 
vertebral (51-53) fractures.   There are fewer prospective studies.  Huang et al (54) 
showed that low QUS was significantly associated with increased risk for hip, for 
non-spine and for any fracture in 590 post-menopausal healthy women over an 
average follow-up period of 2.7 years.   
 
The best prospective studies have been done in elderly populations, as there is a 
higher incidence of fracture allowing shorter follow-up periods.  A large prospective 
study of 5662 independently-living elderly French women, mean age 80.4 years (55), 
showed that both BUA and VOS were significantly associated with incident hip 
fractures over 2 years, independent of femoral neck BMD as measured by DEXA.  
Similar results were seen in a 2-year prospective study of 6189 healthy women over 
the age of 65 years in the United States (56).  QUS also appears useful in the frail 
elderly; Porter et al (57) showed in an elderly, institutionalised population that BUA 
was lower in those suffering hip fracture than those who did not fracture.  More 
recently, a study of 710 residents of nursing homes or apartments for the elderly (58) 
showed QUS to be significantly associated with the risk of incident hip fracture over 
one year follow-up. 
 
With good prospective evidence for the utility of QUS for predicting hip fracture in 
the institutionalized elderly, this portable and safe method of assessing fracture risk is 
ideal for studies such as the FREE study presented here. 
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1.2.1.3  Quantitative computed tomography (QCT) 
Conventional computed tomography techniques can also be used to quantify BMD 
using appropriate software.  The cross-sectional tomographic image allows a true 
volumetric BMD to be calculated in g/cm3, as opposed to the areal value given by 
DEXA, giving a conceptually more meaningful density measure.  The technique has 
the highest diagnostic sensitivity of available assessment methods for disease and age-
related bone loss (59), and has been shown to be an independent predictor of 
prevalent vertebral fracture in cross-sectional studies (60).   However relatively high 
patient exposure to radiation (6), a precision error at the lumbar spine of 2-4% (5) and 
high installation and running costs prohibit the use of QCT clinically.  Peripheral 
QCT of the wrist is still used frequently in research, as radiation is much lower, it 
selectively measures trabecular bone and allows visualization of the bone micro-
architecture. 
 
1.2.2  Biochemical markers 
Bone is a living tissue, which is constantly modeling and remodeling both to 
maximize its function as a supportive structure and to contribute to calcium 
homeostasis.  Biochemical measures of calcium metabolism are generally normal in 
osteopenia and osteoporosis, available assays being not sufficiently sensitive to detect 
the small changes which may theoretically be present.  Serum calcium, phosphate and 
intact parathyroid hormone must nevertheless be measured in osteoporosis to exclude 
the presence of other disease states which may be impacting on bone, such as 
hyperparathyroidism, myeloma, metastatic disease, malnutrition, osteomalacia or 
phosphate wasting diseases.  Vitamin D levels are the exception; as well as indicating 
malabsorption, nutritional deficiency and osteomalacia, 25-OH-vitamin D is 
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important to incorporate calcium into the bone matrix.  Hypovitaminosis D leads to 
loss of bone mineral and osteoporosis. 
 
Bone formation and resorption markers, shown in Table 1.1, give a picture of what is 
happening in bone at the cellular level.  
 
Table 1.1:  Markers of bone turnover 
Bone Formation Markers (serum) 
Bone-specific alkaline phosphatase (bALP) Osteoblast membrane enzyme 
Osteocalcin (OC) Bone matrix protein 
Collagen type 1 propeptides (pro-N, pro-C) Collagen precursors 
 
Bone Resorption Markers (serum and urine) 
Collagen cross-links:  
        Total or free pyridinolines (Pyr, Dpy) 
        Telopeptides (NTx, CTx) 
Collagen breakdown products 
Hydroxyproline, Hydroxylysine glycosides Collagen breakdown products 
Tartrate-resistant acid phosphatase (TRAP) Osteoclast enzyme 
 
Alkaline phosphatase (ALP) is a cell membrane-associated enzyme expressed by 
liver, bone, kidney and placenta.  The bone-specific isoenzyme (bALP) forms 
approximately 40% of the total serum ALP, and is derived from osteoblasts and 
osteoblast precursors.  Immunoassays are specific, with an intra-individual coefficient 
of variance (CV) of less than 10%.  There remains a small cross-reactivity with other 
isoforms of ALP (liver, placenta and intestine). 
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Osteocalcin is a polypeptide expressed by osteoblasts as they actively deposit bone, 
and is under 1,25-OH-vitamin D control.  Serum levels represent a spillover of 
osteoblastic synthetic activity.  It is measured by immunoassay. 
 
The most commonly measured markers of bone resorption are the collagen cross-
links.  These are formed in fibrils, and have no means of metabolism once collagen is 
degraded and so can be measured unaltered in the urine by high-performance liquid 
chromatography (HPLC).  The two forms are pyridinoline (Pyr) and 
deoxypyridinoline (Dpy).  As bone is the largest reservoir for type 1 collagen in the 
body and turns over more rapidly than other sources, the majority of the cross-links 
found in the urine are from bone.  There is a higher proportion of Dpy in bone than in 
other tissues, making it logically more specific for bone degradation. 
 
Collagen telopeptide assays are also useful, targeting the two intermolecular sites of 
Pyr cross-linking in type 1 collagen:  amino-terminal (NTx) and carboxy-terminal 
(CTx) telopeptides.  The remaining markers listed in Table 1 will not be discussed, as 
they are less bone specific and their role in research and clinical practice is less well 
defined (61). 
 
There is some biological variation in bone turnover markers.  There is a distinct 
circadian rhythm, with levels being lowest in the morning.  There are seasonal 
differences, which may be related to seasonal variation in 25-OH-vitamin D levels.  
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Changes in bone markers are strongly associated with BMD changes (62-66).  A 
relationship to fracture is also emerging.  Garnero et al (67) showed in the large 
EPIDOS study that elevated CTx and free Dpy levels were associated with a doubling 
in the risk of hip fracture, but formation markers bALP and OC were not predictive of 
fracture.  Vertebral fracture has also been associated with higher bone turnover 
markers (CTx and OC) (68).  It has been suggested that markers should be interpreted 
in conjunction with BMD measures rather than in isolation (69), and although bone 
turnover markers are at present largely a research tool, there may be a role for their 
use in clinical practice (70). 
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1.3 Bone and Gender 
It is interesting that in most walks of life society is pushing toward gender equality, in 
the workplace, in opportunity and in basic human rights.  However, when it comes to 
bone disease, osteoporosis in men and women is often treated as the same disease 
entity, with the same outcomes and many of the same treatment options.  The WHO 
guidelines for grading osteoporosis are based on normative data from women; there 
are no corresponding well validated measurement scales for men.  Gender differences 
are evident in bone acquisition in childhood, growth and morphometry, peak bone 
mass, bone loss with age and fracture rates, and so bone disease in the two sexes must 
be considered in light of these differences.   
 
1.3.1   Bone in childhood 
In infancy (age 0 – 18 months), absolute bone mineral content (BMC) has been shown 
to be the same in males and females (71), but once weight and age are taken into 
account, males have statistically higher bone mineral density (BMD) and BMC 
(p=0.02).   Total body BMC has also been shown to be significantly higher in pre-
pubertal males than females (72).  Nguyen et al measured BMD and BMC in 94 males 
and 92 females ranging in age from 6 to 36 years, and found no difference between 
measures at any site before puberty (73).  A Tasmanian cohort of 8-year-old children 
observed boys to have significantly higher hip BMD, and girls higher lumbar spine 
BMD, once body size had been taken into account (74).  At puberty, girls had higher 
BMD measures at the pelvis, and higher BMD and BMC at the lumbar spine.  After 
puberty, males generally had higher measures at all sites than their age-matched 
counterparts (73;75).  Rates of BMD increase at the lumbar spine are fastest in early 
childhood (age 0-3 years) and  adolescence (76).  Changes in cortical bone BMD and 
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BMC at the radius show a similar relationship to age and sexual development with 
females reaching their maximum rate of bone increase earlier than males, generally 
within 12 months of the onset of menarche (77;78).  By the age of 17, females had 
reached 93% of their expected peak BMC and BMD, whereas males had reached 86% 
(77;79).  Proximal radius BMD measures in a group of 362 children and young adults 
aged 6 – 23 years by QCT showed no gender differences pre-puberty (78), but after 
reaching Tanner stage 3 of development, girls had higher BMD at this site.   
 
Peak bone mass, measured both by DEXA and QUS, have been shown to have a 
strong genetic influence (80), which is independent of gender.  Nevertheless, 
environmental factors still play a major role in determining both peak bone mass in 
humans and subsequent bone loss with age.  Bone acquisition in 8-year-old boys has 
been shown to be related to participation in sports and muscle strength, whereas in 8-
year-old girls BMD is related to winter sunlight exposure (74).  An interventional 
study of physical activity in 12-16 year old children confirmed a beneficial effect on 
BMC, areal and volumetric BMD at the femoral neck in boys but not in girls (81).  
Retrospective studies of exercise in older age groups confirm an effect of moderate to 
high physical activity on bone density at the lumbar spine and femoral neck in men 
(82;83). 
 
1.3.2   Age-related changes in bone 
From such a gender-defined baseline, BMD measured at the hip is subsequently seen 
to decrease with age in both men and women (84-86).  Cross-sectional data suggests a 
small bone density loss at the hip in pre-menopausal women, and higher rates of loss 
in women after the menopause and in men (86).  When this cohort was re-examined 2 
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years later, again a low rate of BMD loss was seen in pre-menopausal women, which 
tripled at the menopause before decreasing to pre-menopausal rates in the elderly.  In 
men, the longitudinal study showed a small constant BMD loss at the hip with age 
(86). 
 
BMD changes differently dependent on the site of measurement (87).  The picture is 
not so straightforward at the spine, with BMD showing little change with age in men 
in cross-sectional or longitudinal studies (86;88), probably due to osteoarthritis.  Bone 
mineral density changes in women closely followed those described at the hip in one 
study (86), decreasing to zero (no significant change) in the elderly, whereas Krall et 
al (89) showed both sexes to increase BMD at the lumbar spine after the age of 65.  
Relatively few studies have compared the loss of cancellous bone 
histomorphometrically with age between genders (90).  Age-related changes in micro-
architecture, as seen in iliac crest biopsies, include thinning of the trabeculae in men 
more so than women, and loss of trabecular connectivity more marked in women (91-
94).   
 
Cortical bone changes with age, as measured at the radius with QCT, suggest the 
BMD remains stable in women aged 22-40 years, then declines slowly with a more 
rapid drop around the age of 55 years (95).  Males show a higher peak BMD which 
occurs in the 20s, then a rapid decline until the gender difference disappears by the 
age of approximately 60 years.  A large, population-based study in Tromsø, Norway 
(96) looked at BMD at the distal and ultra-distal radius in 3062 men and 4558 women 
using single-energy x-ray absorptiometry.  Bone mineral density decreased by 0.1% 
per 1 year age increase in both sexes.  Over the age of 50, the rate of BMD loss in 
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males increased to 0.6% per year, and by a greater extent to 1.3%-1.5% in females. 
There is little available data on the changes in bone density in the very old. 
 
Cross-sectional studies show that QUS parameters decrease with increasing age (97-
104), although changes in the frail elderly with age have not been as extensively 
documented (57).  Longitudinal age-related bone changes over one year can be 
detectable by VOS and stiffness (101) but the decrease seen in BUA did not reach 
statistical significance.  Such longitudinal studies must be interpreted in light of the 
precision of the instrument used.  Schott et al (105) measured QUS in 88 healthy post-
menopausal women at baseline and again after 2 years.  The study showed a small, 
statistically significant decrease in all parameters, but the decrease in BUA 
approximated the long-term reproducibility precision error for BUA.  Velocity of 
sound and stiffness performed better, decreasing by 0.8% and 1.85% respectively over 
2 years, at 2.5 to 5 times their precision errors.   Studies using QUS to assess bone 
after treatment for osteoporosis have shown the instrument to be sensitive to change 
over 2 to 4 years (106-110) but requires a longer time period for sequential measures 
than DEXA due to higher precision error. 
 
1.3.3   Anatomy and bone strength 
It would be nonsensical to assume that bone size is the same between genders.  Males 
have wider bones, seen as a larger cross-sectional area for matched vertebral bodies 
(111-113), independent of body size (114).  This becomes important when the forces 
imposed on the vertebral bodies are considered; being in general taller and heavier, 
males impose greater forces on any one vertebral body compared to females.  
However, the greater male vertebral cross-sectional area results in the load per unit 
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area being similar between males and females as young adults (112).  As the skeleton 
ages, the increase in vertebral cross-sectional area due to periosteal bone growth is 
more marked in males, whereas age-related endosteal resorption of bone is more 
marked in women (111;115).  This differential change leads to female vertebral 
bodies supporting a greater relative stress on a smaller relative area of bone (116).   
 
Volumetric BMD measures allow comparison of bone density between genders 
allowing for skeletal size.  A recent study of opposite-sex twins confirmed that there 
are only small bone density differences between the sexes (117) measured at the L3 
vertebra, femoral neck and distal third of the radius, when bone volume, age, genetic 
and environmental effects are taken into account.  Ebbesen et al (118) examined the 
L3 vertebral body in 51 female and 50 male cadavers, aged from 18-96, and found 
that although BMD as measured by DEXA and QCT did not vary in absolute value or 
rate of decline with age between the sexes, the ash weight of L3 (vertebral body bone 
mass), vertebral body volume and cross-sectional area were significantly lower in 
females at any age.  Vertebral compressive strength decreased at twice the rate of 
BMD with age.  There was no significant gender difference detected in maximal 
compressive stress (defined as load divided by cross-sectional area), however no 
corrections were made for body size. 
 
Duan et al (112) use the term ‘Fracture Risk Index (FRI)’ to quantify the ratio of 
vertebral body compression load to vertebral body strength, with unity (or less) 
equating to appropriate biomechanics.  Using this definition, they found male FRI 
increased by 21% with ageing, in contrast to 102% in women, and 9% of elderly men 
compared to 26% of older women had an FRI greater than unity.  This is further 
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supported by the cadaveric study by Oyster et al (119), who measured vertebral body 
and phalangeal strength as the force required to crush the bone.  It was shown that a 
significantly higher force was required to fracture the vertebral bodies of men despite 
no differences in vertebral BMD (measured by DEXA) by gender.  Cortical bone was 
also stronger in men, with twice the force required for fracture than the age-matched 
female counterparts. 
 
Hip geometry is related to the risk of hip fracture independent of BMD (120;121).  
The large European Prospective Osteoporosis Study (EPOS) (122) describes the 
epidemiology of the different measures of hip strength in Europeans over the age of 
50 years.  A subset of 1617 individuals underwent femoral DEXA, and scans were 
analyzed for both bone density and geometry.  Men have higher cross-sectional 
moment of inertia (CSMI) and femoral neck cross-sectional area compared to women, 
but lower compressive and tensile strength measures which together indicate stronger 
bone.    After adjusting for age, weight and height, males required higher forces at the 
femoral neck to sustain a fracture.   
 
Other physical attributes of bone have been examined to explain the gender 
differences in fracture rates.  Elastic modulus and hardness of the extra-cellular matrix 
are not different between genders (123).  Macintyre et al (124) examined the non-
dominant radius of 57 males and 88 females, and reported males to have higher 
connectivity index, lower mean hole size and higher BMD, all reaching statistically 
significance.  The connectivity index decreased with age in both genders, but the rate 
of change was higher in females (p<0.001).  An age-related increase in hole size 
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reached statistical significance in women but not men.  All of these differences 
support an increased fragility in female bones when compared to men. 
 
1.3.4   Bone turnover 
Serum levels of bone-related alkaline phosphatase (bALP), N-terminal osteocalcin 
(OC), and C-terminal type 1 collagen products are tools used primarily in research to 
assess bone turnover.  A cross-sectional study of 20-40 year old men and women (75) 
showed serum bALP, OC, Dpy and urinary NTx to be statistically higher in males, 
however all significant differences were lost after correcting for total body BMC, 
suggesting that bone size is important to consider when assessing gender differences 
in bone markers in young adults.  In females, markers are seen to increase with age 
after the 4th decade, and more sharply after the 6th decade, corresponding to 
menopause (125-129), whereas in males most markers are seen to decrease.  Thus 
bone loss in females is related to a biochemical increase in bone turnover, whereas in 
men the opposite would seem to be true (127).  Parathyroid hormone, important in 
maintaining calcium homeostasis and acting directly on bone, increases with age but 
has no differential gender effects (130).   
 
1.3.5  Associations with BMD 
Bone mineral content and BMD of the calcaneus, measured by a 125I photon 
absorption method, were significantly higher in men than women (131), but similar 
relationships are seen with smoking, body mass and early physical activity.  Body 
mass index and weight are associated with BMD at all sites in women, but only at 
weight bearing sites in men (132-134).  Lower fat content is related to lower BMD at 
the femoral neck in women (135;136), although being moderately overweight is seen 
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to be associated with a higher femoral neck BMD in both genders (133).  Lean muscle 
mass is associated with BMD and total body BMC throughout life, similarly in 
prepubescent males and females, but more important in females after menarche; 
Ferretti et al (137) showed women to have higher BMD for a given lean body mass.  
Ratios of total BMC to lean body mass tended to equalize between genders after the 
menopause.  In Japanese subjects, lean body mass is more highly correlated with 
BMC as measured by DEXA in males, whereas the correlation between BMC and fat 
content is more marked in females (138) 
 
1.3.6   Fractures 
Knowing that female bones are smaller, less dense and more fragile, it is hardly 
surprising that age-adjusted incidence of any limb fracture is almost 3 times greater in 
women (139;140) than men.  The incidence of most fractures increases with age in 
men, except for forearm fractures.  Sanders et al (140) found fracture rates were 
highest for hip, then spine, distal forearm and humerus in decreasing order, similarly 
in men and women.  Overall, fracture incidence was 3-4 times higher in women.  In 
the age group 35-55 years, incidence was 65/10,000 person years in women, and 
35/10,000 person years in men, and increased significantly with age independent of 
gender.  Hip fracture rates in Oslo over 50 years were 118/10,000 person years in 
women and 44/10,000 person years in men (141).  A large cross-sectional study 
showed vertebral fractures to be more common in men than women aged 50-59 years, 
but a slower increase in incidence is seen with age in men and by over 80 years, 
females predominate (142).  This study however had some methodological 
inconsistencies in fracture ascertainment, the reporting of some traumatic fractures or 
osteoarthritic change as osteoporotic fracture introducing a spuriously large vertebral 
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fracture incidence in men.  A large 2 year prospective study of 7428 men and 7865 
women showed the incidence of any fracture in men aged 15-49 was 2.3 times that in 
women (143), whereas over 60 years of age women had 2.3 times the number of 
fractures as men.  Peak fracture rates in men occurred in young adult males, the 
elderly of both genders, and in 40 year old women, particularly with respect to wrist 
fracture.  Mortality after fracture is also higher in men (144;145). 
 
Just as there are differential risk factors for BMD between sexes, there are also 
differences in fracture associations.  BMD is an important risk for vertebral fracture in 
both sexes (146), however a case-control study of individuals with vertebral fracture 
did not reveal a significant difference in vertebral body morphometry between men 
and women (146).  Men have been shown to have a higher prevalence of 
morphometric vertebral fracture (147), but they fracture at a higher BMD than 
women, such that at any given spinal BMD, men are 3 times more likely to have 
morphometric fracture.  Men also show a higher risk of multiple (>2) vertebral 
fractures (148) than women.  These observed differences are likely to be in part due to 
the higher incidence of old traumatic fractures in men.  Selby et al (149) replicated 
this gender difference in BMD fracture threshold, with a 50% risk in fracture 
occurring at a significantly higher BMD in men (0.908 g/cm3) than women (0.844 
g/cm3) (150).  Heavy exercise has been shown to be related to vertebral fracture in 
men alone, OR 1.5-1.7 (151), but again there is some question of whether the crush 
fractures recorded were indeed true osteoporotic fractures or the result of earlier 
trauma, which might have resulted from such heavy exercise. 
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A cross-sectional study comparing individuals with hip fracture to age-matched 
controls confirms that men with hip fracture have significantly lower BMD at the 
femoral neck than their male non-fractured counterparts (152), and women with 
fracture have significantly less cancellous bone at the fracture site, less cortical bone 
at impact and significantly larger proximal femur dimensions than female controls.  
The large Mediterranean Osteoporosis Study (MEDOS) (151;153;154) looked at 
gender differences in hip fracture and quantified the contribution of various risk 
factors to this difference.  Five percent of the gender difference was attributable to sun 
exposure, 3% to past history of fracture, 4% to body mass index (BMI), 4% to work-
related exercise and 14% to recreational exercise.  The effect of calcium did not show 
a gender predisposition.  The effect of alcohol consumption also shows a gender bias, 
with a smaller ethanol intake being related to hip fracture risk in women than in men 
(155).  In women, 14 – 27 alcoholic beverages per week inferred a relative risk (RR) 
of hip fracture of 1.44 (1.03-2.03), whereas in men the risk of hip fracture increases at 
an alcohol intake of over 28 drinks per week, RR 1.75 (1.06-2.89).  Current smoking 
is associated with an increase in the risk of hip fracture in women only, but a 
significant interaction is not seen between smoking and gender (156).  After 5 years, 
male ex-smokers show a 25% reduction in fracture risk compared to their smoking 
counterparts, but this protective effect of smoking cessation is not seen in women.   
 
Genetic influences on hip fracture risk are similar in men and women (157;158).  
Peak height in women and magnitude of height loss with age in men are independent 
predictors for hip fracture (151).  Bone morphometry does not contribute significantly 
to the difference in risk of hip fracture between the sexes (159). 
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Similar to other sites, distal forearm fracture is more common in women.  Population-
based studies have found an incidence of 18 wrist fractures per 10,000/year in women 
aged over 35 years, compared to 7/10,000/year in men (140); a similar discrepancy is 
seen in an older cohort of Europeans (incidence 7.3/1000 patient years in women, 
1.7/1000 patient years in men) (139).  Forearm fracture increases progressively with 
age in women in this group (139;160-162), whereas the incidence of wrist fracture in 
men does not increase until a much older age (161-163).  History of diabetes mellitus 
(odds ratio (OR) 0.34, 95% confidence interval (CI) 0.15-0.75) and a history of prior 
osteoporotic fracture (OR 2.72, 95% CI 1.20 – 6.19) were independently associated 
with fracture risk in women but not men (164).   
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1.4   Falls in the Elderly 
Falling and the subsequent problems of injury, loss of mobility and loss of 
independence is a significant public health issue in the elderly.  One in every three to 
four people over the age of 65 years and up to two-fifths of those over 80 will 
experience a fall in the next year (165-167), and many will suffer multiple falls.  
Falling in the community significantly increases the risk of requiring institutionalized 
care (168).  Physiological changes of aging including loss of muscle bulk and strength 
(169), deteriorating peripheral sensation (169), balance (169;170) and vision 
(169;171) combine with disease states, drug-related effects and environmental hazards 
to impede stable posture and gait.  Risk factors for falling in independent-living 
elderly people have been well characterized (Table 1.2).  Intuitively, it is likely that 
the institutionalized elderly are at an even higher risk of falling due to poorer general 
health, increased frailty and increased age. 
 
Rates of falling in institutions for elderly care are significantly higher than amongst 
community-dwelling elders (167).  An early review of falls literature in nursing 
homes (172) revealed an overall mean incidence of falls of 1.5 falls per bed per year 
(range, 0.2 to 3.6).  Studies of falls risks in the institutionalized elderly largely 
identify the same factors as those identified in their community-based compatriots, in 
addition to risks peculiar to institutionalized care.   
 
Fall history remains the strongest risk factor for falling (173), those residents who 
have previously fallen having more than 3 times the risk for subsequent falls.  The 
very old (aged over 87 years) are significantly more likely to fall than their younger 
counterparts. 
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         Table 1.2: Risk factors for falling in community-dwelling elderly persons. 
 
 
                         Demographic Factors: 
Advanced age (166;174) 
History of previous falls (174-179) 
Limitations in activities of daily living (180) 
  Balance and Mobility: 
Poor standing balance (177;178;181-183),  
Impaired gait and mobility (175;184) 
  Sensory and Neuromuscular Factors: 
Altered proprioception (185)  
Altered muscle strength (178;179;182;185) 
Vision problems (acuity, depth perception) (171;184) 
Poor reaction time (169) 
  Medical Factors: 
Parkinson’s Disease (175) 
Arthritis (175) 
Cognitive function (177;186)  
 Foot problems (177) 
 Depression (187;188) 
  Stroke (166;167) 
   Urinary incontinence (189;190) 
  Medications: 
Central nervous system-acting (177;191;192) 
Cardiac drugs (193) 
Analgesics (193) 
Use of four or more medications (194;195) 
Environmental factors: 
  Home hazards (196;197) 
  Use of walking aids (177) 
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Muscle strength, in particular lower limb strength, is important for postural stability.  
Most studies in nursing homes have assessed qualitative muscle strength and its 
relationship with falls.  A case-control study of two distinct populations of elderly 
people found fallers had poorer lower limb strength than non-fallers (167).  'Weak hip 
strength', assessed on physical examination (not described further), was associated 
with being a faller in nursing home residents, mean age 88 years (OR 8.36, 95% 
confidence interval 2.71-25.79) and in community dwelling elders, mean age 69 years 
(OR 10.33, 95% confidence interval 2.64-40.36).  'Weak knee strength' was only 
significantly associated with falling in the community (OR 9.90, 95% confidence 
interval 2.03-48.44).  Tinetti et al. (198) evaluated muscle strength by standard 
physical examination in 79 nursing home residents, and then followed the group 
prospectively for 3 months.  Reduced muscle strength was recorded as 'decreased 
knee strength' or 'decreased lower extremity strength’, but not quantified.  The 
primary outcome measure was 'multiple (2 or more) falls'.   Recurrent fallers were 
more likely to have reduced muscle strength in either category, compared to residents 
who fell once or not at all (p<0.0005). 
 
 Quantitative measures of quadriceps strength were used in a prospective cohort study 
comparing falling and muscle strength between ambulatory residents of aged care 
facilities in Japan and the United States (199).  Strength was measured as maximum 
kilograms lifted at the ankle for a single knee extension, and the average measure for 
each quadriceps used for calculations.  There was a four-fold higher fall incidence in 
the US compared to the Japanese group.  Within the US cohort, increasing muscle 
strength was shown to be related to lower risk of falling (p=0.04), and in both cohorts 
the most falls occurred in residents within the lowest quartile of muscle strength.  This 
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study adds quantitative evidence to the observation that reduced quadriceps muscle 
strength contributes to the risk of falling in the elderly. 
 
Of recent interest has been the role of vitamin D, parathyroid hormone (PTH) and 
calcium homeostasis in balance, muscle strength and falls.  It is known that vitamin D 
deficiency brings with it muscle weakness and abnormal gait (200-202) but most 
studies of the effect of vitamin D on muscle do not consider associated PTH status.  It 
has been suggested that PTH itself has an effect on muscle strength, with muscle 
weakness and fatigue being a feature of primary hyperparathyroidism (203;204), and 
improvements being seen in patients after treatment (205-207).  A study of the effect 
of both vitamin D and PTH levels and their relation to falls in long-term care facilities 
for the aged addressed this issue (208).  Eighty-three hostel residents were recruited.  
Vitamin D levels were universally low (median 25-hydroxyvitamin D level was 27 
mnol/L, interquartile range 18-37 nmol/L), and inversely related to PTH levels.  
Fallers (ascertained retrospectively, but after biochemical analysis) had a significantly 
lower 25-OH-vitamin D and higher PTH level than non-fallers.  Logistic regression 
showed PTH levels to be predictive of having a history of falls, but 25-OH-vitamin D 
levels became non-significant.  This was the first study to link PTH and falling, but 
was limited by small numbers and a retrospective study design.  
 
Anti-depressant use in nursing home patients has been shown to be associated with a 
higher risk of falling (209-212) which is not dependent on the type of anti-depressant 
therapy (tricyclic anti-depressants, selective serotonin-reuptake inhibitors or 
trazodone) (213).  This large retrospective study by Thapa et al. reviewed 2428 
nursing home residents in Tennessee between 1993 and 1996 and identified new users 
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of each of the three anti-depressant types at inception.  These residents and a group of 
randomly-selected non-user controls were then followed for a variable period of time, 
until leaving that institution or ceasing medication for 14 days, whichever occurred 
first.  Falls were recorded as the primary outcome, and a total of 3524 falls were 
experienced over 1460 person-years of follow-up.  Adjusted rate ratio for tricyclic 
anti-depressant use compared to no anti-depressant was 2.0 (95% confidence interval 
1.8-2.2), for SSRI use was 1.8 (1.6-2.0) and for the triazolopyridine derivative 
trazodone 1.2 (1.0-1.4).  The higher fall rates persisted through the first 180 days of 
drug therapy.  The half-life of benzodiazepines had an impact on falls risk within this 
cohort (214), drugs with a longer elimination half-life (>= 24 hours) incurring a 
higher risk of falling, adjusted rate ratio 1.73 (95% confidence interval 1.40-2.14) 
compared to 1.12 (0.94-1.40) for drugs with a half life <12 hours.  Shorter half-life 
drugs did however bring an increased risk of nocturnal falls, consistent with their peak 
period of action, adjusted rate ratio 2.82 (2.02-3.94).  There is no conclusive evidence 
of a different effect of oxidative versus non-oxidative benzodiazepines on femoral 
fracture rate (215). 
 
The same group identified the different range of falls risk factors between those 
residents who were able to ambulate independently and those who are non-
ambulatory (216).  Male residents who were not able to transfer independently were 
twice as likely to sustain an injurious fall, and those residents within the non-
ambulatory group who were more mobile had a higher risk of falling.  In contrast, the 
ambulatory group showed a strong association between the use of psychotropic agents 
and falls, and female residents were twice as likely to fall as their male counterparts.  
Nevertheless, residents who were able to transfer independently remain at a higher 
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risk of falling than the less mobile (173), odds ratio 1.64 (95% confidence interval 
1.52-1.75). 
 
It is not clear if the increased risk of falling in males seen in some studies is a real 
effect (217), with the only well-controlled study of proposed gender differences 
showing similar falls rates (218).  Lord et al. (219) showed that community-dwelling 
men perform better than women at tests of muscle strength, visual field dependence, 
body sway and dynamic balance, all of which could be considered protective against 
falling.  Campbell et al. (178) showed there were different risk factors for falling 
between the genders, men with stroke, arthritis, impaired gait or greater body sway 
being at high risk of falling, while women are at higher risk if they are on 
polypharmacy, psychotropic drugs, have muscle weakness or low systolic blood 
pressure.   It may be that the differential distribution of risk factors does not enable 
reliable comparisons to be made. 
 
The use of physical restraints in nursing home residents has been a widespread 
practice in the past, until it was discovered that their use was associated with a higher 
occurrence of fall-related injury (220).   An increased rate of falls and recurrent falls 
with the use of physical restraints has been described in confused elderly nursing 
home residents (221;222).  An interventional study looking at the effect of a restraint 
reduction program found that non-serious falls were higher after implementation of 
the program, but there was no significant effect on injurious falls (221).  More 
recently, a large 2 year prospective study of education for restraint reduction in the 
nursing home environment has shown a 90% reduction in the use of physical restraint 
31 
use brought with it a significant decrease in the number of moderate and serious 
injuries, rate ratio 1.58 (p=0.003) (223).   
 
So is there a difference between a non-serious fall and a fall that causes injury?  
Tinetti (224) suggests this is the case, finding in a study of 79 nursing home residents 
with chronic disabilities that injured fallers were over three times more likely to have 
bilateral lower extremity weakness, were more independent in ambulation and fell 
less often than uninjured fallers.  In a study of risk factors for falling in the 
community, Lord et al. (225) showed multiple fallers to have weaker quadriceps 
muscles, poorer tactile sensation, more dependence on visual fields and higher body 
sway.  More research needs to be done to define types of fallers, and who are at the 
higher risk of injury; this will be addressed further in Section 1.6.  Vitamin D 
replacement alone has not been shown to have a significant effect on the risk of 
falling (226;227), with the exception of one study of 86 community-dwelling 
Japanese elders suffering from Parkinson’s disease (228).  Even in this group, there 
was a reduction in falls resulting in fracture, but not a significant reduction in falls 
overall.   Two randomized controlled trials have looked at the effect of vitamin D 
replacement in conjunction with calcium supplementation.  Dawson-Hughes et al. 
(229) reported no effect on any fall parameters with 500mg of elemental calcium and 
700IU of vitamin D over 3 years compared to placebo in independently living older 
people; a more recent short-term randomized controlled trial (230) in long-stay 
geriatric care however has shown a beneficial effect on of 1200mg of calcium and 
800IU of vitamin D the total number of falls over 12 weeks, compared to calcium 
supplementation alone.  It is interesting to note that the institutionalized group was 
largely vitamin D deficient, 50% of all participants being profoundly deficient and 
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90% with 25-OH-vitamin D levels below 30 ng/ml (lower limit of normal).  This is 
not surprising as the group was frail, elderly and relatively immobile with reduced 
exposure to sunlight.  Baseline 25-OH-vitamin D levels in the independently-living 
study were within the normal range.  Taken together, these studies would suggest that 
the effect of vitamin D supplementation on falling is dependent on the recipients 
being deficient in vitamin D to be significant. 
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1.5   Fractures in the Elderly 
Osteoporotic fracture is well recognized as an increasing public health problem, 
conferring significant cost both to the individual and the community.  The problem is 
only growing larger as the population ages, due to the increased incidence of fracture 
with increasing age (231): 50-60% of all women over the age of 65 are predicted to 
have a fragility fracture in their lifetime, and up to one third of men (232). 
 
Over the age of 60, women fracture about 2.3 times as often as men, with the 
incidence of all fracture types increasing with age for both genders (143).  Hip 
fracture incidence for women aged 85-89 years is 2.8%, and for men in this age group 
1.4%.  Vertebral fracture is under-reported, but prospective studies using radiological 
fracture as the outcome estimate the incidence to be 1.1% in women and 0.6% in men 
(233).  Using data from the EVOS study (234), the prevalence of morphometric 
vertebral deformity ranges from 7.3% to 19.2% in men, and 3.5% to 16.6% in women 
depending on the stringency of the criteria used in reading the films.   
 
Nursing home residents are not immune to sustaining fractures, with an incidence of 
hip fracture in institutionalized care of 1.9% (235), and a 7.8% incidence of any 
fracture (236), translating into 30% of all admissions to hospital for hip fracture (237). 
 
There are multiple documented risk factors for sustaining a fracture in the elderly 
population, including medications (238),  body mass (239-241) and loss of weight 
(242), falls (243) and low bone mineral density measured by DEXA (14;17;244;245) 
or by QUS (18;55;56;246), but few studies compare the relative contributions of these 
factors. 
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The burden of disease is seen as increased morbidity and mortality at an individual 
level, and increased health resource utilization and health expenditure on a population 
level.  There is significant morbidity associated with vertebral fracture (247), causing 
pain and disability.  Hip fracture increases the risk of subsequent fracture (248) and of 
requiring institutionalized care (237).  It frequently results in loss of mobility and 
independence; even those individuals who return to living in the community have 
significantly impaired mobility and self-reported quality of life (249).  A time trade-
off study of the utility associated with hip fracture revealed that maintaining 
independence in daily life was of utmost importance to elderly women (250), and the 
loss of this independence was perceived to impact greatly on quality of life.  Even 
wrist fracture has been shown to have an associated loss of physical function (251) 
Both vertebral (144;252-254) and hip fracture (144;237) are associated with a 
significant increase in mortality.  The hazards ratio for 10-year mortality is 2.3-2.4 in 
both women and men with prevalent vertebral fracture (253).  Mortality following hip 
fracture is much higher, ranging from 25 to 30% in the first year (255). 
 
Loss of independence also contributes to the community costs of osteoporotic 
fracture.  A one-year longitudinal study of the costs arising from hip fracture in 
Canada showed that the mean 1-year cost of hip fracture for an individual who is 
transferred or readmitted to institutionalized care is over double that of a patient who 
returns to independent living (256), acute hospitalization costs only contributing to 
27% of the overall incurred costs.  Vertebral fracture is associated with significant 
hospitalization costs, estimated to account for over 400,000 bed-days and US$500 
million over one year (257). 
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Thus with a high incidence of fracture in the frail elderly translating into significant 
morbidity, mortality and health-related expenses, it is important that those at highest 
risk can be identified to allow cost-effective, directed interventions.   
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STUDY DESIGN AND DESCRIPTION OF  
ELDERLY POPULATION 
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2.1   Aims  
The Fracture Risk Epidemiology in the Elderly (FREE) study was designed to test the 
following hypotheses: 
1:   That quantitative ultrasound (QUS) parameters combined with clinical risk factors     
      for osteoporosis and for falling are useful tools to predict osteoporotic fractures in  
      a high risk population, the frail older person. 
2:   That vitamin D deficiency contributes to hip fracture risk through an increased  
      risk of falling. 
 
The study was supported by a project grant from the National Health and Medical 
Research Council of Australia (NH&MRC), and employed the equivalent of two full 
time research assistants who were responsible for data collection and maintenance of 
the study database.  Ethics approval was obtained from the Royal North Shore 
Hospital Ethics Committee. 
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2.2   Study Design  
The FREE study was set up as a large population-based prospective study of risk 
factors for falls and fractures, including quantitative ultrasound (QUS) measures to 
assess osteoporosis.  Falls and fractures were then recorded prospectively for a period 
of 2 years.  The study was carried out in the Northern Sydney Health Services area, 
which covers a geographical area of 1301.8 square kilometres and has a population of 
47 275 men and 67 817 women aged 65 years and over (at 2001 Census, 
http://www.ausstats.abs.gov.au). 
 
Recruitment of aged care facilities to participate in the FREE study began in March 
1999.  A database of all hostels and nursing homes for aged care in the Northern 
Sydney Health Services Area was compiled from a list provided by the Department of 
Health and Aged Care, and institutions were randomly assigned to blocks of 10 
nursing homes and 5 hostels.  Facilities were then approached block by block 
(approaching equal numbers of nursing home and hostel blocks) to maintain 
randomization.  Initial contact was made by letter, with a follow up phone call to 
arrange a preliminary visit.       
 
At each participating facility, all eligible residents were visited and invited to 
participate.  Individuals who were totally non-weight bearing (bed bound, bilateral 
amputees), non-English speaking or under the age of 65 years were not included in 
the study.  Residents gave informed, signed consent or if unable, their next of kin was 
approached by letter to give proxy consent.  Information on past medical history, falls 
and fracture risks and a proxy quality of life questionnaire was also obtained from 
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carers when a resident’s cognitive impairment precluded accurate history taking.  
These individuals were identified by facility staff.  If a resident gave independent 
consent but was subsequently found to be cognitively impaired (defined as a Mini 
Mental Score of less than 18), the appropriate carer was then approached prior to 
further participation in the study.  This method of obtaining proxy consent has been 
shown to be valid in other populations (258), and will be further evaluated in this 
study.  Copies of each signed consent form were provided for each patient’s file, 
along with an information sheet about the FREE study and contact details for study 
personnel.  Examples of these forms are given in Appendix 1. 
 
Recruitment of aged care facilities was completed in February 2003, when the target 
of more than 2000 enrolled residents was reached.  Population data from Dubbo, New 
South Wales, Australia identified a fracture rate of 5 to 10% per year for any fracture 
in independently-living elderly men and women, and a hip fracture rate of 3 to 5% 
(232).  Estimates from published trials in nursing homes suggest a hip fracture rate of 
up to 6% per year (259;260).  Over the 2 year follow up period, the cohort would be 
expected to experience approximately 60 (3% per annum) to 120 (6% per annum) hip 
fractures (allowing for some attrition due to death in this elderly group). 
 
 
 
 
 
40 
2.3   Measurements 
Clinical risk factors for both falls and for osteoporosis and fractures were assessed in 
all subjects at interview.  Basic demographics including age, sex, country of birth, 
activities of daily living status (Barthel Index) (261) and co-morbidities (by Resident 
Classification Scale graded 1 (lowest care) to 8 (highest level of care required)) (262) 
were recorded.  The RCS is assigned by an aged care assessment team (independent 
of this research study) and is linked to government funding for ongoing aged care.  It 
incorporates assessments of communication, mobility, ability to eat and drink, 
hygiene, bladder and bowel management, cognition, aggression or emotional 
instability, danger to self or others, social needs, medications and technical nursing 
care requirements (Appendix 2), and as such is a tool to define the degree of nursing 
care and supervision an individual requires on a daily basis. 
 
The following parameters previously shown to be related to falls (Chapter 1.5) were 
assessed: use of a walking aid, medications (ascertained by medical record review), 
history of falls in the previous year, history of stroke, Parkinson’s disease, continence, 
joint replacement, and osteoarthritis of the hip or knee.  Knee pain (263) and 
osteoarthritis of the knee (264) have been associated with objective impairment of 
balance.   
 
Cognitive function was assessed using the Standardised Mini Mental Status 
Examination (SMMSE) (265).  When one or more (up to 7) of the 30 items were not 
completed due to visual or hearing impairment, a correction calculation was made (as 
per personal communication, Dr A. Jorm, NHMRC Psychiatric Epidemiology 
Research Centre):  
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(total score possible * total number of items completed satisfactorily) 
(total score possible – total number of items not attempted). 
When 8 or more items were missing, the total score was recorded as missing as a 
refusal is most likely due to inability to respond correctly (266).  A score of less than 
18 was interpreted as the most appropriate cut-off to define insufficient cognitive 
function to give informed consent for the purposes of this study (267). 
 
Quality of life (QOL) was measured using the EQ-5D (268), a categorized scoring 
model of the generic EuroQol instrument (269) (which uses visual analogue scale 
assessments).  The form used for data collection is shown in Appendix 1.  The EQ-5D 
has been shown to be valid and reliable for measuring health-related QOL in a 
number of different healthy (270-273) and disease populations (274-277), including 
postmenopausal osteoporosis (278).  Choice of health-related quality of life 
instrument is largely a function of the population to be studied (279).  The EQ-5D has 
been shown to be completed more reliably than the other commonly used QOL 
instrument, the SF-36, in elderly patients after a stroke (258), and experience with 
other projects in Northern Sydney has shown the EQ-5D is more easily completed by 
frail older people than either the Sickness Impact Profile or the Medical Outcome 
Study Short Form 12 (personal communication, Prof. Ian Cameron).  Analyses were 
conducted both with and without proxy quality of life data in light of systematic 
differences between individual and proxy reporting (280;281).  A disease-specific 
instrument was not incorporated into the study due to the high number of confounding 
variables and comorbidities in this frail population.   
 
A validated implicit reviewer assigned severity score was given for each resident 
(282), rated at the time of the baseline assessment, where scores are given as: 
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• 1  - no symptoms or medical complications 
• 2   - mild symptoms 
• 3   - moderate symptoms 
• 4   - severe symptoms that severely alter or immediately threaten life or 
prognosis 
according to predefined definitions (Appendix 3). 
 
Information relating to osteoporosis and fracture risk was also collected. This 
included a history of past corticosteroid and hormone replacement therapy (quantified 
where possible), current or past smoking and history of previous low trauma fracture 
(after age > 50).  Self-report of medical conditions (283-285), in particular of previous 
fracture (286-288), has been shown to be reliable in elderly persons. 
 
Falls risk was tested by assessments of quadriceps strength and static balance, 
reaction time, visual contrast sensitivity and proprioception according to published 
methods proven to predict falls and fractures in the elderly (169;245).  Quadriceps 
muscle strength was measured in the sitting position from a standardized chair in the 
subject's dominant leg using a strain gauge, measured in kilograms.  Quadriceps 
muscle strength, the ability to stand from a seated position and visual contrast 
discrimination were measured, but will not be discussed further for the purposes of 
this thesis. 
 
Static balance was measured as the ability of subjects to maintain balance while 
standing on a firm and a compliant surface, comprising a 150 x 150 x 10 cm foam 
mat.  Subjects were classified into 5 grades  
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• 1  - unable to maintain balance for any period without support on a firm 
surface  
• 2  - able to stand for less than but not equal to 30 seconds unsupported 
• 3  - able to stand for 30 seconds unsupported on firm ground but not on a 
compliant surface 
• 4  - able to stand for 30 seconds unsupported on firm ground but less than 
30 seconds on a compliant surface, and 
• 5  - capable of maintaining balance whilst standing on a firm or compliant 
surface for 30 second periods without difficulty. 
 
Weight was measured using the same set of scales in those residents able to stand 
unsupported.  For those who were not sufficiently mobile to use the scales, the scales 
were calibrated to measure ‘0 kg’ with a ramp and empty wheelchair, and then the 
resident was weighed whilst sitting in that wheelchair to give a net resident weight.  If 
neither of these methods was possible, the most recent weight in the patient’s medical 
notes was recorded.  In order to estimate height, the lower leg length from floor to 
knee (bent at 90 degrees) was measured for subsequent calculations (289). 
 
An assessment of bone mass was made using two quantitative ultrasound (QUS) 
machines.  Broadband ultrasound attenuation (BUA) and velocity of sound (VOS) 
were measured at the left calcaneus in all participants using the same McCue CUBA 
Mark II ultrasound machine.   In the event of foot deformity, unilateral foot 
amputation or injury to the left foot, a measurement was made at the right calcaneus 
and the reason documented.  BUA was also measured using a Metra QUS-2 
ultrasound machine in a smaller sample of subjects, as this machine only became 
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available after study commencement.  The coefficient of variation from duplicate 
measurements for BUA in our laboratory is 2.9% for the CUBA machine and 1.3% 
for the QUS-2.  Each QUS measurement was repeated twice in the study population, 
repositioning the foot between measurements; a third measurement was taken when 
the difference between the first two BUA measures was greater than 5 dB/MHz.  Each 
machine was calibrated daily using standard operating phantoms for each machine. 
 
Blood was taken for vitamin D and biochemistry analysis in all consenting 
participants.  Due to the ‘invasive’ nature of venesection, any resident was permitted 
to refuse blood being drawn without being excluded from the remainder of the study.  
Biochemistry was analyzed on a Hitachi 917 analyzer in a single laboratory.  Serum 
25-hydroxyvitamin D (25OHD) was measured using the Diasorin 25-OH-D 
radioimmunoassay (RIA) kit.  Sensitivity was measured at 4 nmol/L, intra-assay 
precision 7.6% and inter-assay precision 9.0%, with a ‘normal’ laboratory range of 39 
– 140 nmol/L.   
 
Baseline serum levels of intact parathyroid hormone (PTH) were determined  
by a two-site chemiluminescent enzyme-linked immunometric assay on a DPC  
Immulite 1000 analyser.  The assay procedure measures the intact PTH  
molecule.  The assay has a typical intra-assay precision of 5.5%, an  
inter-assay precision of 7.9% and the laboratory reference range is 23.7 – 66.2  
pg/mL (2.5 – 7.0 pmol/L). 
 
Serum albumin was measured by BCG colorimetric assay (Roche), with a normal 
range of 40-50 g/L.  The within-run precision (coefficient of variance, CV) given by 
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the manufacturer was 0.4% and the between-run CV was 1.7%.  Inter-assay precision 
in this laboratory has been calculated as 2.0%.  Serum calcium was measured by 
colorimetric assay (Roche) using p-cresolphthalein and adjusted for circulating 
albumin levels, with a normal range 2.15-2.55 mmol/ L, manufacturer’s within-run 
CV 0.9% and between-run CV 1.5%, and measured inter-assay CV in this laboratory 
2.1%.  A modified Jaffé (picric acid) kinetic colorimetric assay was used to measure 
serum creatinine with a normal range in males of 70-110 μmol/L and in females 50-
90 μmol/L, manufacturer’s precision of 0.7% intra-assay and 2.3% inter-assay and a 
measured inter-assay CV of 3.0%.  Inorganic phosphorus levels were measured by an 
endpoint method with sample blanking, based on the formation of ammonium 
phosphomolybdate complex.  The normal range in this laboratory is 0.6-1.3 mmol/L 
and inter-assay precision of 2.5%; manufacturer’s within-run CV is 0.9% and 
between-run CV is 1.4%. 
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2.4   Follow Up 
Once enrolled in the FREE study, residents were followed up on a regular basis to 
record the number of falls, injuries and fractures that had occurred since recruitment.  
A fall was defined as ‘unintentionally coming to rest on the ground, floor or other 
lower level, whether or not an injury occurred’.  An injury was recorded if it required 
treatment, medical consultation, investigation or observation or pain relief.  Any 
fracture was confirmed by x-ray, x-ray report or hospital discharge summary.  Where 
a clinical diagnosis of a fracture was made without radiological evidence, it was 
recorded as ‘unconfirmed’ and not included in subsequent analyses.   
 
Incident reports were examined at each facility to confirm falls, and radiology reports 
obtained to confirm each fracture and its site.  Residents’ medical progress notes were 
also reviewed to confirm incident reports, to assess any injury that might have been 
sustained at the time of the fall and to identify any falls that were not captured on 
incident report.  X-ray reports are recognized as being superior to medical record 
review for ascertainment of fracture incidence (290).  All deaths were recorded.  
Residents who moved facilities were tracked in order to minimize follow up losses. 
 
The first follow up visit took place about 6 weeks after all baseline assessments had 
been completed for that aged care facility.  Visits continued approximately every 2-3 
months for 2 years or until death.  After 2 years, only hip fractures and deaths were 
recorded at follow up.   
 
Previous studies have shown osteoporotic fractures to be associated with a decline in 
QOL (144;168;291) and an increase in overall mortality (144).  To assess whether 
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fractures in frail elderly residents of aged care facilities lead to a decrease in cognitive 
function, quality of life and increased mortality, each resident sustaining a fracture 
during the study period was reassessed four months after fracturing, using the 
SMMSE and EQ-5D instruments.  A control subject, matched for age, gender, 
institution and broad SMMSE function, was also reassessed at that time.   
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2.5   Population Characteristics 
Thirty hostels and 52 nursing homes were included in the study.  A further 2 hostels 
were due to be approached but had closed between randomization and study 
participation.  Four nursing homes were approached but refused to participate, 2 were 
undergoing rebuilding and unable to participate at the time they were approached, and 
5 had closed since randomization.  Numbers of residents available for recruitment and 
the subsequent participation rates are given in Table 2.1.   
 
Table 2.1:  Participation of residents from hostels and nursing homes 
  Hostel Nursing home 
Number of residents (total)  1751 2685 
Excluded Age < 65 years 33 59 
 Bed bound 0 458 
 Non-English speaking 23 89 
 Other 3 3 
 Total 59 701 
Total possible  1692 1984 
Self consent Total 1232 562 
 Included (% response) 958 (77.8%) 428 (76.2%) 
Carers consent Total  460 1432 
 Included (% response) 149 (32.4%) 470 (32.8%) 
Participants Total (% response) 1107 (65.4%) 898 (45.3%) 
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A total of 2005 residents were recruited for the study and completed the baseline 
assessments.  Of these, 67% (n=1386) had been self-consents, and the remaining 33% 
(n=619) had proxy consents completed.  As anticipated, carer consent was more 
difficult to obtain due to a number of reasons, including inability to locate the 
appropriate carer, introduction of privacy laws that restricted access to information 
about carers, non-response to multiple mail-outs, mistrust of clinical trials and a desire 
that a relative be not inconvenienced. 
 
Simple demographic details were collected on non-participants for the first year of the 
study.  Those individuals who refused to participate in the study, either personally or 
through carer advice, were of a similar age to participants (mean age of non-
participants 85.5 years compared to mean age of participants 85.2 years, t=0.79, 
p=0.4).  Non-participants had been residing in aged care facilities for slightly less 
time than participants (mean difference 3.8 months, 95% confidence interval for the 
difference 0.15 to 7.4 months, t=-2.04, p=0.04).  More non-participants fell into RCS 
categories 1 and 2 and less into 6-8 than participants (χ2=116, df 7, p<0.0001) 
suggesting a lower level of dependency on nursing care. 
 
Baseline demographic characteristics of the study group are given in Tables 2.2 and 
2.3.  There was no significant difference in the distribution of RCS scores between 
men and women (χ2 =11.08, df=7, p=0.14), suggesting that the range of disability was 
the same for men as for women.   
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Table 2.2:  Resident classification scores (RCS) for men and women 
RCS Male (n=473) Female (n=1532) 
1 (least care required) 37 (7.8%) 163 (10.6%) 
2 99 (20.9%) 304 (19.8%) 
3 68 (14.4%) 240 (15.7%) 
4 21 (4.4%) 52 (3.4%) 
5 26 (5.5%) 119 (7.8%) 
6 63 (13.3%) 184 (12.0%) 
7 37 (7.8%) 163 (10.6%) 
8 (most care required) 99 (20.9%) 304 (19.8%) 
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Table 2.3:  Baseline characteristics of the FREE cohort 
Male Female  
Hostel NH* Total Hostel NH Total 
Number 263 210 473 844 688 1532 
Age (years), mean (sd) 82.3 (7.42) 83.4 (6.36) 82.8 (7.81) 86.6 (8.24) 86.7 (6.86) 86.6 (6.59) 
1 (no symptoms) 20 (7.5%) 1 (0.5%) 21 (4.4%) 44 (5.2%) 2 (0.3%) 46 (3.0%) 
2 (mild symptoms) 102 (38.8%) 28 (13.3%) 130 (27.5%) 313 (37.1%) 83 (12.1%) 396 (25.8%) 
3 (moderate symptoms) 133 (50.6%) 165 (78.6%) 298 (63.0%) 471 (55.8%) 552 (80.2%) 1023 (66.8%) 
4 (severe symptoms) 7 (2.7%) 14 (6.7%) 21 (4.4%) 10 1.2%) 38 (5.5%) 48 (3.1%) 
Implicit review 
Not yet determined 1 (0.4%) 2 (0.9%) 3 (0.7%) 6 (0.7%) 13 (1.9%) 19 (1.3%) 
Number of fallers in past 12 months (%) 118 (44.9%) 123 (58.6) 241 (51.0%) 381 (45.1%) 411 (59.7) 792 (51.7%) 
Any fracture 56 (21.3%) 61 (29.0%) 117 (24.7%) 409 (48.5%) 372 (54.1%) 781 (51.0%) 
Hip 12 (4.6%) 25 (11.9%) 37 (7.8%) 108 (12.8%) 184 (26.7%) 292 (19.1%) 
Spine 7 (2.7%) 7 (3.3%) 14 (3.0%) 80 (9.5%) 145 (21.1%) 125 (8.2%) 
Number sustaining a low-
trauma fracture since the 
age of 50 (%) 
Wrist 5 (1.9%) 8 (3.8%) 13 (2.7%) 138 (16.4%) 85 (12.4%) 223 (14.6%) 
Smoker (current) 46 (17.5%) 8 (3.8%) 54 (11.4%) 30 (3.6%) 19 (2.8%) 49 (3.2%) 
OA knee 78 (30.0%) 46 (21.9%) 124 (26.2%) 332 (39.3%) 196 (28.5%) 528 (34.5%) 
Hip replacement 14 (5.3%) 18 (8.6%) 32 (6.8%) 84 (10.0%) 74 (10.8%) 158 (10.3%) 
Knee replacement 21 (8.0%) 13 (6.2%) 34 (7.2%) 56 (6.6%) 34 (4.9%) 90 (5.9%) 
Incontinence Day 76 28.9%) 99 (47.1%) 175 (37.0%) 291 (34.5%) 371 (53.9%) 662 (43.2%) 
 Nght 110 (41.8%) 119 (56.7%) 229 (48.4%) 336 (39.8%) 429 (62.4%) 765 (47.5%) 
HRT N/A N/A N/A 55 (6.5%) 23 (3.3%) 78 (5.1%) 
Corticosteroids 28 (10.6%) 10 (4.8%) 38 (8.0%) 81 (9.6%) 59 (8.6%) 140 (9.1%) 
Parkinson’s disease 23 (8.7%) 32 (15.2%) 55 (11.6%) 17 (2.0%) 44 (6.4%) 61 (4.0%) 
History of CVA 69 (26.2%) 62 (29.5%) 131 (27.7%) 151 (17.9%) 153 (22.2%) 304 (19.8% 
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Women were an average of 3.8 years older than their male counterparts (95% 
confidence interval for the difference 2.99 to 4.55, t=9.51, p<0.0001).  Women were 
more three times more likely than men to have a history of minimal trauma fracture 
since the age of 50 years, independent of fracture type (Table 2.4).  There was no 
significant difference in the reporting of falling in the previous 12 months between 
men and women.   
 
Table 2.4:  Odds ratios (OR) for demographic measures for females compared to 
males. 
 OR 95% CI χ2 statistic p 
Nursing home accommodation 0.98 0.80 – 1.21 0.038 0.9 
History of falls 1.02 0.89 – 1.09 0.116 0.75 
History of any fracture 3.18 2.52 – 4.02 101.144 <0.0001* 
     - hip fracture 2.80 1.96 – 4.01 33.051 <0.0001* 
     - wrist fracture 6.09 3.45 – 10.76 49.24 <0.0001* 
     - spine fracture 2.91 1.66 – 5.11 15.143 <0.0001* 
Smoking 0.26 0.17 – 0.39 49.69 <0.0001* 
Incontinence - day 1.36 1.07 – 1.64 6.46 0.01* 
Incontinence - night 1.09 0.89 – 1.34 0.605 0.4 
Parkinson’s disease 0.32 0.22 – 0.46 38.29 <0.0001* 
History of CVA 0.65 0.52 – 0.83 12.32 <0.0001* 
*statistically significant p<0.05) 
 
Elderly persons in Australia who require assisted accommodation are assigned places 
in hostels or nursing homes according to the perceived level of care required, 
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measured by RCS.  It would therefore be expected that nursing home residents, 
requiring a higher level of day to day care, would have significantly more comorbidity 
and poorer levels of function.  When compared to hostel residents, individuals living 
in nursing homes were seen to have approximately a two-fold increase risk of being 
fallers (OR 1.9, p<0.0001), were more likely to have sustained a hip fracture (OR 2.5, 
p<0.0001) and more likely to be incontinent of urine or have a history of stroke (Table 
2.5).  Nursing home residents were significantly less likely to be current smokers, 
most probably related to immobility (smoking now rendered an outdoor activity in 
Australian aged care facilities). 
 
Table 2.5:  Odds ratios (OR) for demographic measures for nursing home residents 
compared to hostel residents. 
 OR 95% CI χ2 statistic p 
Female gender 1.02 0.83 – 1.26 0.04 0.9 
History of falls 1.93 1.61 – 2.31 50.23 <0.0001* 
History of any fracture 1.32 1.11 – 1.58 9.44 0.002* 
     - hip fracture 2.49 1.95 – 3.18 55.80 <0.0001* 
     - wrist fracture 0.77 0.58 – 1.01 3.31 0.07 
     - spine fracture 0.72 0.51 – 1.03 2.97 0.09 
Smoking 0.42 0.27 – 0.66 15.16 <0.0001* 
Incontinence - day 2.34 1.95 – 2.81 83.97 <0.0001* 
Incontinence - night 2.50 2.08 – 3.01 98.00 <0.0001* 
Parkinson’s disease 2.54 1.71 – 3.77 22.88 <0.0001* 
History of CVA 1.38 1.11 – 1.71 8.63 0.002* 
*statistically significant, p<0.05) 
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The FREE cohort has been shown to be a heterogeneous population, with wide ranges 
of comorbidity.  Their commonality lies in their advanced age, and a requirement for 
assisted living which renders them unable to live independently.  This thesis examines 
the health of the frail elderly with respect to bone, specifically their risk of falls and 
fractures which incur significant morbidity and mortality to an already impaired 
population. 
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2.6   Discussion 
The major strengths of this study lie in its size, randomization and prospective follow 
up.  To our knowledge this is one of the largest prospective studies of falls and 
fracture risk that has been undertaken in frail institutionalized elderly population, with 
previous studies recruiting in the low hundreds (176;292-295).  In particular, this is 
the largest cohort of elderly men studied in aged care facilities for any of the falls or 
fracture parameters.  The study is population-based, with rigorous prospective data 
collection over a minimum of 2 years.   Aged care facilities were randomized at the 
outset and this randomization was maintained throughout the study with negligible 
facility refusal or drop-out.  Large numbers of both men and women have been 
recruited.  The response rate from residents able to give self-consent was reasonable, 
and once recruited all participants completed the study with minimal ‘missing’ data.   
 
The population was comparable in age and gender to previous published studies in the 
elderly who live in assisted care facilities (58;173;176), allowing generalizability to 
other groups around the world.  This supports the applicability of our results to other 
frail elderly populations.  Non-participants were of a similar age to participants and 
had lower RCS classifications, so that we can be confident in the assumption that the 
study includes the more frail population.  This does introduce a potential bias in the 
study group, which must be considered when relating the results of the FREE study in 
healthier, more independent populations. 
 
All major outcome measures had been previously validated in published studies, to 
allow meaningful conclusions to be drawn.   
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Quantitative ultrasound of the calcaneus has been shown to be a predictor of fracture 
rate in younger, independently living populations (54-56) and in smaller studies of the 
frail elderly (57;58).  This study has measured BUA and VOS in a much larger 
population, which has not been carried out on such a large scale previously.  It is 
anticipated that this will provide a greater power to predict fracture in a population of 
elderly persons living in aged care facilities.  This is important from a practical 
viewpoint, as QUS is much more easily performed in a frail immobile population than 
the ‘gold standard’ DEXA measurement. 
 
One of the problems encountered in the recruitment of participants for the FREE 
study was a poor carers’ response, resulting in a smaller proportion of cognitively 
impaired residents (compared to those with adequate cognition to give self-consent) 
being included in the study.  This skews the population towards a higher cognitive 
function than truly exists in hostel and nursing home accommodations.  Such a 
recruitment bias must be considered when interpreting results, particularly if poor 
cognitive function contributes to falls and fracture risk (176;296).  This systematic 
bias would result in an underestimate of the true falls and/or fracture risk in assisted 
care facilities, and reduce the power of the study to detect possible relationships 
between cognitive function, falls and fractures. 
 
Those individuals who were non-English speaking, bed-bound or bilateral amputees 
were not included in the analysis, which might impact on the generalizability of our 
results.  There were a total of 112 (2.5%) non-English speaking residents who were 
not approached for the study; care must be taken in applying the findings of the FREE 
study to recent immigrants to Australia.  Nevertheless, 83 (4.1%) of residents included 
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in the study were born in non-English speaking countries, allowing a degree of 
generalizability of results to elderly individuals of different ethnic backgrounds who 
have lived in Australia for some years.   
 
There were 458 residents (10.3%) in the nursing homes participating in the study who 
were bed bound and therefore not included; this is unlikely to have affected outcomes 
as it is deemed that if a resident does not mobilize in any way, the only factor 
important in future risk of falling is nursing care, which is not the purpose of this 
study.  The remaining 6 exclusions form only 0.1% of the aged care facility 
population, and so even if they fell in the highest or lowest risk categories, their 
exclusion would not impact the final results. 
 
Loss to follow up is a major difficulty in this elderly population, due to the high 
mortality rate in the frail elderly.  Cox regression has been carried out to maximize the 
information collected during the study, allowing all residents who completed baseline 
assessment to be included in the analyses up until the time of death.  The large 
number of residents recruited for the study will in part offset the expected losses to 
mortality from all causes. 
 
In summary, this is a large well-constructed population-based prospective study of 
falls and fracture risks in the frail elderly living in aged care facilities which is 
expected to yield valuable information to ultimately assist in formulating preventative 
strategies for this high-risk population.
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VARIANCE OF QUANTITATIVE ULTRASOUND 
MEASUREMENT IN THE FRAIL ELDERLY 
 
3.1   Introduction 
Osteoporosis is an increasing community health problem, particularly as the 
population ages. Bone mineral density (BMD) measured by dual energy X-ray 
absorptiometry (DEXA) is the current gold standard for the diagnosis of osteoporosis.  
BMD has been shown to predict fracture risk, with each standard deviation reduction 
in femoral neck BMD increasing the age-adjusted risk of hip fracture by about two 
fold (range 2.0 to 3.5) as well as the risk of any atraumatic fracture by two (range 1.7 
to 2.4) (14;17;244;245).  DEXA is however not always feasible, for example in large 
population ‘screening’ and in elderly, less mobile groups.  Calcaneal ultrasound is a 
portable, easy to use and non-invasive method of assessing trabecular bone and has 
been recently shown to predict risk of osteoporotic fracture in community-dwelling 
postmenopausal women (55;56).  Little is known of the reliability or reproducibility 
of heel ultrasound techniques in the very elderly and how this may vary with 
increasing age.  
 
This study aimed to investigate the reliability and reproducibility of two calcaneal 
ultrasound machines in a population of frail elderly institutionalized subjects, 
exploring the variability of broadband ultrasound attenuation (BUA) and velocity of 
sound (VOS) in the very elderly and to assess sensitivity to change with extreme 
ageing. 
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3.2   Methods 
As this analysis was carried out prior to the completion of patient recruitment, only 
the first 1587 subjects recruited into the FREE study who had calcaneal ultrasound 
measurements were included in this analysis, of which 1210 (76.2%) were female. 
 
3.2.1  Measurements 
Broadband ultrasound attenuation (BUA) and velocity of sound (VOS) were 
measured in all participants using the same CUBA Mark II ultrasound instrument 
(McCue Ultrasonics, London, UK).   BUA was also measured using the QUS-2 
ultrasound machine (Quidel Corporation, San Diego, USA) in 684 (509 females) of 
the participants.  BUA measurements were taken in a lesser number of subjects with 
the QUS-2 machine, as the machine only became available for use after study 
commencement.  Assessments were made at the left calcaneus, unless foot deformity 
or oedema precluded measurement and then the right heel measurement was taken.  
Two consecutive measurements were made, repositioning the foot for each 
measurement.  Fifty-six consecutively recruited residents of hostels were remeasured 
using the same technique on the CUBA after an average period of 2.2 years.  T-scores 
were calculated using machine-defined normal ranges. 
 
Patient details including age and medication history were collected, and weight was 
measured in all participants, using a wheelchair ramp for those patients unable to 
stand unsupported on the scales.  Height was not measured in this population. 
 
Ambient temperature has been shown to affect QUS accuracy and precision of the 
Achilles (Lunar) water bath machine, giving higher values at lower temperatures 
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(297), but it is not known if this is applicable to dry systems.  Air conditioning in 
hostels and nursing homes kept relatively stable room temperatures throughout our 
study.  Moreover, follow-up measures were taken in the same season as the original 
measurements to avoid temperature measurement errors longitudinally. 
 
3.2.2  Statistical methods 
Analysis of reproducibility 
Three sample statistics were computed to assess the reproducibility of each measure: 
(a) the standard error measurement (SEM, within-subject standard deviation) which 
was calculated as the square root of the average variance from individual subjects, (b) 
this SEM was then expressed in relation to the overall mean as the coefficient of 
variation, and (c) the limit of agreement (LoA) as described by Bland and Altman 
(298).   
 
Analysis of concordance between CUBA and QUS-2 machines  
The concordance between the CUBA and QUS-2 instruments for BUA was addressed 
by calculating the coefficient of concordance (299) as  
( )
( )222 ,2 qcqc
qc
BUABUAss
BUABUACov
C −++= .   Cov(BUAc, BUAq) is the covariance between the 
measurement of BUA by CUBA, and BUA by QUS-2 instrument, 2cs  and 
2
qs  are the 
between-subjects variance of BUA measurements by the CUBA and QUS-2, 
respectively, and BUAc and BUAq are the respective means of BUA measured by the 
two instruments.  The coefficient C is an index of agreement of measurements 
between two instruments, i.e. the degree to which pairs of measurements fall on the 
line of identity.  Thus, even with a high correlation between the two methods, if their 
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means are different, the value of C is still small, e.g. poor agreement.  Limits of 
agreement between machines were calculated using repeated BUA measures for each 
of the two instruments (12).  The weighted Kappa statistic was used to assess the 
degree of agreement between the two instruments in various T-score-based 
classifications.  
 
Longitudinal analysis 
Statistical analysis was carried out following the method of Nguyen and Eisman 
(300).  For subjects with two visits, the rates of change in BUA and VOS (CUBA) 
were expressed in actual units and in percentage terms.  In the latter, the difference 
between the mean measurement at the follow-up visit and the mean baseline 
measurement was calculated, then divided by the mean baseline measurement, and 
expressed as a percentage change.  Because each measurement (either at baseline or 
follow-up visit) was subjected to random measurement error, a change was considered 
"significant" if it exceeds the change that may be expected from random fluctuation 
with a certain probability.  In traditional analysis, the variance of difference between 
two successive measurements, x0 and x1  is equal to the sum of individual variances, 
i.e., ( ) 210 2var sxx =− , where s is an estimate of SEM as mentioned above.  Under the 
assumption of the Normal distribution, s296.1 ×  (also known as the least significant 
criterion (LSC)) covers 95% of the random variability of within-subject differences.  
However, the above formulation is based on the assumption that successive 
measurements within an individual are independent.  This is unlikely to be true, as 
measurements within an individual are correlated, although the correlation decreases 
with increasing intervals between measurements.  Therefore, a more logical 
formulation must take this correlation into account.  Assuming a simple 
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autoregressive model, the variance of difference between successive measurements 
can be shown to be equal to: ( ) ( )[ ]22210 /12var sssxx aii ρρ +−=− , where iρ  is the 
serial correlation between two consecutive measurements; and 2aσ , the analytical 
variance (e.g. its square root, aσ , is referred to as measurement error) included in the 
within-subject variance, s2.  As the analytical variance is small relative to the within-
subject variance, the formula can be reduced to: ( ) ( )isxx ρ−=− 12var 210 .  Therefore, 
in this study, we used two criteria to assess the longitudinal change in each ultrasound 
measure  
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3.3   Results 
 
3.3.1  Demographics 
The characteristics of the study population are shown in Table 3.1.  Females were on 
average of 3.94 years older than their male counterparts (95% confidence interval 
3.13 to 4.74 years, p <0.001) and weighed 14.4kg less (95% CI 12.8 - 15.9, p <0.001).   
 
Table 3.1:  Descriptive statistics of the study population and duplicate ultrasound 
measures, given as mean and standard deviation. 
 Female Male 
Number 1210 377 
Age (years)  86.26 (6.68) 82.32 (7.78) 
Weight (kg)  56.76 (12.52) 71.14 (13.47) 
Measure 1 45.70 (18.13) 71.83 (23.00) CUBA BUA (dB/MHz) 
Measure 2 45.44 (18.31) 71.88 (23.02) 
Measure 1 1558.73 (42.83) 1596.46 (47.60) CUBA VOS (m/s) 
Measure 2 1558.45 (43.52 1596.26 (47.97 
Number 509 175 
Measure 1 53.52 (14.88) 73.50 (21.19) 
QUS-2 BUA (dB/MHz) 
Measure 2 53.43 (14.81) 73.46 (21.96) 
 
The mean difference between repeated BUA measures on the CUBA machine for the 
entire cohort was 0.315 dB/MHz, standard deviation 2.388 (t=5.2, p<0.0001).  This is 
not a clinically meaningful difference, but statistically significant due to the large 
sample size.  Similarly the mean difference between repeated BUA measures on the 
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QUS-2 machine (for the entire cohort) was -0.014 dB/MHz, standard deviation 2.885 
(t=-0.1, p=0.9).   
 
3.3.2  Reproducibility 
 Reproducibility statistics are given in Tables 3.2 and 3.3.  Mean CUBA BUA 
(F=10.93, p<0.0001), mean CUBA VOS (F= 21.14, p<0.0001) and mean QUS BUA 
(11.92, p<0.0001) all decreased significantly with increasing age.  The within-subject 
SEM for BUA was 1.6 dB/MHz in the CUBA and 2.0 dB/MHz in the QUS-2 and the 
within-subject coefficient of variation (wCV) for BUA was 3.1% for CUBA and 3.4% 
for QUS-2, neither value being significantly different between machines.  Variation in 
SEM was independent of mean BUA and of age (r = -0.01, p = 0.78) as seen in figure 
3.1.  Limits of agreement between duplicate measurements of BUA ranged from –4.4 
to 5.0 dB/MHz with the CUBA, and from –5.7 to 5.6 dB/MHz with the QUS-2. 
 
For VOS (CUBA), the within-subject SEM was 5.0 m/s and the CV 0.3%.  The 
within-subject SEM significantly increased as the mean VOS increased (r = 0.11, p < 
0.001), but there was no significant correlation between SEM and age (r = 0.01; p = 
0.89).  The limits of agreement between two measurements ranged from -15 to 16 
m/s. 
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Table 3.2.  Analysis of reproducibility of CUBA BUA, CUBA VOS, and QUS-2 
BUA in an elderly institutionalized population. 
 
  
                                CUBA         QUS-2 
                                                          
Statistic and parameter BUA (dB/MHz) VOS (m/s) BUA (dB/M
   
  
Mean  ± SD 51.8 ± 22.4 1567.5 ± 46.9 58.6 ± 18.9 
 
Error variance  2.6 25.2 4.2 
“True” variance 378.7 1975.4 354.3 
Coefficient of reliability 0.993 0.987 0.988 
Coefficient of reliability 
                 (T scores) 0.10 0.12 0.16 
 
Within-subject SD (SEM) 1.6 5.0 2.0 
Coefficient of variation 3.1% 0.3% 3.4% 
Limits of agreement -4.4 to 5.0 -14.8 to 15.8 -5.7 to 5.6 
 
LSC ( iσ296.1 × ) 4.5 13.9 5.7 
 (8.6%) (0.9%) (9.7%) 
 
( )iiLSC ρσ −×= 1296.1 a 1.3 5.4 1.6 
 (2.4%) (0.3%) (2.7%) 
  
a: The correlation between two consecutive measurements was estimated to be 0.92 for BUA 
measurement and 0.88 for VOS.   
LSC – least signfigicant change
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Table 3.3.   Mean, between-subjects standard deviation (bSD), within-subjects 
standard deviation (wSD) and within-subject coefficient of variation (wCV) stratified 
by age group. 
 
Variable <80 80-89 90+ All Ages 
CUBA BUA Mean* 59.6             52.2             46.3          51.9 
 wSD 1.7 1.8 1.6 1.7 
 wCV 2.8 3.4 3.4 3.3 
 bSD 22.4 22.0 21.6 22.4 
 bCV (%) 37.6 42.1 46.7  
      
CUBA VOS  Mean* 1579.8 1569.1 1557.4 1567.7 
 wSD 5.0 5.9 5.2 5.5 
 wCV 0.3 0.4 0.3 0.4 
 bSD 46.7 47.6 43.8 46.9 
 bCV (%) 3.0 3.0 2.8  
      
QUS-2 BUA Mean* 65.2 57.2 55.6 58.5 
 wSD 2.0 1.8 2.4 2.0 
 wCV 3.1 3.2 4.3 3.5 
 bSD 19.3 18.5 18.3 1.5 
 bCV (%) 29.6 32.3 32.9  
      
*statistically significant, p<0.0001). 
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Figure 3.1a:  Difference between duplicate measures for BUA in women measured 
by CUBA 
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Figure 3.1b:  Difference between duplicate measures for BUA in women measured 
by QUS-2 
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3.3.3  Concordance between CUBA and QUS-2 
BUA was measured using both machines in 684 subjects (Table 3.4).  The correlation 
coefficient for BUA between the two instruments was 0.87 (p < 0.001).  On average, 
BUA measured by the QUS-2 was significantly higher (p < 0.0001) than that 
measured by the CUBA by approximately 1.9 dB/MHz (standard deviation of the 
differences corrected for repeated measures 9.547 dB/MHz). QUS-2 BUA measures 
may range from 16.5 dB/MHz below CUBA BUA measurement to 20.3 dB/MHz 
above CUBA BUA (95% confidence interval).   
 
Table 3.4.  Comparison of BUA (dB/MHz) and T-scores measured by CUBA and 
QUS-2 instruments 
  
 CUBA QUS-2 Difference  
   (95% CI) 
  
Males 
 Number of subjects 175 175 
 BUA (dB/MHz) 73.1± 20.7 73.7 ± 21.4 0.6  (-1.0 to 2.2) 
 T-scores -2.1 ± 1.2 -1.2 ± 1.6 0.9  (0.8 to 1.0) 
Females 
 Number of subjects 509 509 
 BUA (dB/MHz) 51.1 ± 15.6 53.4 ± 14.8 2.3  (1.2 to 3.4) 
 T-scores -2.3 ± 0.9 -2.8 ± 1.1 -0.4  (-0.38 to -0.50) 
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When stratified by gender, the difference remains significant in females (average 
difference 2.3 dB/MHz, 95% LoA –15 to 19 dB/MHz) but not seen in males (average 
difference 0.6 dB/MHz, 95% LoA –21 to 23dB/MHz).  Nonetheless, when BUA is 
expressed relative to the young normal mean, the QUS-2 T-scores were significantly 
higher than the CUBA T-scores in males; the reverse was observed in females (Table 
3.4).  As a result, there was a poor agreement between the two instruments in the 
classification of subjects based on T-scores (Table 3.5).   
 
Table 3.5.  T-score classifications from BUA by CUBA and QUS-2 instruments 
  
 Males Females 
  
Cuba BUA T-scores 
 Less than -2.5 74 (42.3%) 269  (52.9%) 
 Between -1 and -2.5 74  (42.3%) 184  (36.2%) 
 More than or equal to -1 27  (15.4%) 55  (10.8%) 
 
QUS-2 BUA T-scores 
 Less than -2.5 47  (26.9%) 331  (65.0%) 
 Between -1 and -2.5 49  (28.0%) 130  (25.5%) 
 More than or equal to -1 79  (45.1%) 48  (9.5%) 
 
Agreement between 
two instruments (Kappa) 0.44 ± 0.04 0.62 ± 0.03 
  
Product-moment correlation coefficient for BUA:  0.88 (p < 0.0001), and T-score BUA:  0.76 
(p < 0.0001).  
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For example, in males, 42% had CUBA T-scores less than -2.5, while the same 
classification was found in 27% by QUS-2 T-scores.  In contrast, more females are 
seen with QUS-2 T-scores less than -2.5 (65%) than with CUBA T-scores (53%).  
The Kappa coefficients for males and females were 0.44 ± 0.04 and 0.62 ± 0.03, 
respectively.  
 
3.3.4  Longitudinal Measurements 
 
There were 56 residents with longitudinal measurements.  During the 2.2 years 
(range: 2.0 to 2.3 yrs) of follow-up, the mean ± SD change in BUA (measured by 
CUBA) was -1.9 ± 8.3 dB/MHz (p = 0.09, not statistically significant), but percentage 
change from baseline was statistically significant at -5.2 ± 16.5 %  (p = 0.02).  For 
VOS, the change was not statistically significant either in absolute units (0.8 ± 21.5 m/s; 
p = 0.79) or in percentage terms (0.1 ± 1.3 %; p = 0.76).  Changes in QUS measures 
were not related to calcium, vitamin D supplementation or to bisphosphonate use in 
this small study.  Eight of the 10 residents measured at 2 years who were on bone 
preserving medications or commenced these over the study period decreased in BUA 
(range -1.33 to -17.73 dB/MHz), one resident being maintained on calcium and 
vitamin D increased BUA by 5.46 dB/MHz and one resident commenced on calcium 
and vitamin D during the study increased by 29.92 dB/MHz. 
 
As expected, the correlation between baseline and follow-up measurements was 
statistically significant for both BUA (r = 0.92; p < 0.001) and VOS (r = 0.85; p < 
0.001).  Using the criteria of least significant change with the serial correlation being 
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taken into account ( ( )iiLSC ρσ −×= 1296.1 ), any change in BUA of more than 1.3 
dB/MHz and in VOS of more than 5.8 m/s, in either direction, can be considered 
statistically significant.  Accordingly, 28% and approximately 60% of the changes in 
BUA were classified as “decreased” and “increased”, respectively, while the 
remainder (12%) were classified as “unchanged”.  Similarly, 46% of the changes in 
VOS were regarded as a “significant increase” and 54% were regarded as “significant 
decrease” (table 3.6).  Approximately 39% of subjects had significant decrease in both 
BUA and VOS, while 18% had significant increase in both measurements (Figure 
3.2). 
 
 
Table 3.6:  Changes in BUA and VOS (N=56), measured by CUBA. 
 
  
 Increased Decreased Unchanged 
  
Using ( )iiLSC ρσ −×= 1296.1 as criteria 
BUA (n; %) 16 34 7 
 (28.1) (59.7) (12.3) 
 
VOS (n; %) 26 31 0 
 (45.6) (54.4) (0) 
 
Using LSC = iσ296.1 ×  as criteria 
BUA (n; %)  9 21 27 
 (15.8) (36.8) (47.7) 
 
VOS (n; %) 12 13 32 
 (21.1) (22.8) (56.1) 
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Figure 3.2:  Percentage of individuals with significant change in BUA and VOS over 
2.2 years using CUBA (N=56) 
 
 
 
a:  Using (LSC = iσ296.1 × ) as criteria for significant change 
 
b: Using ( ( )iiLSC ρσ −×= 1296.1 ) as criteria for significant change 
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3.4   Discussion 
The interpretation of any diagnostic tool requires a good understanding of the 
accuracy and reliability inherent in that test.  This study has described the precision 
and reproducibility of two calcaneal ultrasound instruments in an elderly population, 
in order to estimate the prevalence of osteoporosis (Chapter 4) and assess bone loss 
over time in this group.  Coefficients of variation for BUA for the CUBA ultrasound 
instrument (3.1%) and the QUS-2 instrument (3.4%) compare well with other 
machines which measure BUA, but are higher than for VOS or for BMD measured by 
DEXA (301).  VOS appeared more sensitive to change than BUA with the LSC for 
BUA being 2.4% compared to 0.3% for VOS measurement, but longitudinally VOS 
was not seen to change in our population, with equivalent numbers of patients 
increasing as decreasing VOS.  This has important implications for study design; 
choice of sample size and the most appropriate bone measurement will depend on the 
magnitude of change expected for each parameter measured and the power required in 
addition to machine precision. Our data suggests age has little influence on the 
precision and within subject variance of calcaneal ultrasound even in the very elderly, 
making it a useful tool for epidemiological studies of bone loss in an older population.  
 
Statistically, the correlation in BUA between CUBA and QUS-2 instruments was high 
(r = 0.87, p<0.0001), however, there was a poor concordance between the two 
instruments. It is interesting to observe that BUA measured by CUBA was 
significantly higher than that measured by QUS-2, although the difference was found 
in women but not in men, probably due to the smaller sample size in the latter group. 
It is not clear why there was a systematic difference in BUA between the instruments, 
given the fact that they have virtually identical degree of precision. Nevertheless, the 
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discordance between the instruments raises the question of accuracy of BUA 
measurement. 
 
Results of the present study also suggest that if QUS is used for the diagnosis of 
osteoporosis (or low bone mass) then standardisation across instruments must be 
addressed first. Between the two instruments evaluated in this study, there was a high 
discordance in the diagnosis of low bone mass. If the criteria of T-scores < -2.5 was 
used as a definition of "low bone mass" then QUS-2 was more likely to classify a 
women as "low bone mass" (65%) compared to CUBA (53%). On the other hand, in 
men, the prevalence of low bone mass was significantly higher in CUBA T-scores 
(42%) than in QUS-2 (27%). This suggests that the two instruments use 
systematically different referent databases, or different algorithms to compute the T-
scores. Each instrument is programmed with its own specific normal range, the CUBA 
using a British normal population and the QUS-2 a US population; inherent differences 
between these groups may contribute to the different T-score classifications seen.  It 
would seem from our comparative data for two quantitative ultrasound instruments, and 
the variable precision, reproducibility and sensitivity to change reported by other 
investigators using other machines, that the use of QUS for the assessment of 
osteoporosis is instrument specific and should not be generalised between models. Thuy 
et al (302) recently showed poor agreement between data-based and machine-based T-
score classifications (κ=0.65) in a large Vietnamese population-based study using the 
QUS-2 instrument.  The use of T-scores as a means of classifying osteoporosis was 
initially described in post-menopausal women using DEXA BMD values at the hip (8) 
and is not necessarily generalizable to other measurement modalities.  Machine-derived 
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T-scores for QUS must certainly be interpreted with caution, and can be a trap for the 
unwary when QUS is used in the clinical setting.  
 
Over 2 yrs of follow-up more than 50% of subjects had significant changes in BUA.  
This change appears quite sensitive, because with BMD one might expect that almost 
50% would experience no change.  Individual changes could not be attributed to the use 
of bone preserving medications.  Despite being a more precise and reproducible 
measure, VOS was not shown to change significantly over 2 years in this population, 
limiting its use in this setting.  Although the sample size was small compared to the 
cross-sectional study, it should be sufficient to detect a difference in VOS which was 
more precise and reproducible than BUA.  It is possible that VOS is measuring a 
different property of bone to BUA, which changes at a different rate with time in the 
elderly.  This does not explain the discrepancies between the FREE longitudinal study 
of QUS and previous studies showing significant longitudinal changes in VOS.  It 
should be noted that a different ultrasound method (the Achilles system) was used in 
the Schott study (105), and we have shown in our correlation analysis between the 
CUBA and QUS-2 methods there are quite large differences in absolute terms 
between different ultrasound machines.  Moreover the sample size of both studies is 
modest. Importantly, although VOS or SOS is quite precise, it is acknowledged to be 
much less sensitive to change than BUA and the % differences in change between the 
two studies (0.1% vs 0.8%) are not large.  The only identifiable selection bias in this 
sub-sample of 56 residents was the institution; as sequential patients who were enrolled 
in the FREE study were followed up at 2 years, all had lived in one of only 3 hostels at 
enrolment.   Their baseline QUS values however did not differ from the FREE cohort as 
a whole.  The FREE study is older and frailer than previous studies, and we see in 
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Chapter 4 that QUS does not change rapidly in the very old; it is possible that there is a 
differential rate of change between BUA and VOS in very old age.  Certainly BUA is 
more informative for longitudinal studies in this population. 
 
It is difficult to determine whether the statistically significant change in BUA of 5% 
from baseline is clinically important without prospective fracture data.  Changes in 
DEXA measurements at both hip and spine of 5% confer a clinically important 
change in fracture risk, but this is not generalizable to other modes of bone density 
assessment.  It does not fulfill the ‘one standard deviation’ drop in BUA which Bauer 
et al showed to correspond to a doubling in fracture risk (56).  The effect was diluted 
by some residents increasing BUA over time.  There was no identifiable factor which 
may have caused this effect, and it is likely that it is an example of regression to the 
mean. 
 
Only a few previous studies have examined changes in QUS longitudinally.  Schott et 
al (105) followed 88 post-menopausal women (mean age 63 years) over 2 years, 
showing a decrease in BUA of 1% (p=0.02) and a decrease in VOS of 0.8% 
(p=0.0001).    This change in BUA approximated the long-term precision value, while 
the change in VOS was more meaningful at 5 times the precision for BUA.  The 
derived parameter of stiffness decreased by 1.85%, approximating 2.5 times the 
precision, giving intermediate sensitivity to change.  A larger cross-sectional study of 
270 female nursing home residents (mean age 85 years) incorporated longitudinal data 
for 60 women after 1 year (101).  This shorter study failed to show a significant 
decrease in BUA, whereas VOS reached statistical significance decreasing by 0.3% 
(p=0.001).  The coefficient of variation for this study was 1.8% for BUA and 0.3% for 
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VOS.  Other groups have shown QUS to be sensitive to change in high risk 
populations, including otherwise healthy patients with acute spinal injury (303), 
prolonged bed rest (304), and in children with rheumatic diseases (305).  Daly et al 
(306) used QUS to look at bone changes with exercise, measuring calcaneal BUA and 
VOS over an 18-month period in elite male gymnasts and matched normoactive 
controls.  Over 18 months, BUA increased significantly in the gymnasts from baseline 
whereas VOS did not increase in either group. 
 
In an interventional clinical trial (108) BMD in postmenopausal osteoporotic women 
treated with alendronate increased by 5.0%, compared with a rather modest increase 
in VOS (0.7%) and BUA (1.4%) after two years.  Change in BMD was poorly 
correlated with change in QUS.  The minimum significant difference between two 
measurements was 0.8% for VOS and 5.6% for BUA, consistent with our findings.  
Among the QUS parameters, the authors concluded the calculated value of ‘stiffness’ 
showed the greatest longitudinal sensitivity, which was only slightly lower than 
BMD.   Another study of the effect of anti-resorptive therapy on QUS parameters over 
2 years in osteoporotic women (107) concluded that the minimum significant 
difference in BUA was 3 times greater than that for BMD.  Sahota et al (106) showed 
a similar relationship between QUS and BMD over 4 years therapy with hormone 
replacement therapy in 60 early post-menopausal women.  Therapy with calcitonin 
(109) gave a significant improvement in VOS over 2 years but no improvement in 
BUA.  Conversely, BUA was sensitive to increases with vitamin D and calcium 
supplementation (110) over a similar time period in elderly institutionalized women 
who were vitamin D deficient, whereas VOS was seen to decrease.  Studies of 
osteoporosis therapies must be interpreted with caution, as the effect of the 
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intervention may differ between therapies and therefore cannot be attributed to the 
method of measurement alone. 
 
In conclusion, QUS measurements were highly reliable and sensitive to longitudinal 
change. However, the accuracy of BUA measurement could be problematic, and as a 
result, its use in the diagnosis of osteoporosis remains contentious. 
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PREVALENCE OF OSTEOPOROSIS IN THE FRAIL ELDERLY 
 
4.1  Introduction 
Osteoporosis, a disease characterised by skeletal fragility, is a major public health 
problem. Hip fractures are the most costly osteoporotic fracture to treat and are due to 
a fall or injury in over 90% of cases (307).  Nursing home and hostel residents 
account for approximately 40% of total hip fractures (308) and as populations age, 
health care costs in this frail elderly group will increase substantially.   
 
Skeletal bone quantity can be assessed by measurement of bone mineral density 
(BMD), usually by dual energy x-ray absorptiometry.  BMD is considered the best 
predictor for risk of fracture, however its routine use in the frail and institutionalised 
older person is often impractical.  Recently quantitative ultrasound (QUS), a less 
expensive and more portable technology, has been shown to predict risk of 
osteoporotic fracture in older women, independently of BMD (55;56) and may have 
particular use in a high risk elderly population.  However there have been few studies 
of gender differences in QUS.     
 
The aims of this study are as follows: 
(1) To describe bone density as measured by QUS of the calcaneus in a large 
population of frail elderly residents of hostels and nursing homes 
(2) To identify differences in QUS between men and women   
(3) To show whether QUS changes with age similarly in men and women 
(4) To show whether QUS changes with age similarly in this frail elderly 
population as in previously studied groups 
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(5) To describe the relationship of QUS to risk factors for falling in this 
population. 
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4.2   Methods 
All subjects enrolled in the FREE study (described in detail in Chapter 2) up until the 
end of June 2001 were included in this analysis.  Broadband ultrasound attenuation 
(BUA) and velocity of sound (VOS) were measured at the left calcaneus in all 
participants using the same McCue CUBA Mark II ultrasound machine, and BUA 
measured in a smaller number using the Metra QUS-2 ultrasound machine. Each QUS 
measurement was repeated twice in the study population and the average of the two 
values used in the analysis.   
 
The following clinical risk factors were assessed in all subjects at interview: age, 
gender, weight, height, activities of daily living status (Barthel Index) (261), cognitive 
function (Standardised Mini Mental Status Examination or SMMSE) (265), 
co-morbidities (by Resident Classification Scale graded 1 (lowest care) to 8 (highest 
level of care required)) (262), medications, falls risk and history of previous low 
trauma fracture (after age > 50).  Falls risk was tested by assessments of quadriceps 
strength and static balance, according to published methods proven to predict falls and 
fractures in the elderly (169;245), explained in detail in Chapter 2.   
 
QUS measurements in the elderly population were expressed as T-scores using the 
BUA and VOS means and standard deviations from a healthy control population.  
Controls comprised healthy twin pairs (a total of 264 males and 936 females) aged 18-
85 years as previously reported (37).  Only one twin from each identical pair, 
randomly selected, was included.  Individuals with a history of underlying bone 
disease, past or present corticosteroid use, serious concomitant disease and weight 
over 100kg were excluded. T-scores were calculated using the mean and standard 
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deviation compared to the control subjects aged 20-30 years, defined as representing 
‘young normals’.   
 
Statistical analyses were carried out using the SPSS 11.0 statistical software package.  
Independent sample student’s t-test was use to compare means between continuous 
variables, and Pearson’s chi-squared statistic calculated to test differences between 
proportions.  One-way analysis of variance (ANOVA) was used to evaluate univariate 
associations for continuous variables.  Multiple linear regression was performed using 
a stepwise backward method.  Comparison of regression lines was carried out using 
the method described by Armitage (309). 
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4.3   Results 
By June 2001, 1193 residents from 52 randomly selected aged care institutions had 
been enrolled representing a 50% participation rate for eligible residents.  This 
participation rate is only moderate, but expected and reflects the difficulty in 
obtaining informed consent from proxy informants in this population.  Residents who 
required proxy consent were less likely to participate in the study than those able to 
give independent consent (27% vs 68%, p<0.0001).  Responders and non-responders 
were identical with respect to mean age, sex distribution and time of residence in 
institutionalized care (mean differences not statistically significant, p>0.09). 
 
The study sample comprised 294 men and 899 women.  The men were on average 5 
years younger than the women (mean + SE age 81.2 + 7 and 86.7 + 6 vs years 
respectively, p < 0.001).  Summary findings according to sex and residential status 
(nursing home or hostel) are shown in Table 4.1.   
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Table 4.1.  Characteristics of hostel and nursing home populations, divided by gender 
Mean (SD) Men Women 
Institution Type Nursing Home Hostel Nursing Home Hostel 
Number of residents 124 170 460 439 
Age (years) 82.5 (8.8) 81.5 (7.5) 86.2 (7.1) 81.5 (6.4) 
Weight (kg) 67.3 (12.1) 73.9 (14.2) 55.7 (12.4) 58.8 (12.8) 
SMMSE (score, 0-30) 15.9 (9.7) 24.4 (5.7) 15.3 (10) 24.1 (6.3) 
EQ-5D (score, 7-18) 11.9 (2.9) 9.4 (2.1) 12.1 (2.8) 9.8 (2.3) 
Quads Strength (kg) 21.7 (9.4) 27.3 (8.5) 15.9 (5.5) 15.9 (6.2) 
Static Balance (score, 1-5)* 2.1 (1.2) 4.1 (1.1) 1.9 (1.1) 3.9 (1.2) 
BUA CUBA (dB/MHz) 65.6 (24.1) 73.6 (20.0) 41.2 (18.8) 49.2 (16.9) 
BUA QUS-2 (dB/MHz) 70.6 (22.8) 74.6 (20.1) 51.6 (15.6) 53.3 (14.8) 
Prevalence of prior fracture 19.0% 15.7% 36.9% 35.7% 
Length of stay (years) 2.41 (2.17) 3.9 (3.9) 2.42 (2.63) 4.44 (5.39) 
25-OH-vitamin D (nmol/L) 21.4 (1.9) 26.2 (2.2) 16.9 (1.3) 17.3 (0.9) 
*Static balance was measured on a scale of 1 to 5, where 1 represents 'not able to 
stand unsupported' and 5 represents 'good balance (able to stand for 30 seconds on an 
uneven surface unsupported)'. 
 
In nursing home residents, men were younger (p < 0.002), heavier (p < 0.001), and 
had higher BUA and VOS (p<0.0001) than women (Table 4.1).  There were no 
significant differences in length of stay or cognitive status.  Similarly in hostel 
residents, men were younger (p < 0.001), heavier (p < 0.001), had better static balance 
(p=0.013) and higher BUA and VOS (P<0.0001) than women.  There were no 
significant differences in SMMSE, but length of stay was longer in women than men 
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in hostels (p < 0.051).  Residents of nursing homes had not been institutionalized for 
as long as those in hostel accommodation (p<0.001), but no gender difference was 
seen.  Gender remained significantly associated with BUA (p<0.0001), VOS 
(p<0.0001) and 25(OH)D levels (p=0.005) after adjusting for age and institution type.  
A history of previous low trauma fracture after age 50 was more common in women 
than men (p < 0.001) but did not differ by institution.   Overall fracture prevalence 
was 32%; sites of fracture, some of which were multiple in certain subjects, were hip 
(11.7%), wrist (2.9%), humerus (2.7%), and other (16.0%).  Mean BUA was 44 (+ 18) 
dB/MHz and mean VOS 1553 (+39) m/s in subjects with a history of previous 
fracture compared to BUA 56 (+ 22) dB/MHz and VOS 1578 (+52) m/s in those 
without (p < 0.001 for both comparisons).  Those individuals reporting previous hip 
fracture had significantly lower BUA measures than individuals reporting other 
fractures (mean difference 8.3 dB/MHz, p < 0.001) but VOS did not reach a 
statistically significant difference. Use of medications for osteoporosis was infrequent 
(bisphosphonates 2.3%, raloxifene 0.7%, hormone replacement therapy 2.8%, vitamin 
D 4% and calcium supplements 13.7%).  The above results were unaffected if these 
subjects were excluded. 
 
BUA measured by the CUBA was highly correlated with BUA measured by the QUS-
2 (R2 = 0.74, p<0.001), the latter reading on average 10% higher.  There was no 
significant decline in BUA or VOS measured by either machine with age in men 
however in women BUA declined by 2-8-4.7% per decade (p<0.0001) and VOS by 
1% per decade (p< 0.001) (Figure 4.1).   
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Figure 4.1:  BUA (dB/MHz) measured by CUBA versus age (years) in  
                     (a) women and (b) men 
(a) 
BUA = 85-0.46*Age; R2 = 0.029 
 
(b) 
 
 
When compared to a healthy population of volunteers in Sydney aged 18-80 years 
(Figure 4.2), the data suggest that although the sex difference in QUS measures is 
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maintained into very old age, only minor loss occurs at the calcaneal site in BUA and 
VOS with very old age in both men and women.  These results were obtained from a 
cohort measured over 10 years before, using a different software version for the 
ultrasound machine so it was decided not do a formal statistical comparison.   
 
Figure 4.2:  BUA changes with age, in a ‘normal’ healthy population of men and 
women and the institutionalized elderly. 
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Figure 4.3 shows the data from this elderly population in comparison to an aged 
cohort of female subjects measured as part of the Dubbo Osteoporosis Epidemiology 
Study (310) with the same CUBA machine.  The DOES population comprises 452 
subjects (age range 58-92 years).  Similarly to the young normal population, 
comparison of the linear regression of age vs BUA for each group (DOES n = 452, 
FREE n = 1197) suggests a significant difference in intercept (mean + SE 126.4 + 8.9  
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Figure 4.3 (a):  BUA in institutionalized elderly women, compared with a cohort of 
independent older women taken from the DOES study (310), related to age. 
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Figure 4.3 (b):  BUA in institutionalized elderly women, compared with a cohort of 
independent older women taken from the DOES study (310), related to age, shown 
with separate regression lines. 
Age (years)
1101009080706050
B
U
A
 (d
B
/M
H
z)
140
120
100
80
60
40
20
0
Study 
DOES
Rsq = 0.0217 
FREE
Rsq = 0.0494 
 
91 
 
vs 91.4 + 6.7, p<0.05) but not for the slope of the regression lines (mean slope + SE –
0.90 + 0.13 vs -0.531 + 0.078, p=0.1) suggesting  a similar pattern of bone loss with 
age and considerable generalizability of the BUA data across different populations.   
 
Compared to a young normal population sample measured in Sydney using a McCue 
CUBA II (37), the mean BUA T score at age 85 was –1.35 in men compared to –2.33 
in women and at age 95 –1.72 versus –2.55 for men and women respectively.  For 
VOS the mean T score at age 85 in men was –1.67 compared to –3.32 in women and 
at age 95 it was –1.95 versus –3.54 for men and women respectively.  Compared to 
186 healthy women aged 65-85 years living in the community, mean BUA was 1.2 
standard deviations lower in the institutionalized females.  Similarly compared to 37 
healthy men aged 65-85 years, mean BUA was 0.8 standard deviations lower in the 
institutionalized males.  BUA and VOS were significantly inversely related to 
Resident Classification Scale, a measure of comorbidities (p < 0.0001 respectively). 
 
Univariate analyses showed there were significant correlations between BUA and 
VOS and body weight (p<0.0001) in both sexes.  There were significant correlations 
in women but not men between BUA, VOS and quadriceps muscle strength (p < 
0.0009 and 0.02 respectively).  In multiple regression analysis, weight was the only 
significant predictor of BUA in men (Table 4.2).  However in women, significant 
predictors of BUA included weight and history of previous fracture, age and type of 
institution (Table 4.2).  When both men and women were included in the multivariate 
model, significant predictors of BUA values included gender, institution type, weight 
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and history of fracture, which together account for 38% of the variability of BUA.  
Age did not contribute significantly to the model.  
 
Table 4.2.  Independent predictors of BUA in men and women. 
Males 
Model variables β estimate Standard error t value p value 
Intercept 38.32 6.81   
Weight 0.46 0.09 4.90 <0.0001 
 
Females 
Model variables β estimate Standard error t value p value 
Intercept 40.99 9.68   
Age -0.22 0.09 -2.47 0.014 
History of fracture -5.52 1.12 -4.94 <0.0001 
Weight 0.45 0.049 9.19 <0.0001 
Institution type -6.89 1.19 -5.77 <0.0001 
 
Pooled population 
Model variables β estimate Standard error t value p value 
Intercept 53.02 5.22   
Gender -17.11 1.44 11.90 <0.0001 
Institution type -5.57 1.13 -4.94 <0.0001 
History of fracture -5.34 1.07 -4.98 <0.0001 
Weight 0.47 0.043 10.86 <0.0001 
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4.4   Discussion 
This study measured sex differences in QUS parameters in a frail elderly 
institutionalized population of men and women.  It was carried out on the first 1000 
residents enrolled in the FREE study, in late 2000 and 2001.  Past history of minimal 
trauma fracture in this group was low compared to the total population at the end of 
the study (Chapter 2), but otherwise the subgroup is representative of the whole study.  
There are no clear reasons for this phenomenon; there were no notable changes in 
interviewers who might have elicited a more definitive response from residents.  
Standards of care in nursing homes and hostels are constantly under scrutiny with 
quality assurance programs.  It is possible that the quality of medical record reporting 
had improved over the period of the study, resulting in a larger proportion of previous 
fractures being reported.  Personal recall of previous fracture is thought to be reliable 
in the elderly (286;288), but it may be that the discrepancies seen are a reflection of 
inherent measurement error due to recall bias.  The lower prevalence of reported 
previous low trauma fracture in this subgroup does not impact on the results of the 
ensuing study of QUS and gender differences in the frail elderly. 
 
As expected, the prevalence of low bone density as measured by quantitative 
ultrasound was high in the elderly FREE cohort.  Women had significantly lower 
bone density than men of a similar age, an expected finding as the female population 
is by definition post-menopausal and has therefore undergone a period of accelerated 
bone loss as a response to withdrawal of physiologic oestrogen.  At advanced age, the 
rates of bone loss were seen to be similar between men and women suggesting 
hormonal changes have a less important role in this population. 
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Although rates of BMD loss measured at the femoral neck have been reported to 
increase significantly in both sexes with advancing age (310), there have been few 
studies of other skeletal sites and most studies include only small numbers of very 
elderly men.  This study suggests only minor loss occurs at the calcaneal site in BUA 
and VOS with advanced age in either sex.  However one limitation of this study is its 
cross-sectional nature which allows only inferences about rates of loss.  Another 
explanation would be that increased mortality associated with low bone mass has lead 
to a survivor bias for ‘healthier’ elderly subjects who are losing at a slower rate.  This 
seems unlikely given the subjects were all ‘institutionalized’ and so were frail elderly.  
Of interest, the sex difference in QUS parameters is maintained into very old age.  
 
A number of studies have examined QUS in older women, mainly in relation to its 
value as a predictor of osteoporotic fracture risk (55;56).  Studies in elderly women 
have identified age, body composition and physical activity as determinants of QUS 
parameters (40;45), but there have been few studies of QUS in men, or indeed elderly 
men.  One study compared QUS in 169 normal men and 210 normal women aged 20-
80 years (41).  BUA was higher in men than women at all ages but showed little 
decline in either sex after age 60.  Another study of 224 men attending an 
osteoporosis clinic identified significant correlations between weight (and body mass 
index) and BUA, but no age related decline in QUS measures was observed, except in 
VOS in 76 fracture cases (27).  In both these studies only a small number of subjects 
were aged greater than 70 years.  Pluijm et al (58) measured BUA in 132 men and 578 
women aged > 70 but did not report determinants of QUS or sex differences.  Truscott 
(40) examined age-related trends in QUS in 2087 women aged from 16 to 93.  No 
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decline in QUS measures was observed between the age bands 75-79 and 80-84, 
however there were a total of only 20 subjects in these groups.  
 
When compared to an independently living population aged over 65 years (taken from 
the Dubbo study (310)), the frail elderly group were seen to lose bone at a similar rate.  
However, the baseline bone density was lower in the FREE study as seen by the 
different intercepts of regression lines for the two groups.  This is logical, as the 
Dubbo group are by definition healthier and more mobile than those of the FREE 
study who require supportive care with activities of daily living, and it could be 
assumed that independently living individuals spend more time actively weight 
bearing (recognized as important to maintain bone density).  Interestingly this has an 
effect on baseline but not rate of bone loss.  It might be concluded that other factors, 
such as age and hormonal changes, are more important than exercise and weight 
bearing for maintaining bone density from any baseline.   
 
There are currently few published studies of the prevalence of osteoporosis in the frail 
institutionalized elderly.  Intuitively it would be expected that BMD and QUS should 
be low in this aged, frail population, but the practicalities of measuring BMD in this 
relatively frail group have precluded large studies.  A recent North American study 
(18) of 1427 elderly female nursing home residents using distal radius BMD 
measured by single energy x-ray absorptiometry reported that 82% were osteoporotic 
(T-score < -2.5) and 54% fell under a T-score of -3.5.  
 
It is also important to consider the meaning of a T-score derived from calcaneal 
ultrasound in terms of fracture risk.  Faulkner et al (11) illustrated the differential 
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classification of an individual as osteoporotic or not using T-scores derived from 
different techniques of bone mass estimation, including DXA, QCT and QUS at 
different skeletal sites.  It is likely that a QUS-derived T-score of -2.5 is in fact related 
to a much higher fracture rate than a hip DXA-derived T-score of -2.5; one cannot use 
the two derivations interchangeably in the estimation of the prevalence of 
osteoporosis.   
 
Prospective information on fracture incidence will be important to define appropriate 
cut-offs for QUS measures as they pertain to fracture risk in the frail institutionalized 
elderly population.   This information will then allow more definitive 
recommendations about the usefulness of BUA and/or QUS in assessing osteoporosis 
in the frail elderly. 
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CHAPTER 5 
 
 
DISTRIBUTION, DETERMINANTS AND 
ASSOCIATIONS OF 25-OH-VITAMIN D LEVELS IN 
AGED CARE FACILITIES  
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DISTRIBUTION, DETERMINANTS AND 
ASSOCIATIONS OF 25-OH-VITAMIN D LEVELS IN 
AGED CARE FACILITIES 
 
5.1 Introduction 
Vitamin D deficiency is a silent epidemic, affecting men and women both in Australia 
(311-313) and around the globe (311;314-317).  Its prevalence increases in older 
populations as mobility and general health decline (318-320), related to inadequate 
sunlight exposure, poor diet and increasing renal insufficiency (321;322).    
Institutionalized elderly persons are at particular risk for low 25-OH-vitamin D levels 
(323-327), but there is less known about the relationships between vitamin D, gender, 
season and biochemical measures of calcium homeostasis in this frail elderly 
population.   
 
The aims of this study are as follows: 
1:  To describe the distribution of serum 25-OH-vitamin D levels in elderly 
men and women living in residential aged care facilities (hostels and nursing homes) 
in northern Sydney.   
2:  To determine if serum 25-OH-vitamin D levels differ with age, gender, 
residential status or season. 
3:  To describe the association between 25-OH-vitamin D levels and other 
bone-related biochemical parameters, including serum creatinine (as a surrogate for 
renal function), serum parathyroid hormone (PTH), corrected serum calcium and 
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serum albumin levels.  What is the independent influence of age, gender and 
institution on these associations? 
4:  To define hypovitaminosis D by relating 25-OH-vitamin D levels to 
subclinical secondary hyperparathyroidism. 
5:  To identify the key independent predictors of serum 25-OH-vitamin D 
level (continuous) and hypovitaminosis D (categorical) in the frail elderly. 
6:  To estimate the prevalence of vitamin D supplementation in this 
population, including the use of vitamin D supplements, analogues, combinations of 
these or other bone active medications. 
7:  To identify the determinants of the use of vitamin D supplementation.  Is 
the use of vitamin D supplements associated with age, gender or residential status?  
Does this supplementation impart a benefit on circulating 25-OH-vitamin D levels? 
 
This chapter will describe the distribution and determinants of serum 25-OH-vitamin 
D levels in an elderly population living in aged care facilities, and identify the 
significant biochemical interrelationships with serum 25-OH-vitamin D in this 
population. 
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5.2   Methods 
 
5.2.1  Subjects 
Each resident enrolled in the FREE study (a full description of the FREE study 
population methods is given in Chapter 2) was asked to give a blood sample for 25-
OH-vitamin D and other biochemical analyses.  Sixty-three percent of the cohort (268 
men and 1000 women) agreed.  Remaining study participants or their carers declined 
venesection and a small percentage of venesections were technically overly difficult 
and abandoned after one failed attempt.  Carer consent was obtained where 
appropriate.  Current medications were recorded from interview and verified by 
medical records and medication charts, including prescription drugs and over-the-
counter vitamin preparations.  Individuals with biochemical primary 
hyperparathyroidism (15 residents with an elevated parathyroid hormone and 
associated hypercalcaemia) or major renal insufficiency alone (6 individuals with a 
serum creatinine >300 μmol/L) were excluded from the analyses, resulting in a final 
study population of 979 women and 264 men. 
 
5.2.2  Biochemical measurements 
Serum 25-hydroxyvitamin D (25OHD), intact parathyroid hormone (PTH), calcium 
(adjusted for circulating albumin levels), creatinine and inorganic phosphorus levels 
were measured in 1268 residents using methods described in Chapter 2.  Creatinine 
clearance was calculated using the Cockcroft-Gault formula.  For males: 
 Creatinine clearance (ml/min) =              (140 – age)*weight         . 
            72*serum creatinine (mg/100ml) 
 
The same calculation is used in women, adjusted by x 0.85. 
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5.2.3  Statistical analysis 
Analyses were carried out using the SPSS 11.0 statistical software package.  
Independent sample student’s t-test was use to compare means between continuous 
variables (log transformed if required to confer normality), and Pearson’s chi-squared 
statistic calculated to test differences between proportions.  Vitamin D levels were 
treated both as a continuous variable, and divided into categories to define 
‘hypovitaminosis D’.  One-way analysis of variance (ANOVA) was used to evaluate 
univariate associations for continuous variables.  Logistic and multiple linear 
regressions were performed using a stepwise backward method.  
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5.3  Results 
 
5.3.1  Baseline demographics 
Nine hundred and seventy-nine women and 264 men were included in the analysis.  
The women were on average 3.7 years older than the men (p<0.0001) and were less 
mobile, being more likely to require a walking aid (usually a frame).  Demographics 
of the group are shown in Table 5. 1. 
 
Table 5.1:  Demographics of institutionalized elderly cohort with biochemical 
measures. 
Gender  
Male Female 
Test 
statistic Significance 
Age (mean)  83.10 86.76 t=7.2097 p<0.0001 
Hostel 136 (48.5%) 560 (57.2%) Institution 
Nursing Home 128 (51.5%) 419 (42.8%) 
χ2=2.73 p=0.11 
Walks unaided 94 (35.9%) 287 (29.6%) 
Uses a stick 65 (25.0%) 213 (22.0%) 
Uses a frame 59 (22.5%) 324 (33.4%) 
Mobility 
Wheelchair 44 (16.4%) 146 (15.0%) 
χ2=11.65 p=0.009 
On Vitamin D 
supplements 
 16 (6.1%) 115 (11.7%) χ2=7.13 p=0.007 
 
Descriptive statistics for biochemical variables are shown in Table 5.2.  Fourteen 
individuals exhibiting biochemical primary hyperparathyroidism were excluded from 
analysis.  This group had serum PTH levels ranging from 72.3 pg/mL to 602 pg/mL 
(median 108 pg/mL) and corrected calcium levels between 2.57 mmol/L and 3.08 
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mmol/L (median 2.66 mmol/L).  Five individual with PTH levels above 400 pg/mL 
but no available calcium measures were also excluded – this did not significantly 
change any of the calculations.  Finally, six individuals with renal insufficiency 
(creatinine values greater than 300 μmol/L) associated with elevated PTH but normal 
corrected calcium levels were also excluded. 
 
Table 5.2:  Biochemical measures grouped by gender and institution, given as mean 
+/- standard error of the mean (range), median. 
 Hostel Nursing Home 
 Male Female Male Female 
25-OH-vitamin D 
(nmol/L) 
35.8 +/- 1.48  
(5 - 92), 34 
29.8 +/- 0.64  
(2 – 104), 27 
29.5 +/- 1.59  
(5 – 103), 26 
25.7 +/- 0.80  
(2 – 101), 21 
PTH (pg/mL) 57.5 +/- 3.58  
(12.6 – 238.0), 45.5 
72.8 +/- 2.04  
(4.6 – 337.0), 61.2 
65.2 +/- 3.39  
(12.2 –  209.0), 57.3 
71.2 +/- 2.44  
(5.6 – 309.0), 55.8 
Corr. Calcium 
(mmol/L) 
2.34 +/- 0.017  
(1.96 - 2.91), 2.33 
2.36 +/- 0.009  
(1.87 – 2.73), 2.35 
2.34 +/- 0.018  
(2.01 – 2.60), 2.36 
2.36 +/- 0.010  
(1.86 – 2.68), 2.37 
Inorg. phosphorus 
(mmol/L) 
1.15 +/- 0.021  
(0.75 - 1.66), 1.14  
1.25 +/- 0.012  
(0.77 – 2.11), 1.25 
1.13 +/- 0.020  
(0.76 – 1.67), 1.11 
1.20 +/- 0.012  
(0.59 – 1.77), 1.21 
Albumin (g/L) 42.0 +/- 0.38  
(32 – 49), 42.0 
41.7 +/- 0.23  
(30 – 58), 42.0  
40.1 +/- 0.44  
(32 – 50), 40 
39.3 +/- 0.22  
(26 – 47), 39 
Creatinine 
clearance 
(μmol/L) 
70.0 +/- 21.4  
(33.2 – 131.1), 58.0 
44.7 +/- 18.6  
(16.1 – 140.8), 54.0 
57.4 +/- 21.3  
(22.9 – 124.4), 41.4 
44.0 +/- 18.4  
(11.8 – 147.3), 
40.6 
 
 
Nine hundred and sixty-two residents (77.4%) had low 25-OH-vitamin D levels when 
compared to the laboratory normal range (39 – 140 nmol/L).  Serum parathyroid 
hormone was low in 103 residents (8.3%) and high in 508 individuals (40.9%) 
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(normal range 23.7 – 66.2 pg/mL).  Hypocalcaemia was seen in 38 residents (7.2%) 
and hypercalcaemia in 22 (4.2%), (normal range 2.15 – 2.55 mmol/L).  Inorganic 
phosphorus was elevated in 136 (25.7%) individuals (normal range 0.6 – 1.3 
mmol/L).  Albumin was low in 181 (34.2%) and elevated in two individuals (normal 
range 40 – 50 g/L).  One hundred and twenty men (94.5%) had a reduced creatinine 
clearance (normal range in males 97 – 137 ml/min), and 399 women (97.6%) had a 
creatinine clearance which fell below the normal range for females (88 – 128 ml/min). 
 
5.3.2   Distribution of 25-OH-vitamin D levels 
Table 5.3 shows the prevalence of ‘hypovitaminosis D’ in men and women, using 
different cut-off values previously described in the literature concerning 25-OH-
vitamin D in elderly populations (322;328;329).  The majority of both men and 
women had low 25-OH-vitamin D levels independent of which cut-off value is used 
to define ‘hypovitaminosis D’.   
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Table 5.3:  Classification of residents with low 25-OH-vitamin D levels  
Gender 25-OH-vitamin 
D cut-off 
Hypovitaminosis 
D (number, %) 
Mean age 
(years) 
Mean vit D 
(nmol/L) 
Mean PTH 
(pg/mL) 
Male Vit D < 25 109 (42.9%) 83.31  17.7 72.9 
 Vit D < 30 139 (54.4%) 83.12 19.9 68.5 
 Vit D < 39 187 (75.4%) 83.71 23.7 65.9 
 Vit D < 50 217 (85.3%) 83.34 26.0 63.1 
 Vit D 25-50 108 (42.4%) 83.38 34.5 53.3 
 Low quartile < 18 46 (15.5%) 83.87 12.9 70.9 
 Low tertile < 20 62 (24.6%) 83.67 14.4 71.4 
 Low quintile < 17 38 (13.9%) 82.29 12.0 68.3 
      
Female Vit D < 25 525 (57.2%) 87.00 17.0 78.2 
 Vit D < 30 643 (70.2%) 86.86 19.0 76.7 
 Vit D < 39 732 (84.7%) 86.92 21.6 76.8 
 Vit D < 50 884 (94.2%) 86.81 24.3 73.5 
 Vit D 25-50 359 (37.0%) 86.60 35.0 66.6 
 Low quartile < 18 267 (25.6%) 86.65 12.8 83.6 
 Low tertile < 20 336 (36.9%) 86.63 14.0 80.5 
 Low quintile < 17 232 (21.2%) 86.72 12.2 80.7 
 
 
5.3.3   Determinants of serum 25-OH-vitamin D levels 
Serum 25-OH-vitamin D and PTH were not normally distributed (Figure 5.1), and so 
have been log transformed to allow comparisons as continuous variables.  Serum 25-
OH-vitamin D decreased with increasing age in the total cohort (t = -2.71,  p = 0.007), 
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but did not reach statistical significance in either males or females alone.  Serum 25-
OH-vitamin D levels were higher in hostel accommodation than in nursing home 
residents in both males (mean difference 6.24 nmol/L, 95% confidence interval 1.94 -
10.94, p = 0.005) and females (mean difference 4.10 nmol/L, 95% confidence interval 
2.13 - 6.08, p<0.0001).  Males had significantly higher 25-OH-vitamin D levels than 
women, independent of institution.  Serum 25-OH-vitamin D levels were significantly 
associated with the use of a walking aid (F=10.73, df=3, p<0.0001), being highest in 
those residents able to walk independently or with a stick, and lowest in those who 
use a wheelchair.  There was no association between current smoking and 25-OH-
vitamin D (mean 25-OH-vitamin D levels in smokers 27.4 nmol/L compared to 27.2 
nmol/L in non-smokers, t=0.214, p=0.9). 
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 Figure 5.1:  Distribution of serum 25-OH-vitamin D and PTH for males and females. 
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There were a similar proportion of men and women venesected each season, shown in 
Table 5.4 (χ2=4.73, df=3, p=0.19).   
 
 Table 5.4:  Number of residents recruited each season for men and women. 
Gender  
Season Male Female Total 
Spring 71 (26.9%) 264 (27.0%) 335 
Summer 73 (27.7%) 231 (23.5%) 304 
Autumn 42 (15.9%) 210 (21.5%) 252 
Winter 78 (29.5%) 274 (28.0%)  352 
Total 264 979 1243 
 
When those individuals taking vitamin D supplements are excluded from the analysis 
(n=131), 25-OH-vitamin D levels were significantly associated with season in both 
males (F=4.76, df=3, p=0.003) and females (F=6.46, df=3, p<0.0001).  Levels were 
lowest in winter in both sexes (Table 5.5), but males had an earlier peak in 
spring/summer compared to an autumn peak in women (Figure 5.2). 
 
Table 5.5:  Mean 25-OH-vitamin D level (standard error of the mean) for each season  
Gender 
Season Male Female 
Mean 
Difference 
95% Confidence 
Interval Significance 
Spring 34.91 (2.017) 24.84 (0.848) 10.07 5.72 - 14.42 p<0.0001* 
Summer 34.77 (2.259) 26.80 (0.932) 7.97 3.11 - 12.82 p=0.002* 
Autumn 28.33 (1.879) 29.21 (1.071) -0.89 -5.21 – 3.43 p=0.7 
Winter 26.55 (1.815) 23.93 (0.799) 2.61 -1.37 - 6.55 p=0.2 
*statistically significant difference between males and females, p<0.05. 
109 
Figure 5.2:  Changes in 25-OH-vitamin D levels with season in males and females. 
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5.3.4  Serum 25-OH-vitamin D and associated biochemical parameters 
Males had significantly higher creatinine levels and lower PTH and phosphate levels 
than women, independent of institution (p<0.05).  Using the laboratory-derived upper 
limit of normal for creatinine clearance, 120 men (94.5%, normal range in males 97 – 
137 ml/min), and 399 women (97.6%, normal range 88 – 128 ml/min) had a degree of 
renal insufficiency.  There was no statistically significant difference in PTH levels 
between institution type in either gender (p>0.1).  Serum albumin was lower in 
nursing homes than in hostels in both males and females (p<0.001), and phosphate 
levels were higher in hostels than nursing homes in females (p=0.02) but not 
significantly different between institutions in males (p>0.5).  Creatinine clearance was 
not significantly different between institutions in either males (p=0.4) or females 
(p=0.7). 
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Albumin decreased with increasing age in both males and females (p<0.05), and PTH 
increased with age (p<0.005).  Creatinine clearance decreased with age in both males 
and females (p<0.0001), and calcium and phosphate were not related to age in either 
gender (p>0.2).   
 
Parathyroid hormone levels increased as 25-OH-vitamin D decreased in both men and 
women (Figure 5.3) as would be expected biologically.  There was not a clear level of 
serum 25-OH-vitamin D below which a rise of PTH is seen (secondary 
hyperparathyroidism) which might support a definition of hypovitaminosis D.  Log 
transformation of 25-OH-vitamin D, iPTH or both does not reveal any point of 
inflection or level of 25-OH-vitamin D above which iPTH levels might increase 
exponentially.   
 
 
Figure 5.3:  Parathyroid hormone levels related to 25-OH-vitamin D. 
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      (Intercept=85.8, slope=-0.50, R2=0.023) 
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However when 25-OH-vitamin D was split into quintiles, mean PTH levels were seen 
to rise between the third and fourth quintiles (Figure 5.4), representing a mean 25-
OH-vitamin D level of 29 nmol/L, supporting the use of either 25 or 30 nmol/L as an 
appropriate cut-off for defining hypovitaminosis D in this frail elderly population.  
 
 
Figure 5.4:  Mean PTH values relating to 25-OH-vitamin D quintiles. 
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Examination of each of the quintiles for 25-OH-vitamin D does not reveal the serum 
levels to be normally distributed within each quintile.  When the median iPTH values 
are plotted against 25-OH-vitamin D quintiles, a lower cut-off level of 22 nmol/L is 
seen (Figure 5.5). 
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Figure 5.5:  Median PTH values relating to 25-OH-vitamin D quintiles 
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Univariate analysis corrected for age showed 25-OH-vitamin D levels to be 
significantly and inversely associated with PTH in men (t= -3.630, p<0.0001) and in 
women (t= -3.718, p<0.0001).  In females, 25-OH-vitamin D was associated with 
creatinine clearance (t= -2.901, p=0.004) and with albumin (t=2.429, p=0.016) but 
there was no association observed in the smaller sample of males (p>0.2).  Serum 25-
OH-vitamin D was not associated with calcium or phosphate in either gender 
(p>0.15). 
 
5.3.5  Independent predictors of 25-OH-vitamin D levels 
All significant univariate parameters were entered into a multiple regression model for 
men and women separately (Table 5.6).  With multiple regression modeling, lower 
vitamin D levels in men were associated only with higher PTH and the use of a 
walking aid.  Lower creatinine clearance, higher PTH, more advanced age and the use 
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of a walking aid were significant independent predictors of low vitamin D levels in 
females.  When the total cohort is examined, female gender, reduced mobility, higher 
PTH, increasing age, cooler season and lower creatinine clearance were independently 
related to lower 25-OH-D levels.
 
Table 5.6:  Independent determinants of serum 25-OH-vitamin D 
 Variable B Std. Error t Significance
(Constant) 4.264 0.217 19.653 <0.0001 
Ln PTH -0.178 0.053 -3.331 0.001 
Males 
(R2=0.14) 
Walking aid -0.116 0.029 -3.951 <0.0001 
(Constant) 5.112 0.545 9.381 <0.0001 
Age -0.011 0.005 -2.056 0.04 
Ln PTH -0.149 0.053 -2.812 0.005 
Cr. clearance 0.007 0.002 -3.261 <0.0001 
Females 
(R2=0.06) 
Walking aid -0.086 0.028 -3.045 0.003 
(Constant) 5.090 0.479 10.625 <0.0001 
Age -0.009 0.005 -2.000 0.046 
Gender -0.151 0.064 -2.367 0.018 
Ln PTH -0.141 0.046 -3.064 0.002 
Cr clearance -0.006 0.002 -3.386 0.001 
Walking aid -0.100 0.024 -4.158 <0.0001 
Entire 
cohort 
(R2=0.10) 
Season 0.052 0.024 2.205 0.028 
Excluded variables:  In males, season, age; in females, season, institution, albumin; in total 
cohort, institution, albumin. 
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Independent predictors of hypovitaminosis D, defined as a serum 25-OH-vitamin D 
level less than or equal to 30 nmol/L in this population, are shown in Table 5.7.  As 
for the continuous variable 25-OH-vitamin D, hypovitaminosis D is predicted by 
higher serum PTH values, use of a walking aid and lower creatinine clearance.  In 
men, use of a walking aid, PTH and creatinine clearance remain independently 
associated with vitamin D deficiency.  Season is an important predictor of 
hypovitaminosis D in women, along with use of a walking aid and PTH levels.   
 
Table 5.7:  Independent determinants of hypovitaminosis D (25-OH-vitamin D <= 30 
nmol/L) 
 Variable Wald 
statistic 
df Signif. 
(p) 
Likelihood 
ratio (LR) 
95% confidence 
interval for the LR 
Walking aid 3.35 1 0.07 1.02 N/A 
ln(PTH) 5.30 1 0.002 2.32 1.13 – 4.74 
Males 
(R2=0.18) 
Cr clearance 3.35 1 0.07 1.02 1.00 – 1.05 
Walking aid 19.48 3 0.0001 N/A N/A 
Season 12.47 3 0.006 N/A N/A 
Females 
(R2=0.10) 
ln(PTH) 5.37 1 0.02 1.67 1.08 – 2.57 
Gender 9.25 1 0.002 0.47 0.28 – 0.76 
Walking aid 28.39 3 0.0001 N/A N/A 
ln(PTH) 11.39 1 0.001 1.87 1.30 – 2.68 
Whole 
cohort 
(R2=0.11) 
Cr clearance 5.77 1 0.02 1.02 1.00 – 1.03 
Excluded variables:  In males, season, age, institution; in females, age, institution, creatinine 
clearance, albumin. 
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5.3.6  Vitamin D Supplementation 
The use of vitamin D supplementation and other bone-active medications was low 
overall in this population (Table 5.8).  There was not a statistically significant 
difference between men and women in the use of mixed vitamin supplements 
containing either vitamin D or calcium; however the use of specific bone-targeted 
compounds including calcium alone, vitamin D analogues (calcitriol) and 
bisphosphonates was more frequently seen in females than males.  A small number of 
individuals were taking both vitamin D supplements and analogues. 
 
Table 5.8:  Frequency of bone-active medication use among men and women living 
in aged care facilities. 
Medication Male Female Test statistic Significance
Vitamin D analogue 8 (3.0%) 91 (9.3%) χ2=11.113 p<0.0001* 
Vitamin supplements containing D 12 (4.5%) 76 (9.6%) χ2=3.272 p=0.079 
Any vitamin D preparation 16 (6.1%) 115 (11.7%) χ2=7.13 p=0.007* 
Calcium 13 (4.9%) 94 (9.6%) χ2=5.782 p=0.018* 
Vitamin supplements with calcium 21 (8.0%) 117 (12.0%) χ2=3.365 p=0.077 
Hormone therapy 1 (0.4%) 33 (3.4%) χ2=6.696 p=0.005* 
Bisphosphonates 3 (1.1%) 57 (5.8%) χ2=9.938 p=0.001* 
*statistically significant difference, p<0.05 
 
Supplementation was equally distributed between hostel and nursing home 
accommodation (χ2=3.85, p=0.05).  Residents taking vitamin D preparations were 
much more likely to be taking concomitant calcium supplements (χ2=235.0, 
p<0.0001).  Age did not appear to influence the use of vitamin D compounds (Table 
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5.9).  Mean 25-OH-vitamin D levels were 45.2 nmol/L in the supplementation group, 
which was significantly higher than 27.2 nmol/L for the group without 
supplementation (mean difference 18.0 nmol/L, 95% CI for the difference 14.0-22.0, 
p<0.0001), although still below the 50 nmol/L cut-off recommended for vitamin D 
sufficiency by many authors.  This significant difference is maintained in men and 
women (Table 5.9).   
 
Table 5.9:  Comparison of residents on vitamin D supplementation at baseline with 
those not receiving supplements (mean (sd)). 
Male Female  
Vit D Suppl No Suppl Vit D Suppl No Suppl 
N 16 (6.1%) 248 (93.9%) 115 (11.7%) 864 (88.3%) 
Age (years) 81.16 (7.246) 83.23 (7.727) 86.85 (5.174) 86.75 (6.518) 
25-OH-vitamin D (ng/mL) 55.56 (24.147) 31.28 (16.505)* 43.71 (21.944) 25.99 (13.388)* 
PTH (pg/mL) 46.24 (32.771) 62.23 (43.574) 50.36 (45.016) 74.98 (48.686)* 
Corrected calcium (mmol/L) 2.379 (0.0946) 2.335 (0.1407) 2.440 (0.1267) 2.349 (0.1330)* 
Creatinine (μmol/L) 119.30 (39.721) 100.81 (26.539) 90.05 (28.984) 89.34 (28.040) 
Albumin (g/L) 40.6 (3.44) 40.3 (1.32) 41.1 (3.45) 40.8 (2.96) 
*significantly different to supplemented group, p<0.001 
 
Corrected calcium levels were significantly higher in those individuals receiving 
vitamin D supplements (mean difference 0.082, 95% CI 0.045-0.119).  Mean PTH 
levels were significantly lower in the supplementation group, 49.9 pg/mL compared to 
72.1 pg/mL in those not receiving supplements, mean difference 22.3 pg/mL (95% CI 
14.3-30.3, p<0.0001).  When men and women are considered separately, corrected 
calcium remains higher and PTH lower in the supplementation group although this 
117 
does not reach statistical significance in males (p=0.33 and p=0.12 respectively), 
likely due to smaller numbers of male participants in the study.  Albumin levels were 
similar between supplemented an d non-supplemented residents (males, t=0.29, 
p=0.77; females, t=0.55, p=0.58).
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5.4   Discussion 
Sydney is situated at 33 degrees 55’ south of the Equator, with average temperatures 
in summer of 23 degrees Celsius and 17 degrees Celsius in winter.  At this latitude, 
similar to Buenos Aires, there is sufficient sunlight to provide adequate UV exposure 
for vitamin D synthesis in the skin of healthy individuals all year round (330), with an 
average of 340 sunny days each year.  Despite this, serum 25-OH-vitamin D levels 
were almost universally low in this cohort of frail elderly people living in residential 
aged care facilities in northern Sydney.   Similarly, a cross-sectional study of 99 
elderly men and women conducted in Melbourne, Australia (324) showed that 52% of 
residents of the aged care facilities studied had 25-OH-vitamin D levels below the 
normal range, compared to 77% in this more northerly group.  Equally low levels of 
vitamin D in aged care facilities have been described elsewhere (323;326;327), which 
would suggest that elderly persons living in such facilities are not benefiting from 
sunlight-derived vitamin D. 
 
Males had higher 25-OH-vitamin D levels than women independent of season or 
institution, as has been shown previously (331).  Residents in hostel accommodation 
had higher 25-OH-vitamin D and higher albumin levels than their counterparts in 
nursing homes.  If one considers that serum albumin is a reasonable measure of 
general nutrition and morbidity (332-334), it is logical to infer that differences in 
vitamin D status between institutions are likely to reflect the poorer mobility and 
general health of nursing home residents rather than inadequate nutrition.  
Nevertheless, nutritional intake may confound the relationship between 25-OH-
vitamin D and residential status, when you consider that poor nutritional intake 
impacts on general health and mobility.  It might also be that poor general health was 
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the primary event, and subsequent reduction in dietary intake is seen.  It would be 
interesting to examine the relationship of 25-OH-vitamin D and residential status 
when variables such as dietary intake are also considered. 
 
Sunlight exposure is important for maintaining adequate 25-OH-vitamin D levels.  
Melin et al showed prospectively that seasonal variation of 25-OH-vitamin D levels 
requires three or more hours per week of sunlight exposure during summer months in 
Scandinavia (335), and that 25-OH-vitamin D levels measured in autumn reflect this 
exposure during summer.  Individuals living in aged care facilities are less mobile 
than those living independently, and therefore less likely to get outdoors, contributing 
to an increased prevalence in hypovitaminosis D (323;326) which is not compensated 
by dietary intake (327).  It has previously been shown that seasonal variation of 25-
OH-vitamin D levels is less marked in residents of aged care facilities than in 
independently-living elderly people (325;336).  Nevertheless, we have seen a distinct 
seasonal variation of 25-OH-vitamin D levels in this institutionalized group, with 
lowest levels occurring in winter as has been shown in previous cross-sectional (337-
340) and longitudinal studies (341) in independently-living elderly populations.  
Serum 25-OH-vitamin D peaks during the spring/summer in men and in autumn in 
women; this difference might be explained by the poorer mobility of the female 
group, resulting in fewer trips outside and hence a slower accumulation of sunlight 
exposure over the warmer months. 
 
Age-related changes in biochemistry were seen as expected, with increasing age 
conferring lower albumin and 25-OH-vitamin D and higher PTH levels in both 
genders.  Creatinine clearance was seen to decrease with age in both males and 
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females as expected.  Overall, biochemical changes in this frail elderly group did not 
behave differently to expected changes in any older population.  It was of concern to 
note that although general nutrition was good in two thirds of the group, reflected by 
normal albumin values, 35% of residents of hostels and nursing homes have sub-
optimal albumin levels.  This proportion of nutritional deficiency warrants further 
investigation and appropriate intervetional program to improve general nutrition.   
 
Serum 25-OH-vitamin D levels were inversely associated with PTH levels as 
expected, reflecting secondary hyperparathyroidism occurring in response to low 
vitamin D stores.  Creatinine clearance (as a surrogate for renal function) was an 
important determinant of 25-OH-vitamin D in women but not in men; it is possible 
that this was due to insufficient numbers of male participants to confer statistical 
significance.  It is also possible that creatinine clearance is in part measuring general 
debility, which then confers poorer mobility, reduced sunlight exposure and 
subsequently lower vitamin D acquisition in women than in men. 
 
There has been much debate about the most appropriate definition of hypovitaminosis 
D, with cut-off values previously quoted from as low as 8-10 nmol/L (342) up to 50-
80 nmol/L (314;322;343;344).  Differences in 25-OH-vitamin D assays might account 
for some of this variability (345;346), and so associating low 25-OH-vitamin D levels 
with other parameters such as PTH is important to assess clinical significance.  The 
most commonly used cut-off is below 30 nmol/L (315;318;329;339;347;348), on the 
basis that at this level of 25-OH-vitamin D a mild increase in serum parathyroid 
hormone is seen in response to subclinical hypovitaminosis D (329) and so has 
clinical significance.  Our laboratory uses a standard cut-off of 39 nmol/L, being the 
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lower end of the ‘normal’ range in healthy adults.  This study however supports the 
use of 22-30 nmol/L as a cut-off for defining hypovitaminosis D in the frail elderly 
living in aged care facilities.  Nevertheless, thinking of 25-OH-vitamin D on a 
continuum instead of in discrete terms may be more appropriate when assessing a 
patient’s risk for comorbidities such as osteoporosis, fracture and general health. 
 
This study showed creatinine clearance and PTH are both independent predictors of 
25-OH-vitamin D levels in females, those individuals with lower creatinine clearance 
and higher PTH values having significantly lower 25-OH-vitamin D levels.  
Creatinine clearance was not an independent predictor of vitamin D in males, again 
most likely due to insufficient numbers of males in this study.  This relationship may 
well be confounded by muscle bulk in men, with higher baseline creatinine levels in 
men obscuring any effect of renal insufficiency on 25-OH-vitamin D levels.  
Mobility, as measured by the use of a walking aid, was also an independent predictor 
of 25-OH-vitamin D; both men and women who were independently mobile or used a 
stick had higher 25-OH-vitamin D levels than those using a frame or wheelchair.  If 
this is interpreted as a surrogate for sunlight exposure, then those individuals who are 
healthier (higher creatinine clearance and higher albumin in women, hostel 
accommodation in men) and more mobile are more likely to obtain vitamin D from 
direct sunlight, and less likely to develop secondary hyperparathyroidism. 
 
Vitamin D supplementation was infrequent in the FREE study, introducing a potential 
for selection bias.  Nevertheless, vitamin D supplementation was seen to appropriately 
increase serum 25-OH-vitamin D levels in this elderly group, with a mean difference 
in levels between residents on supplements and those not taking vitamin D of 
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18mnol/L, bringing those individuals on treatment just above most cut-offs for 
hypovitaminosis D.  It has been suggested that the elderly require higher doses of 
vitamin D to overcome hyperparathyroidism related to increasing creatinine levels 
(349).  With a well recognized relationship between low 25-OH-vitamin D levels and 
a higher risk of osteoporosis and ensuing fracture, the low rate of vitamin D 
supplementation seen in this frail elderly population was disappointing.  Only 10.5% 
of residents (n=131) were receiving vitamin D supplementation or vitamin D 
analogues, leaving 60% (n=741) of the total cohort with untreated low 25-OH-vitamin 
D levels (<30 nmol/L).  Despite taking a wide variety of preparations and doses for 
unspecified indications, those on supplements had higher 25-OH-vitamin D levels and 
lower PTH levels suggesting appropriate biochemical responses to such therapy.  
Vitamin D supplementation has been shown to improve bone mineral density (350-
352), muscle strength (227;230) and falling rates (230), and is a simple and 
economical intervention which might improve quality of life in this frail population.  
Its underutilization in frail elderly persons suggests an important lack of awareness 
and education which needs to be addressed. 
 
Elderly institutionalized men and women have a high prevalence of hypovitaminosis 
D which is not adequately addressed by appropriate replacement therapy, and may 
have important implications for bone and muscle health.  The relationship between 
low 25-OH-vitamin D, falls and fractures is an important area for future study in this 
high-risk elderly population. 
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CHAPTER 6 
 
 
VITAMIN D AND OSTEOPOROSIS 
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6.1   Introduction 
Vitamin D is important for maintaining calcium homeostasis and in the mineralization 
of healthy bone.  Ageing results in impairment of vitamin D metabolism, with reduced 
capacity to generate pre-vitamin D in the skin in response to ultraviolet light exposure 
(353) combining with poor oral intake resulting in low circulating 25-OH-vitamin D 
levels.  The ability to convert 25-OH-vitamin D to its active form, 1,25-OH-vitamin 
D, in the kidney (regulated by PTH) is also reduced (354;355).  Calcium absorption 
from the intestine is modulated by circulating vitamin D metabolites (356), and with 
ageing the normal absorption of approximately 30% of dietary calcium is reduced, 
initiating the ionized calcium-driven feedback loop which results in normalization of 
serum calcium by way of compensatory secondary hyperparathyroidism, increased 
renal tubular reabsorption of calcium and increased bone resorption.  A low 
calcium/phosphorus product is also seen, which causes an increase in the deposition 
of unmineralized osteoid.   
 
It has been shown in Chapter 5 that there is widespread vitamin D insufficiency and 
secondary hyperparathyroidism in the frail elderly living in aged care facilities.  But 
does this abnormal calcium homeostasis translate into lower bone mass and an 
increased risk of fracture?   Cross-sectional studies have shown BMD is lower at the 
hip and lumbar spine in younger vitamin D deficient populations (347;357;358), and 
interventional studies of calcium and vitamin D supplementation have shown reduced 
bone loss (229) or significant BMD increases at both sites (351;352;359-361).  
Fracture incidence has also been shown to be significantly reduced by vitamin D 
supplementation (260;350;362;363). 
125 
There is less known about the relationship between 25-OH-vitamin D levels and QUS 
measures, which may be of more relevance to frail populations.   
 
The aims of this study are as follows: 
1:  To confirm the distribution of BUA and VOS as measured by quantitative 
ultrasound of the calcaneus in a subpopulation of elderly men and women living in 
residential aged care facilities (hostels and nursing homes) in northern Sydney.   
2:  To establish the effect of vitamin D supplementation on BUA and VOS. 
3:  To describe the association between QUS measures and bone-related 
biochemical parameters, including serum 25-OH-vitamin D levels and serum 
parathyroid hormone (PTH).   
4:  To define hypovitaminosis D by relating 25-OH-vitamin D levels to BUA 
and VOS measures. 
5:  To identify the key independent predictors of BUA and VOS in the frail 
elderly. 
 
This large cross-sectional study aims to show the relationship between serum 25-OH-
vitamin D levels and bone mass as measured by QUS in frail elderly men and women, 
and to describe the independent predictors of low BUA and VOS. 
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6.2 Methods 
 
6.2.1  Subjects 
The population described in Chapter 5 has been used for this analysis, comprising 979 
women and 264 men enrolled in the FREE study between 1999 and 2002.  Individuals 
with biochemical primary hyperparathyroidism or significant renal failure were 
excluded (Chapter 5.2). 
 
6.2.2  Measurements 
Serum 25-OH-vitamin D analysis and quantitative ultrasound of the left calcaneus 
were performed as described in Chapter 2. 
 
6.2.3  Statistical analysis 
For describing the basic population demographics and the effect of vitamin D 
supplementation on QUS measures, Pearson’s chi-squared statistic was used for 
comparing frequencies between categorical variables, and student’s independent t-test 
for comparing the means of continuous variables.  Univariate analysis for BUA and 
VOS was performed using one-way ANOVA for continuous variables, log 
transforming 25-OH-vitamin D to fulfill assumptions of normality.  Associations with 
categorical variables were carried out using independent sample t-tests for binomial 
variables and one-way ANOVA for multinomial variables.  Multivariate analysis was 
carried out including all significant univariate variables, using multiple linear 
regression. 
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6.3 Results 
 
6.3.1  Baseline demographics 
Demographics for the group, including age, QUS values and mean serum 25-OH-
vitamin D levels are shown in Table 6.1.   
 
Table 6.1:  Mean Vitamin D levels and QUS values for men and women in hostels 
and nursing homes 
 Male Female 
 Hostel  
(N=136) 
Nursing home 
(N=128) 
Hostel  
(N=560) 
Nursing home 
(N=419) 
Age (years),  
mean (sd), range 
82.5 (7.5),  
65.2 – 100.7 
83.7 (7.9),  
65.6 – 101.7 
86.8 (6.1),  
65.6 - 100.7 
86.8 (6.8),  
65.1 – 101.3 
BUA (dB/MHz),  
mean (sd), range 
77.4 (22.0),  
16.5 – 135.3 
69.5 (24.8),  
18.8 – 138.2 
50.5 (17.1 
13.9 – 119.8 
41.8 (17.9), 
12.2 – 117.9 
VOS (m/s),  
mean (sd), range 
1608.8 (45.6), 
1473.5 – 1738.5 
1590.8 (51.6), 
1472.5 – 1748.5 
1567.7 (42.5), 
1484.0 – 1733.5 
1551.4 (42.1), 
1459.5 – 1721.0 
25-OH-vitamin D (nmol/L), 
mean (sd), range 
36 (17),  
5 - 92 
30 (18), 
5 - 103 
30 (15),  
2 - 104 
26 (16), 
2 - 101 
25-OH-vitamin D < 30 nmol/L 
(number, %) 
57 (41.9%) 82 (64.1%) 329 (58.8%) 314 (74.9%) 
 
 
6.3.2  Demographic determinants of BUA and VOS 
Females were older than males (mean difference 3.7 years, 95% confidence interval 
(CI) for the difference 2.7 – 4.7 years, t-7.10, p<0.0001).  Serum 25-OH-vitamin D 
was an average of 4.7 nmol/L (95% CI for the mean difference 2.3 – 7.1 nmol/L) 
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higher in men than women (t=3.86, p<0.0001).  BUA was significantly higher in men 
(mean difference 27.1 dB/MHz, 95% CI 23.5 – 30.8, t=14.79, p<0.0001) than women, 
as was VOS (males an average of 39.8 m/s higher than women, 95% CI for the 
difference 32.8 – 46.9 m/s, t=11.06, p<0.0001).  Quantitative ultrasound measures 
were significantly lower in individuals with primary hyperparathyroidism (mean BUA 
39.1 dB/MHz, p=0.02 and mean VOS 1544.6 m/s, p<0.05).  There were significantly 
more women with hypovitaminosis D (25-OH-vitamin D <30 nmol/L) than men, 
χ2=15.13, p<0.0001). 
 
Resident mobility was assessed by their use of a walking aid (Table 6.2).  Individuals 
were ranked on their minimum requirements; a resident classified as using a walking 
frame was unable to walk only using a stick.  Those individuals classified as ‘unable 
to walk unassisted’ could mobilize with the assistance of nursing staff, but were 
unable to walk independently using a walking frame. 
 
Table 6.2:  Number (%) of men and women classified by mobility. 
Mobility  Men (n=262) Women (n=970) Total group (n=1232)
No walking aid 94 (35.9%) 287 (29.6%) 381 (30.9%) 
Walking stick 65 (24.8%) 213 (22.0%) 278 (22.6%) 
Walking frame 59 (22.5%) 324 (33.4%) 383 (31.1%) 
Unable to walk 44 (16.8%) 146 (15.1%) 190 (15.4%) 
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6.3.3  Vitamin D supplementation 
Those individuals receiving vitamin D supplementation at the time of enrolment into 
the study have been retained in the analysis.  There is no statistically significant 
difference in BUA between these people and those not receiving supplements 
(supplemented group BUA=48.3 dB/MHz compared to 52.4 dB/MHz in the non-
supplemented group, mean difference 4.1 dB/MHz, 95% confidence interval for the 
difference -0.7 to 8.9 dB/MHz, p=0.1).  For the whole group, VOS is significantly 
lower in the supplemented group (1558.9 m/s compared to 1569.2 m/s in the non-
supplemented, mean difference 10.3 m/s, 95% CI 0.1 to 20.6, p=0.047).  When the 
cohort is split by gender (Table 6.3), vitamin D supplementation has no effect on 
either BUA or VOS measures in men or women.   
 
Table 6.3:  Comparison of residents on vitamin D supplementation at baseline with 
those not receiving supplements. 
Male Female  
Vit D Suppl No Suppl Vit D Suppl No Suppl 
N 16 (6%) 248 (94%) 115 (11.5%) 864 (88.5%) 
Age (mean (sd)) 81.2 (7.3) 83.2 (7.7) 86.9 (5.2) 86.8 (6.5) 
BUA (dB/MHz) 85.6 (26.1) 72.4 (23.4) 42.6 (15.6) 46.5 (18.3) 
VOS (m/s) 1598.3 (39.3) 1599.2 (50.1) 1552.9 (39.1) 1560.2 (43.2) 
25-OH-vitamin D 55.6 (24.2) 31.3 (16.5)* 43.7 (21.9) 26.0 (13.5)* 
*significantly different to supplemented group, p<0.05 
 
6.3.4  Quantitative ultrasound and 25-OH-vitamin D 
Figures 6.1 to 6.3 show the linear relationship between 25-OH-vitamin D and QUS 
parameters.  In order to examine these relationships more closely, it was necessary to 
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log-transform 25-OH-vitamin D to fulfil assumptions of normality (as shown in 
Chapter 5) for univariate analysis.    In men, BUA was not significantly related to log 
transformed 25-OH-vitamin D (F=3.13, p=0.08) or lnPTH (F=1.88, p=0.2).  In 
women, mean BUA was significantly associated with lnPTH (F=4.30, p=0.04) but not 
with log transformed 25-OH-vitamin D (F=1.51, p=0.2).  Mean VOS was not 
associated with 25-OH-vitamin D or PTH in men (25-OH-vitamin D, F=3.09, p=0.08; 
PTH F=1.49, p=0.2) or in women (25-OH-vitamin D, F=1.69, p=0.2; PTH F=2.69, 
p=0.2).   
 
Figure 6.1:  Mean BUA and VOS vs 25-OH-vitamin D in men 
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Figure 6.2:  Mean BUA and VOS vs 25-OH-vitamin D in women 
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Figure 6.3:  Mean BUA and VOS vs 25-OH-vitamin D in the whole cohort 
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6.3.5  Univariate associations with BUA and VOS 
Those variables shown to be related to BUA and VOS in Chapter 4 were also included 
for analysis.  Univariate analysis of mean BUA in men showed a significant 
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relationship between BUA and weight (F=23.23, p<0.0001), but BUA was not related 
to age (F=0.25, p=0.6).  In women, mean BUA was significantly associated with age 
(F=21.45, p<0.0001) and weight (F=102.47, p<0.0001).  Mean VOS in men did not 
reveal statistically significant associations with either age (F=0.009, p=0.9) or weight 
(F=1.32, p=0.3).  In women, mean VOS was significantly associated with both age 
(F=11.87, p=0.001) and weight (F=8.53, p=0.004).  Serum albumin was not 
associated with BUA in men (F=-0.093, p=0.93) or with VOS in men (F=-0.516, 
p=0.61).  Similarly in women, there was no association between albumin and BUA 
(F=ß0.572, p=0.57) or between albumin and VOS (F=-0.202, p=0.84) 
 
Interestingly, when men and women are considered together, univariate analysis 
reveals that mean BUA is significantly associated with age (F=39.95, p<0.0001), 
weight (F=266.74, p<0.0001), lnPTH (F=14.21, p<0.0001) and 25-OH-vitamin D 
(F=10.95, p=0.001), and mean VOS also shows statistically significant univariate 
associations with age (F=24.43, p<0.0001), weight (F=51.77, p<0.0001), lnPTH 
(F=9.10, p=0.003) and vitamin D (8.77, p=0.003).  Serum albumin was not associated 
with BUA (F=0.393, p=0.70) or with VOS (F=0.053, p=0.96) in the whole group. 
 
Both QUS measures and 25-OH-vitamin D levels decrease with decreasing mobility 
as measured by the use of walking aids in men and women (table 6.4).  In men, QUS 
variables are significantly higher in more mobile individuals (for BUA, F=4.64, 
p=0.004, and for VOS F= 4.51, p<0.0001), and serum 25-OH-vitamin D levels are 
higher (F=3.51, p=0.02).  Similarly significant relationships are seen in women, with 
higher mobility inferring higher BUA (F=22.6, p<0.0001), VOS (F=21.7, p<0.0001) 
134 
and serum 25-OH-vitamin D (F=7.7, p<0.0001).  These relationships are shown 
pictorially in Figures 6.4 and 6.5. 
 
 
Table 6.4:  Mean QUS and 25-OH-vitamin D levels for each category of mobility in 
men and women. 
 Mobility Men (mean (sd)) Women (mean (sd)) 
Independent 79.8 (23.3) 52.5 (16.2) 
Stick 74.9 (23.1) 48.6 (18.3) 
Frame 69.6 (25.6) 42.9 (17.6) 
BUA (dB/MHz) 
Unable to walk 62.8 (19.4) 38.0 (17.5) 
Independent 1615.1 (48.1) 1576.1 (41.2) 
Stick 1597.3 (48.8) 1561.2 (45.4) 
Frame 1591.2 (53.2) 1550.4 (38.9) 
VOS (m/s) 
Unable to walk 1581.2 (41.9) 1544.1 (42.9) 
Independent 36.0 (18.2) 29.2 (15.3) 
Stick 35.0 (16.2) 30.4 (16.0) 
Frame 29.9 (19.6) 28.3 (16.3) 
25-OH-vitamin D 
(nmol/L) 
Unable to walk 26.8 (16.5) 22.7 (13.9) 
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Figure 6.4:  Box and whisker plots* of BUA and VOS related to level of mobility in the 
whole cohort. 
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Figure 6.5:  Box and whisker plots* of 25-OH-vitamin D levels related to level of 
mobility in the whole cohort. 
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Both BUA and VOS were significantly lower in nursing home residents than in hostel 
dwellers.  In men, mean BUA in nursing homes was 69.53 dB/MHz, compared to 
77.40 dB/MHz in hostels (mean difference 7.87 dB/MHz, 95% CI 1.20 – 14.53, 
p=0.02), and mean VOS in nursing homes was 1590.79 m/s compared to 1608.77 m/s 
in hostels (mean difference 18.00 m/s, 95% CI 4.14 – 31.83 m/s, p=0.01).  In women, 
mean BUA in nursing homes was 41.77 dB/MHz, compared to 50.50 dB/MHz in 
hostels (mean difference 8.74 dB/MHz, 95% CI 6.18 – 11.29, p<0.0001), and mean 
VOS in nursing homes was 1551.39 m/s compared to 1537.74 m/s in hostels (mean 
difference 16.35 m/s, 95% CI 10.17 – 22.53 m/s, p<0.0001). 
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6.3.6  Hypovitaminosis D and QUS measures 
In order to establish the existence of a distinct 25-OH-vitamin D level below which 
BUA and VOS are significantly low, QUS parameters were plotted against quintiles 
of vitamin D (Figure 6.6).  Low levels of vitamin D are seen to correspond to low 
levels of both BUA and VOS, but the cut-off value is approximately 22 nmol/L, lower 
than that identified by secondary hyperparathyroidism (Chapter 5). 
 
Figure 6.6:  Mean BUA and VOS values relating to 25-OH-vitamin D quintiles 
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When men and women are considered separately, hypovitaminosis D (defined at two 
different cut-off levels, 25-OH-vitamin D <30 nmol/L as was related to secondary 
hyperparathyroidism in Chapter 5, and 25-OH-vitamin D <22 nmol/L, as is suggested 
by Figure 6) was not related to either BUA or VOS (tables 6.5, 6.6) in men.  A cut-off 
of 30 nmol/L was also too high to show a significant relationship between 25-OH- 
vitamin D and QUS in women; using the lower cut-off of 22 nmol/L revealed 
significantly lower BUA in these vitamin D-deficient women, but no significant 
differences in VOS.  When the group was combined, both QUS variables are 
significantly lower in individuals with either definition of hypovitaminosis D.   
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Table 6.5:  Unadjusted relationship between hypovitaminosis D and QUS variables 
(where the mean difference is the magnitude of QUS in 25-OH-vitamin D replete 
residents less QUS in residents with 25-OH-vitamin D < 30 nmol/L) 
  Mean 
difference 
95% CI t p 
BUA (dB/MHz) Men 4.32 -2.52 – 11.16 1.25 0.2 
 Women 1.94 -0.89 – 4.78 1.35 0.2 
 Total cohort 4.43 1.38 – 7.49 2.85 0.005*
VOS (m/s) Men 9.47 -4.78 – 23.72 1.31 0.2 
 Women 5.46 -1.31 – 12.23 1.58 0.1 
 Total cohort 9.22 2.47 – 15.96 2.79 0.005*
*statistically significant at p<0.05 
 
Table 6.6:  Unadjusted relationship between hypovitaminosis D and QUS variables 
(where the mean difference is the magnitude of QUS in 25-OH-vitamin D replete 
residents less QUS in residents with 25-OH-vitamin D < 22 nmol/L) 
  Mean 
difference 
95% CI t p 
BUA (dB/MHz) Men 3.49 -3.52 – 10.50 0.98 0.3 
 Women 3.08 0.45 – 5.71 2.30 0.02* 
 Total cohort 4.87 1.98 – 7.77 3.30 0.001*
VOS (m/s) Men 9.44 -5.13 – 24.00 1.28 0.2 
 Women 5.65 -0.65 – 11.95 1.77 0.08 
 Total cohort 8.91 2.75 – 15.07 2.84 0.005*
*statistically significant at p<0.05 
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6.3.7  Independent predictors of BUA and VOS 
Results for multivariate analysis for BUA and VOS are shown in Table 6.7.  All 
variables which were significantly associated with the QUS parameters (age, gender, 
institution type, mobility, lnPTH, ln25-OH-vitamin D, weight) were included in the 
analysis.  Only mobility, lnPTH, weight and gender remain independently related to 
BUA in this elderly population, accounting for 41% of the variability of BUA.  VOS 
is predicted by mobility, weight and gender alone, comprising 21% of the variability 
of VOS.  25-OH-vitamin D becomes nonsignificant in both models.  When a binomial 
variable of ‘hypovitaminosis D’ is substituted for the continuous log transformed 25-
OH-vitamin D variable,  hypovitaminosis D is not an independent predictor of either 
BUA or QUS for either a 22 or 30nmol/L cut-off (p>0.8), data not shown.  
 
 
Table 6.7:  Multivariate analysis of BUA and VOS  
 Variable β t p 
Mobility -0.239 -9.032 0.0001 
lnPTH -0.058 -2.177 0.03 
Weight 0.315 10.904 0.0001 
BUA 
R2 = 0.41 
Gender (female) -0.366 -12.613 0.0001 
Mobility -0.259 -8.461 0.0001 
Weight 0.093 2.775 0.006 
VOS 
R2 = 0.21 
Gender (female) -0.318 -9.500 0.0001 
Excluded from model:  For BUA: Age, Institution, lnvitD.  For VOS: Age, Institution, lnvitD, lnPTH. 
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When men and women are considered separately, slightly different parameters are 
independent predictors for QUS (Tables 6.8, 6.9), but 25-OH-vitamin D levels remain 
unrelated to BUA and VOS. 
 
Table 6.8:  Multivariate analysis of BUA (dB/MHz) in men and women 
 Variable β t p 
Mobility -0.265 -3.819 0.0001 
Age 0.215 3.061 0.003 
Men 
R2 = 0.19 
Weight 0.345 4.980 0.0001 
Mobility -0.261 -6.792 0.0001 
Weight 0.336 9.714 0.0001 
Institution -0.083 -2.138 0.03 
Women 
R2 = 0.23 
 
lnPTH -0.069 -2.030 0.04 
Excluded from model:  For men: Institution, lnvitD, lnPTH.  For women: Age, lnvitD. 
 
Table 6.9:  Multivariate analysis of VOS (m/s) in men and women 
 Variable β t p 
Men 
R2 = 0.06 
Mobility -0.245 -3.358 0.001 
Mobility -0.284 -7.682 0.0001 
Weight 0.086 2.293 0.02 
Women 
R2 = 0.10 
 Age -0.075 -1.985 0.05 
Excluded from model:  For men: Age, Institution, lnvitD, lnPTH, weight.  For women: Institution, 
lnvitD, lnPTH. 
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6.4   Discussion 
Vitamin D deficiency was extremely common in both elderly men and women living 
in institutions in Sydney, but serum 25-OH-vitamin D was not independently 
associated with BUA or VOS in this study.  Elderly populations have previously been 
reported as having low 25-OH-vitamin D levels (327;339) at similar latitudes in 
Europe and the US, and a case-control study of elderly men in Virginia showed 25-
OH-vitamin D levels to be significantly lower in men residing in nursing homes than 
living independently (326).  There is some observational evidence suggesting that 25-
OH-vitamin D levels relate to bone mass.  In a group of postmenopausal women 
undergoing screening for osteoporosis, those with subclinical vitamin D deficiency 
were found to have lower vertebral bone mass as measured by quantitative computed 
tomography than those with normal 25-OH-vitamin D levels (364).  A Spanish group 
has also recently shown a correlation between 25-OH-vitamin D levels and BMD at 
the lumbar spine and femoral neck in otherwise healthy postmenopausal women 
(358).   
 
However the relationship between QUS measures and 25-OH-vitamin D is not as 
clear.  A cross-sectional study of elderly institutionalized men and women showed 25-
OH-vitamin D levels to be associated with both BUA and VOS, largely through the 
effect of secondary hyperparathyroidism (365).   Calcium and vitamin D 
supplementation in this group was shown to have a significant beneficial effect on 
BUA over 2 years compared to placebo, but no effect on VOS (110).  An 
observational study of perimenopausal women did not reveal a similar association 
between vitamin D supplementation and QUS measures in this younger cohort (366).  
In the FREE study, cross-sectional analysis did not reveal a relationship between 
vitamin D supplementation and BUA or VOS, despite significantly higher 25-OH-
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vitamin D levels in the supplemented group.  This may be related to the small 
numbers of patients receiving vitamin D supplements, since the trend in women was 
for those on supplements to have lower BUA and VOS measures (despite not 
reaching statistical significance).  It may be that these individuals were preferentially 
identified as having a high risk of osteoporosis and thus self-selected to have lower 
QUS readings.   
 
Serum 25-OH-vitamin D was univariately related to BUA in this group of frail elderly 
men and women.  When vitamin D status was considered as ‘hypovitaminosis D’ at a 
cut-off of <30nmol/L or <22nmol/L, those individuals classified as being vitamin D 
deficient had significantly lower BUA and VOS measures.   This suggests that a 25-
OH-vitamin D level less than 30nmol/L may have an important effect on bone health 
(as there is on the development of secondary hyperparathyroidism, seen in Chapter 5).  
Prospective studies of QUS as a predictor of fracture have shown that a decrease of 1 
standard deviation in BUA is associated with an approximate doubling of hip fracture 
risk (54;56;58); the clinical significance of the smaller differences in BUA shown in 
this study is not clear but prospective fracture analysis will address this issue.  When 
VOS is considered, a distinct cut-off to define ‘hypovitaminosis D’ is not so clear, and 
seems to be higher as seen in Figure 6.6.  However, the previous studies of 
prospective fracture support the lower cut-off seen with BUA (22-30nmol/L).  
Prospective fracture data from the FREE study will help to more clearly elucidate 
whether BUA or VOS is more important for fracture risk in this frail elderly cohort. 
 
It makes sense to assess 25-OH-vitamin D levels in relation to serum PTH levels, as 
this will reflect changes over a shorter time frame.  Quantitative ultrasound is 
measuring the outcome of longer periods of vitamin D deficiency.   Nevertheless, this 
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has important clinical implications, with univariate analysis suggesting that vitamin D 
supplementation in the elderly should be considered even in mild cases of suboptimal 
serum 25-OH-vitamin D, and widens the population at risk of impaired bone 
metabolism.  If those patients with low 25-OH-vitamin D levels can be identified 
before longstanding bone changes have occurred, then any intervention is likely to be 
more successful in ultimate fracture prevention. 
 
Independent predictors of BUA include mobility, weight, gender and PTH but not 25-
OH-vitamin D.  However, when mobility is not included in the analysis, 25-OH-
vitamin D remains in the model as a significant independent predictor.  It has been 
shown that 25-OH-vitamin D levels are strongly linked to mobility, which suggests 
that 25-OH-vitamin D is either an intervening variable that plays a role in determining 
mobility perhaps by improving muscle strength (and hence is lost in a multivariate 
analysis), or that mobility is a strong determinant of vitamin D status independent of 
bone health.  Weight bearing is important in maintaining BMD, and hence it is logical 
to assume that the relationship between mobility and QUS measures might be solely 
due to the amount of time a resident spends standing or walking.  The picture is 
complicated by vitamin D, as an individual who is more mobile is more likely to get 
outside into the sunlight and have adequate UV light exposure to synthesize vitamin 
D.  Conversely, if it is assumed that vitamin D plays a role in maintaining muscle 
strength (200;202), it may be that those individuals with higher 25-OH-vitamin D 
levels are going to be more mobile independent of sunlight exposure.  It is likely that 
25-OH-vitamin D, mobility and QUS are closely entwined in elderly persons; the 
relationship between 25-OH-vitamin D and muscle strength relating to falls will be 
addressed in Chapter 7. 
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Parathyroid hormone levels remain an independent predictor of BUA but not VOS in 
multivariate analysis.  It has been shown previously in case control studies that 
primary hyperparathyroidism is associated with low BUA measures (367-369), and 
that surgical correction results in significant improvement of BUA but not VOS (367).  
This is supported by the lower BUA seen in individuals with biochemical primary 
hyperparathyroidism in this elderly cohort.  When secondary hyperparathyroidism is 
considered, Krieg et al (365) in a smaller study of 264 women and 103 men living in 
aged care facilities found that VOS was also related to PTH levels, but did not correct 
for mobility.  It was suggested that the relationship between secondary 
hyperparathyroidism and QUS is likely to be mediated by low 25-OH-vitamin D 
levels, but the bone changes reflect the effect of the PTH levels directly rather than 
vitamin D deficiency.  Continuous exposure to PTH at a bone level results in 
mobilization of calcium from the bone surface (370) and to an increase in the number 
and activity of osteoclasts (371), and secondary hyperparathyroidism might therefore 
predispose to changes which might be detectable by QUS.   
 
Vitamin D and PTH play a role in determining BUA and VOS at the calcaneus in the 
frail elderly, however how much is a direct action on bone and how much is via 
improved general health and mobility is not clear.  Nevertheless, this study gives 
further evidence to support vitamin D supplementation in D-deficient elderly persons. 
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CHAPTER 7 
 
 
VITAMIN D AND PTH AND THEIR RELATIONSHIP TO 
FALLING IN THE ELDERLY 
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7.1   Introduction 
Falling is a serious health problem in the elderly, bring with it significant morbidity 
and mortality.  There are a myriad of factors associated with an increased risk of 
falling in this group, including increasing age, balance, muscle strength and cognitive 
function (Chapter 1.4).  The elderly are at particularly high risk, with 33% of 
community dwellers over the age of 65 having at least one fall each year 
(176;177;372).  The risk is higher in the institutionalized elderly (293;294;373),  and 
it is estimated that 6-7% of fallers sustain a fracture as a direct result of falling 
(177;374). 
 
Vitamin D levels are low in residents of aged care facilities (326;327) as seen in 
Chapter 5, due to inadequate sunlight exposure, impaired ability to convert vitamin D 
in the skin and poor diet.  Vitamin D insufficiency has also been related to poorer 
muscle strength (200;375), which could logically increase the risk of falling in this 
group.  Cross-sectional studies have not consistently shown a higher incidence of falls 
in vitamin D deficiency (176;376-378).  There is one large prospective study of time 
to first fall in women living in residential care (379) which shows that lower 25-OH-
vitamin D levels are related to a shorter time to falling.   
 
Parathyroid hormone has also been shown to be indirectly associated with muscle 
strength, with secondary hyperparathyroidism patients exhibiting muscle weakness 
(380).  One study of falls in the elderly describes an independent association of higher 
PTH levels with an increased falls risk (OR 5.6 for each natural logarithmic unit of 
PTH) (208). 
 
147 
This study aims to: 
     (1)  Prospectively measure the incidence of falls in a population of elderly 
residents of aged care facilities in Sydney, Australia   
     (2)  Describe the demographic factors associated with falling in aged care facilities 
     (3)  Describe the association between serum 25-OH-vitamin D levels and 
prospective falls in the elderly 
     (4)  Describe the association between serum PTH levels and prospective falls in 
the elderly 
     (5)  Establish the independent factors, both physical and biochemical, associated 
with prospective falls in the institutionalized elderly.  Do 25-OH-vitamin D and PTH 
both contribute to falls risk in this population?
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7.2   Methods 
 
7.2.1  Subjects 
The first 1010 women and 270 men enrolled in the FREE study to reach one year of 
prospective follow up have been included in this analysis.  All falls and deaths were 
recorded over the follow up period, as described in Chapter 2. 
 
7.2.2 Measurements 
Measurements of physical function and biochemistry are described in full in Chapter 
2.  Potential risk factors for falling in an elderly population, including age, weight, 
type of accommodation, urinary incontinence, cognitive function and overall health as 
assessed by both RCS and implicit review were recorded.  Two different methods of 
assessing balance were examined: the 30 second stand test on both firm and pliable 
surfaces, and the use of a walking aid in daily life as a surrogate for balance on 
mobilization.   
 
7.2.3  Statistical analysis 
Baseline characteristics were examined with relation to falls status using independent 
t-tests for continuous variables and chi-square tests for categorical variables.  Risk to 
first fall was calculated using proportional cox regression.  
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7.3   Results 
 
7.3.1  Distribution of falls 
The number of falls occurring in the study population at 6 and 12 months is shown in 
Table 7.1.  There was no significant difference in the incidence of falls at 6 months 
(χ2=16.78, df=15, p=0.3) or at 12 months (χ2=31.65, df=23, p=0.1) between men and 
women.  In the first 6 months of follow-up, there were more falls in hostels than in 
nursing homes (χ2=26.96, p=0.03) but there was no significant difference between 
institution type after 12 months follow up (χ2=32.90, p=0.08). 
 
Table 7.1:  Incidence of falls at 6 and 12 months in men and women 
At 6 months At 12 months  
Men  
(N=270) 
Women 
(N=1010) 
Men  
(N=270) 
Women 
 (N=1000) 
No falls 172 (64%) 628 (62%) 142 (53%) 492 (49%) 
1 fall 48 (18%) 203 (20%) 51 (19%) 224 (22%) 
2 falls 14 (5%) 73 (7%) 21 (8%) 98 (10%) 
3 falls 16 (6%) 39 (4%) 11 (4%) 64 (6%) 
4 falls 4 (2%) 20 (2%) 6 (2%) 34 (3%) 
5 falls 6 (2%) 20 (2%) 9 (3%) 17 (2%) 
6 falls 2 (0.7%) 7 (0.7%) 7 (3%) 24 (2%) 
7 falls 1 (0.4%) 9 (1%) 3 (1%) 11 (1%) 
8 falls 1 (0.4%) 2 (0.2%) 2 (0.7%) 13 (1%) 
9 falls 3 (1%) 3 (0.3%) 2 (0.7%) 6 (0.6%) 
>=10 falls 3 (1%) 6 (0.6%) 16 (6%) 27 (3%) 
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7.3.2  Serum 25-OH-vitamin D and balance 
At baseline, univariate analysis showed serum 25-OH-vitamin D was significantly 
related to balance (F=14.09, df 4, p<0.0001) and to implicit review score (F=4.31, df 
3, p=0.005).  Those individuals who performed badly in either score were seen to 
have lower 25-OH-vitamin D levels than those with better balance performance 
(Figure 7.1) or higher implicit review scores (Figure 7.2).  Balance was measured on 
both a firm and compliant surfaces, as described in Chapter 2.3, with 1 being an 
inability to stand for any length of time unaided on a firm surface and 5 being able to 
stand on a pliable surface for 30 seconds unsupported. 
 
Figure 7.1:  Relationship between mean 25-OH-vitamin D levels and balance  
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Table 7.2:  Independent determinants of balance 
 χ2 statistic P value 
25-OH-vitamin D < 30nmol/L 67.12 <0.0001 
Age 32.65 <0.0001 
Weight 27.73 <0.0001 
Gender 11.86 0.02 
Incontinence 91.00 <0.0001 
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Logistic regression modeling showed that the relationships between hypovitaminosis 
D and balance (Table 7.2) and between low 25-OH-vitamin D and implicit review 
(Table 7.3) were independent of age, weight, gender or presence of urinary 
incontinence . 
 
Figure 7.2:  Relationship between mean 25-OH-vitamin D levels and function, as 
graded by the implicit review score. 
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Table 7.3:  Independent determinants of implicit review score 
 χ2 statistic P value 
25-OH-vitamin D < 30nmol/L 22.53 <0.0001 
Age 5.05 0.17 
Weight 19.88 <0.0001 
Gender 4.59 0.21 
Incontinence 51.90 <0.0001 
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Table 7.4:  Baseline characteristics and status with respect to falls at 6 months 
Characteristics No falls in 6 months One or more falls P value 
Age (years) 85.5 +/- 6.9 86.7 +/- 6.7 0.004* 
Female sex (%) 628 (78.5%) 382 (79.6%) 0.67 
Hostel accommodation (%) 483 (60.4%) 235 (49.0%) <0.0001* 
Walking aid (%) <0.0001* 
     No walking aid 252 (31.5%) 137 (28.5%)  
     Walking stick 194 (24.3%) 92 (19.2%)  
     Walking frame 216 (27.0%) 184 (38.3%)  
     Unable to walk 134 (16.8%) 60 (12.5%)  
Balance   <0.0001* 
     Unable to stand unassisted  154 (66.4%) 78 (33.6%)  
     Stands for <30 seconds 61 (47.7%) 67 (52.3%)  
     Stands 30 seconds on firm surface 99 (45.8%) 117 (54.2%)  
     Stands <30 seconds on soft surface 186 (60.2%) 123 (39.8%)  
     Stands 30 seconds on soft surface 297 (76.3%) 92 (23.7%)  
Weight (kg) 60.6 +/- 13.7 57.9 +/- 13.0 0.001* 
BUA (dB/MHz) 51.7 +/- 22.1 50.45 +/- 22.7 0.44 
VOS (m/s) 1566.0 +/- 45.7 1567.3 +/- 47.6 0.62 
25-OH-vitamin D (median) (nmol/L) 29.6 +/- 17.0 (26) 27.7 +/- 15.2 (24) 0.04* 
PTH (median) (pg/mL) 75.1 +/- 71.9 (57.8) 79.5 +/- 67.6 (59.5) 0.28 
SMMSE 21.6 +/- 8.1 19.2 +/- 8.7 <0.0001* 
Resident classification    <0.0001* 
     RCS 1 72 (9.0%) 48 (10.0%)  
     RCS 2 142 (17.8%) 113 (23.5%)  
     RCS 3 96 (12.0%) 95 (19.8%)  
     RCS 4 26 (3.3%) 19 (4.0%)  
     RCS 5 64 (8.0%) 40 (8.3%)  
     RCS 6 115 (14.4%) 50 (10.4%)  
     RCS 7 203 (25.4%) 87 (18.1%)  
     RCS 8 73 (9.1%) 19 (4.0%)  
Implicit review   <0.0001* 
     No symptoms 32 (80%) 8 (20%)  
     Mild symptoms 255 (72.4%) 97 (27.6%)  
     Moderate and severe symptoms 505 (57.7%) 361 (42.3%)  
Incontinence 352 (68.3%) 163 (31.7%) <0.0001* 
 *statistically significant p<0.05. 
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Table 7.5:  Baseline characteristics and status with respect to falls at 12 months 
Characteristics No falls in 12 months One or more falls P value 
Age (years) 85.4 +/- 6.8 86.5 +/- 6.8 0.005* 
Female sex (%) 492 (77.6%) 518 (80.2%) 0.27 
Hostel accommodation (%) 388 (61.2%) 330 (51.1%) <0.0001* 
Walking aid (%) <0.0001* 
     No walking aid 203 (32.1%) 184 (28.9%)  
     Walking stick 152 (24.1%) 134 (21.0%)  
     Walking frame 162 (25.6%) 238 (37.4%)  
     Unable to walk 113 (17.9%) 81 (12.7%)  
Balance   <0.0001* 
     Unable to stand unassisted  130 (56.0%) 102 (44%)  
     Stands for <30 seconds 45 (35.2%) 83 (64.8%)  
     Stands 30 seconds on firm surface 70 (32.4%) 146 (67.6%)  
     Stands <30 seconds on soft surface 137 (44.3%) 172 (55.7%)  
     Stands 30 seconds on soft surface 250 (64.3%) 139 (35.7%)  
Weight (kg) 60.3 +/- 13.8 59.0 +/- 13.2 0.10 
BUA (dB/MHz) 51.4 +/- 22.2 52.0 +/- 23.4 0.71 
VOS (m/s) 1565.0 +/- 45.1 1568.0 +/- 47.6 0.26 
25-OH-vitamin D (median) (nmol/L) 30.2 +/- 17.0 (26) 28.0 +/- 15.6 (24) 0.006* 
PTH (median) (pg/mL) 73.3 +/- 70.0 (56.9) 80.1 +/- 70.6 (59.5) 0.09 
SMMSE 21.8 +/- 8.1 19.6 +/- 8.5 <0.0001* 
Resident classification    <0.0001* 
     RCS 1 55 (8.8%) 65 (10.2%)  
     RCS 2 112 (17.9%) 143 (22.5%)  
     RCS 3 74 (11.8%) 117 (18.4%)  
     RCS 4 21 (3.3%) 24 (3.8%)  
     RCS 5 46 (7.3%) 58 (9.1%)  
     RCS 6 91 (14.5%) 74 (11.7%)  
     RCS 7 172 (27.4%) 118 (18.6%)  
     RCS 8 56 (8.9%) 36 (5.7%)  
Implicit review   <0.0001* 
     No symptoms 32 (80.0%) 8 (20.0%)  
     Mild symptoms 210 (59.7%) 142 (40.3%)  
     Moderate symptoms 386 (44.1%) 489 (55.9%)  
Incontinence 294 (57.1%) 221 (42.9%) <0.0001* 
*statistically significant p<0.05 
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Tables 7.4 and 7.5 show the baseline characteristics of those residents who suffered 
one or more falls over 6 and 12 months respectively, compared to residents who did 
not fall over the same period.  Fallers were seen to be older, more likely to use a 
walking aid, of lower weight and requiring more nursing care (as measured by 
resident classification score, RCS) than non-fallers.  Fallers had lower serum 25-OH-
vitamin D levels than non-fallers, but PTH levels were not significantly different 
between the groups although there was a trend at 12 months.  Similar relationships 
were seen at both 6 and 12 months, and so further analyses have been limited to 12 
month data.  Time to first fall was calculated, as it gives more useful information than 
simple comparisons between fallers and non-fallers.  
 
7.3.3  Survival analysis 
The median time from baseline assessment to first fall was 274 days (range 244 to 
304 days).  One hundred and eighty-seven residents (14.6%) died over the first 12 
months of follow-up.  The incidence of a first fall decreased over time as shown in 
Figure 7.3, censoring residents at the time of their first fall, at death or at the end of 
follow-up.  Serum 25(OH)D distribution was close to normal for this subgroup and 
hence not log transformed; PTH was log transformed to preserve analysis 
assumptions.  
 
When time to first fall was considered (Table 7.6), similar relationships were seen 
with baseline demographic variables as were seen with fall status.    
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Figure 7.3:  Survival curve for time to first fall. 
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Table 7.6:  Univariate associations with time to first fall 
 LR Wald statistic P value 
Age 1.02 15.28 <0.0001* 
Institution type 0.71 19.20 <0.0001* 
Walking aid N/A 33.15 <0.0001* 
Balance N/A 27.77 <0.0001* 
SMMSE 0.98 34.43 <0.0001* 
RCS N/A 43.38 <0.0001* 
Implicit review N/A 10.26 0.016* 
Weight 0.99 9.40 0.002* 
Incontinence 1.37 6.21 0.013* 
25-OH-vitamin D 1.00 3.55 0.06 
PTH 1.00 4.99 0.025* 
*statistically significant at p<0.05. 
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Cox regression analysis results for the entire cohort are shown in Table 7.7.  
Independent predictors for falling included increasing age (p =0.001), poor balance 
(p=0.001), incontinence (p=0.06) and implicit review (p=0.10).  Whether treated as a 
continuous or a categorical variable (using cutoffs for hypovitaminosis D as described 
in Chapter 5), serum 25-OH-vitamin D was not significantly related to falling.   
 
Table 7.7:  Survival analysis for time to first fall 
 Hazards ratio (HR) 95% Confidence Interval P value 
  Lower Upper  
Age 1.03 1.01 1.05 0.001 
Incontinence 1.28 0.99 1.65 0.058 
Balance N/A N/A N/A 0.001 
Implicit review N/A N/A N/A 0.10 
Excluded variables:  25-OH-vitamin D, lnPTH, SMMSE 
 
Because it has previously been shown there may be different risk factors for falls in 
the population according to whether a subject can stand or not (381), a subgroup 
analysis was performed in more healthy individuals, ie. those aged < 90 years, 
relatively independent (RCS >=5) and able to walk.    Univariate analysis in this 
subgroup of 455 residents showed 25-OH-vitamin D was related to time to first fall 
(HR 0.99, 95% CI 0.98-1.00, p=0.002).  However in multivariate analysis that 
included age, balance, continence status and cognitive function, 25-OH-vitamin D 
was no longer significant (Table 7.8).  In univariate analysis, serum PTH (log 
transformed) was also related to time to first fall (HR 1.43, 95% CI 1.20-1.70, 
p<0.0001).  In multivariate analysis, PTH remained significant (HR 1.52, CI 1.21-
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1.91, p<0.0001) as shown in Table 7.8.  However PTH was not independently related 
to falls in elderly residents over the age of 90 years (p=0.9). 
 
Table 7.8:  Survival analysis for time to first fall in residents aged <90 years with 
RCS >=5 and able to walk. 
 Hazards ratio (HR) 95% Confidence Interval P value 
  Lower Upper  
lnPTH 1.52 1.21 1.91 <0.0001 
SMMSE 0.97 0.94 1.00 0.047 
Incontinence 1.51 1.11 2.05 0.009 
Balance N/A N/A N/A <0.0001 
Implicit review N/A N/A N/A 0.017 
Excluded variables:  25-OH-vitamin D 
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7.4   Discussion 
This study showed that 50% of residents in aged care facilities in Sydney will have 
one or more falls over a year, most of which occurred in the first 6 months.  Fallers 
were more likely to live in hostels than nursing homes, were slightly older, lighter, 
more cognitively impaired, more likely to be incontinent and had poorer balance and 
general health scores than non-fallers, consistent with current falls literature (Chapter 
1.4).  Fallers had significantly lower 25-OH-vitamin D levels than non-fallers (median 
25-OH-vitamin D level for fallers 24 nmol/L, compared to 26 nmol/L for residents 
who did not fall).  Parathyroid hormone levels showed a trend towards being higher in 
fallers although this did not reach statistical significance. 
 
It is considered that low 25-OH-vitamin D levels increase fracture risk (382) and that 
supplementation reduces the incidence of fractures in the elderly (383;384), but 
perhaps this effect may not be solely through changes in bone mass such as those seen 
in Chapter 6.  Vitamin D deficiency may lead to reduced muscle strength through loss 
of type 2 muscle fibres (385), and hence an increased risk of falling.  Cross-sectional 
studies relate lower 25-OH-vitamin D levels to reduced quadriceps and grip strength 
in elderly people (386;387).  Bischoff et al (200) examined the relationship between 
muscle strength and vitamin D deficiency in ambulatory elderly subjects (103 women, 
216 men, mean age for women 74, for men 77 years).  Twelve percent of women and 
18% of men had 25-OH-vitamin D values below the normal range (< 30 nmol/L).  
Strength of leg extension showed a modest, but significant, positive correlation with 
25-OH-vitamin D in male but not female subjects.  A study of both independent living 
and hospitalized people over 70 years of age (377) showed serum 25-OH-vitamin D 
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levels were significantly lower in those with poorer handgrip strength and stair-
climbing ability. 
 
 Interventional studies have shown varied results.  A small study in elderly women 
(378) showed that 6 months of vitamin D replacement improved extensor muscle 
strength and walking distance over 2 minutes in vitamin D-deficient (25-OH-vitamin 
D <20 nmol/L) older women.  Measures of functional ability and activities of daily 
living in the frail elderly have been shown to improve in uncontrolled studies of 
vitamin D supplementation (388;389).  Studies in healthier, non-vitamin D deficient 
populations have failed to show a significant improvement in quadriceps muscle 
function after vitamin D supplementation (390;391).  A comprehensive review of the 
relationship between 25-OH-vitamin D and muscle function published in 2002 (375) 
concluded that there is a threshold effect, with vitamin D deficiency being associated 
with reduced muscle strength but the relationship not persisting in 25-OH-vitamin D 
replete individuals.    
 
Few studies have prospectively looked at the effect of 25-OH-vitamin D levels on 
falling.  Supplementation with oral calcium and vitamin D has been recently shown to 
reduce the incidence of fallers and falls by approximately 50% (230;392).  Our study 
showed that balance was related to serum 25-OH-vitamin D, and that fallers had 
significantly lower 25-OH-vitamin D levels than non-fallers in residents of aged care 
facilities.  This supports findings of a retrospective study by Stein et al (208) in a 
group of 83 ambulatory residents of hostels and nursing homes in Melbourne, 
Australia.  The mean age was 84 years and the median 25-OH-vitamin D level was 27 
(18-37) nmol/L, similar to the participants of the FREE study (393).  Fallers had a 
median 25-OH-vitamin D level of 22 nmol/L, compared to 29 nmol/L for non-fallers 
160 
(p=0.019).  Parathyroid hormone levels were also shown to be significantly associated 
with falling (OR=5.6, 95% CI 1.7-18.5 per logarithmic unit of PTH), independent of 
25-OH-vitamin D levels. 
 
The only large prospective study of vitamin D and falling in residential care facilities 
published to date has been an extension of this Melbourne cohort (379),  measuring 
25-OH-vitamin D and prospective falls in 1261 ambulatory women living in hostels 
and nursing homes.  Higher serum 25-OH-vitamin D levels were independently 
associated with a lower risk for falling (p<0.01).  Parathyroid hormone levels were 
not reported.  When only residents of nursing homes were examined (who as a group 
had a higher incidence of falls than the hostel residents), the relationship was not seen.  
The authors postulate that the relationship might be obscured in this population by the 
substantially higher falls rate in this group.  Our study did not show a relationship 
between vitamin D and falls risk by cox regression analysis, either in the population 
as a whole or in any subgroup analysis.   
 
There are a number of explanations for the discrepancy seen between the two studies.  
Flicker et al found a relationship between 25-OH-vitamin D and time to first fall after 
correcting for psychotropic medication use, the presence of wandering behaviour and 
previous Colles fracture which were not examined in our group.  Likewise, the 
Melbourne group did not report any association between vitamin D and mobility 
which was seen in the FREE study.  It is likely that the use of different cofactors has 
impacted the different relationships seen in the two studies.  If we accept earlier 
findings of differing risk factors for falling in the elderly dependent on frailty (381), 
our results are more in keeping with the Melbourne group. When the frailest elderly 
(aged >90 years or unable to stand unassisted) were excluded from the analysis, a 
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higher serum PTH was independently associated with increased falls risk in Sydney.  
It is plausible that the relationship between 25-OH-vitamin D and time to first fall in 
the more ‘healthy’ elderly population is mediated by PTH.   It is possible that iPTH 
may be a more sensitive marker of vitamin D deficiency than serum 25-OH-vitamin 
D.  Another explanation for the apparent discrepancy between the study of Flicker et 
al and the present study is that the assay used for PTH in the present study was in fact 
a more sensitive marker of vitamin D deficiency than the serum 25OH D assay 
employed.  This merits further studies to tease out the proportional roles of 25-OH-
vitamin D and PTH in falling in the elderly. 
 
High levels of PTH have previously been linked to muscle weakness (380), which 
was reversible after treatment hyperparathyroidism and independent of vitamin D 
status.  It may be that the effect we have seen on falling in this elderly population is 
reflecting a direct action of PTH on muscle, however serum 25-OH-vitamin D levels 
are known to be tightly linked to PTH and it might be that secondary 
hyperparathyroidism is in fact an intermediate variable in the relationship between 
hypovitaminosis D and falling.  The absence of a relationship between 25-OH-vitamin 
D and falling in this subgroup analysis does not support the theory that both 25-OH-
vitamin D and PTH act independently on muscle function and falling; more studies 
are required to further define the relationship.   
 
A similar collinearity problem was encountered with balance, general health and 25-
OH-vitamin D levels.  Residents with lower 25-OH-vitamin D levels had significantly 
poorer balance and worse implicit review scores.  It is likely that the relationship 
between balance and 25-OH-vitamin D is mediated in part by the action of 25-OH-
vitamin D on muscle strength and function.  Serum 25-OH-vitamin D levels may also 
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be an indirect measure of general health, reflecting mobility, nutrition and 
comorbidities which may all contribute to falls risk. 
 
In conclusion, hypovitaminosis D was not shown to be independently predictive of 
falling in the frail institutionalized elderly, but may be indirectly related to falls risk 
through secondary hyperparathyroidism.  Falling in this population is a common 
problem, with multiple interacting factors contributing to increase an elderly person’s 
risk which still need to be adequately defined. 
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8.1   Introduction  
In order to implement preventive health strategies, the first step is to fully understand 
the size of the problem.  Osteoporotic fracture is an important issue both in terms of 
human morbidity and mortality, and with regard to the health care dollar.  Costs 
associated with fracture increase substantially with age (394), just as the incidence of 
fracture also increases.  Those elderly individuals who are too frail to live 
independently are at high risk of falling, of involutional osteoporosis and hence of 
osteoporotic fracture.  This thesis aimed to describe the magnitude of the problem of 
osteoporotic fracture in the frail institutionalized elderly, by assessing risk factors for 
falls and fractures in a large population of elderly residents of hostels and nursing 
homes in Sydney, Australia.  It is hoped that this will provide a valuable baseline 
from which interventional studies can be designed to identify the most appropriate, 
effective strategies for fracture prevention in the frail elderly.
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8.2   Summary and implications of each study 
This thesis described a range of features related to falls and fractures in the frail 
elderly.  The study was unique in being a large, prospective study of risk factors in a 
group of frail elderly people in residential care facilities, a group who have not been 
previously extensively studied. The key findings of this thesis are summarized as 
follows:   
 
(1) Quantitative ultrasound is a reliable tool for assessing bone density in the frail 
elderly, as both precision and sensitivity to longitudinal change were independent 
of age (Chapter 3). 
 
Measurement of BUA and VOS was reliable, least significant change for BUA being 
2.4% and for VOS 0.3% using the CUBA McCue instrument and 2.7% for BUA 
using the Metra QUS-2.  Comparison of the instruments showed the QUS-2 measures 
BUA higher than the CUBA by 1.9 dB/MHz (+/- 9.55 dB/MHz).  Moreover 
classification of individuals as osteoporotic by machine-derived T-score was different 
between instruments (k=0.44 in men and k=0.62 in women).  In women, BUA was 
observed to decrease by 5.2% over 2 years without significant change in VOS, 
suggesting BUA is more useful in longitudinal studies.   
 
Ultrasound measurements at the calcaneus are reliable and sensitive to longitudinal 
change even in the extreme elderly, which makes it a useful tool in frail, immobile 
populations.  Measurements are however instrument-specific, and should be 
interpreted with caution in the assessment of fracture risk.  It is now widely accepted 
that the same machine should be used for progress studies of DEXA measurements; 
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this study extends the recommendation to the use of QUS machines for measuring 
bone.  The same QUS machine should be used for baseline and follow-up 
measurements in longitudinal studies to ensure meaningful conclusions. 
  
(2) There is a high prevalence of low bone density as measured by QUS in the 
frail elderly (Chapter 4). 
 
Broadband ultrasound attenuation and VOS were higher in men than women by 
approximately 30% and 2% respectively, and this difference was maintained at all 
ages.  There was no significant decline in BUA or VOS with age in men; however, for 
women BUA declined by 2.8-4.7% per decade and VOS by 1% per decade.  Mean 
BUA T-scores were -1.55 and -2.48 at age 90 years in men and women. 
 
This study confirms that both men and women of advanced age are at significant risk 
of low bone density.  In a group recognized to have a high incidence of falls, this is 
likely to be an important risk factor for future fracture.   Although limited by its cross-
sectional design, this study suggests only minor bone loss occurs at the calcaneal site 
with very old age in either sex.  Treatment must be aimed not merely at preventing 
bone loss in this group, but at improving bone density in order to reduce potential 
fracture risk. 
 
(3) The prevalence of low 25-OH-vitamin D is high in this population and  
under-treated (Chapter 5). 
 
Over 77% of the population had low serum 25-OH-vitamin D levels compared to the 
laboratory reference range, and almost 41% had secondary hyperparathyroidism.  A 
167 
25-OH-vitamin D cut-off of 30 nmol/L predicted secondary hyperparathyroidism.  
Independent predictors of lower serum 25-OH-vitamin D levels included female 
gender, increasing age, elevated PTH levels, cooler season, decreased mobility and 
lower creatinine clearance. Independent predictors of hypovitaminosis D (25-OH-
vitamin D < 30 nmol/L) included female gender, reduced mobility higher PTH levels, 
and a lower creatinine clearance.  Only 6% of men and 12% of women were on 
vitamin D supplementation.  Vitamin D supplementation conferred significantly 
higher serum 25-OH-vitamin D and lower PTH levels, but this was not apparently 
related to nutritional status as albumin levels were not different between the groups. 
 
Although Sydney has adequate sunlight hours all year long this population was not 
being exposed on a regular basis.  Vitamin D supplementation is a simple and cheap 
intervention strategy that could be undertaken in a frail elderly population to improve 
calcium metabolism, particularly in less mobile individuals. 
 
(4)   The relationship between QUS and 25-OH-vitamin D levels was significant 
only in elderly people who were vitamin D deficient, and secondary 
hyperparathyroidism was an independent predictor of BUA (Chapter 6). 
 
Mean 25-OH-vitamin D levels ranged from 26 nmol/L in female residents of nursing 
homes to 36 nmol/L in male residents of hostels.  Women were more likely to be low 
in vitamin D than men.  There was no difference in BUA between residents on 
vitamin D supplementation and those not receiving therapy.  Univariate associations 
with BUA and VOS included age, weight, serum 25-OH-vitamin D and PTH levels.  
Quantitative ultrasound measures were seen to change significantly at a 25-OH-
vitamin D cut-off of 22 nmol/L, lower than that seen to correspond to secondary 
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hyperparathyroidism in Chapter 5.  Multivariate analysis showed BUA to be 
associated with mobility, gender, weight and PTH but not with serum 25-OH-vitamin 
D.  Velocity of sound was not independently related to 25-OH-vitamin D or to PTH. 
 
This study gives further evidence to support vitamin D supplementation in D-deficient 
elderly persons.  Whether it is the improvement in 25-OH-vitamin D levels which is 
most important to maintain BUA or the suppression of secondary 
hyperparathyroidism is not clear.  The relevance of PTH as an independent factor in 
bone density in the elderly requires further exploration. 
 
(5)   Falls are common in aged care facilities but not related to 25-OH-vitamin D 
(Chapter 7). 
.   
The incidence of falls in aged care facilities was 50% over 12 months.  Serum 25-OH-
vitamin D levels were related to the incidence of falls in univariate analysis.  Fallers 
were significantly older, lighter, required more walking aids, more nursing care and 
had lower serum 25-OH-vitamin D levels than non-fallers over 12 months.  The 
median time to first fall was 274 days.  Falling was independently associated with 
increasing age, poorer balance, incontinence and poorer implicit health grade but not 
25-OH-vitamin D or PTH.  When subgroup analyses were performed, falling was 
associated with higher PTH levels in residents under 90 years of age who could walk 
but not in older residents.  
 
It may be that falling in the frail elderly is related to secondary hyperparathyroidism, 
which obscured a possible link with vitamin D deficiency.  It is important that the 
mechanism of PTH action in muscle is more fully described in the setting of muscle 
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strength and balance in the elderly, in order to estimate the role of PTH in falling.  
The problem of falling in this group is however multifactorial, and vitamin D and/or 
PTH are possibly only a small part of the picture.  
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8.3   Future directions  
This thesis has described the characteristics of elderly residents of aged care facilities 
in the northern Sydney area, with respect to risk factors for falls and fractures.  We 
know that they are osteoporotic, which confers an increased risk of low-trauma 
fracture.  We know they have a high incidence of falling, which also predisposes to 
fracture.  The predictive role of serum 25-OH-vitamin D is less clear; this population 
is overwhelmingly deficient in 25-OH-vitamin D but this thesis does not show a 
straightforward relationship between vitamin D and either falling or QUS measures.  
The complex interplay between serum 25-OH-vitamin D and PTH and their 
relationship to objective measures of falls risks needs further investigation. 
 
Analysis of muscle strength and quantitative balance will also be important to 
quantify the contribution of falls to the prospective incidence of fracture.  Ultimately 
it is important that we are able to define discrete risk factors for osteoporotic fracture, 
which might be modified by targeted interventions to reduce the incidence of fracture 
in the frail institutionalized elderly and thereby improve not just morbidity and 
mortality, but quality of life.  A trend is emerging that implicates vitamin D as 
important in both muscle and bone strength – prospective studies need to confirm this 
relationship to allow this relatively cheap and simple intervention to be introduced 
into everyday practice. 
 
The most important issue to be addressed is which, if any, of the demographic and 
physiologic characteristics of this group predict fracture.  The FREE study is 
measuring prospective fracture incidence at all sites, and so the baseline 
characteristics of the population described in this thesis will be examined for any 
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relationship to fracture.  This will further define the role of both vitamin D and PTH 
in falls and fractures. 
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